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Lay summary of thesis 
Influenza virus (IFV), respiratory syncytial virus (RSV), parainfluenza virus 
(PIV), and metapneumovirus (MPV) are the most common viruses 
associated with acute lower respiratory infections. Global seasonality of 
these viruses is needed to inform public health strategies and programmes 
for their control. The viral-pneumococcal association has been recorded over 
the past one century but existing studies report inconsistent findings. This 
thesis aims to understand global seasonality of IFV, RSV, PIV, and MPV; 
aims to assess the effectiveness and efficiency of different approaches of 
RSV immunisation programmes in lower and middle income countries 
(LMICs); and aims to understand the viral-pneumococcal association. 
For the global seasonality of respiratory viruses, this thesis uses viral activity 
data from systematic literature search, online datasets, and research 
datasets shared by collaborators in the RSV Global Estimates Network (RSV 
GEN). The thesis describes the global seasonal patterns of each virus and 
highlights the important differences between seasonality of IFV and RSV. An 
online practical tool was developed to predict IFV and RSV seasonal 
epidemics using temperature and humidity. Furthermore, this thesis shows 
that a seasonal approach for both RSV long-acting monoclonal antibody and 
maternal vaccine is favourable for most LMICs with clear RSV seasonality.  
For viral-pneumococcal association, the thesis first presents a systematic 
review of existing studies on this topic and then presents an ecological study 
using laboratory confirmed data in Scotland, the results of which support an 
association between IFV and RSV, and invasive pneumococcal disease in all 
age groups. 
The global seasonality work in the thesis has important implications for 
health-care planning and immunisation strategies, especially for RSV 
prevention strategies. Unveiling the viral-pneumococcal association can help 
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Abstract 
Introduction 
Influenza virus (IFV), respiratory syncytial virus (RSV), parainfluenza virus 
(PIV), and metapneumovirus (MPV) are the most common viruses 
associated with acute lower respiratory infections in young children and the 
elderly. A global report of seasonality of these viruses is needed to inform 
public health strategies and programmes for their control. The association 
between viral infection and subsequent pneumococcal disease has been 
long recognised but the existing studies report inconsistent findings, possibly 
due to a variety of methodological challenges in these studies. This thesis 
aims to understand global seasonality of IFV, RSV, PIV, and MPV, and to 
understand the role of RSV seasonality on lower and middle income 
countries (LMICs) planning of introduction of RSV prevention strategies. This 
thesis also aims to understand the existing evidence regarding the 
association between viral infection and pneumococcal disease as the first 
step, and as the second step, to assess the association using Scottish health 
data. 
Methods 
Laboratory-confirmed viral activity data were collected from systematic 
literature searches, public datasets, and research datasets shared by 
collaborators in RSV Global Epidemiology Network (RSV GEN). Monthly 
annual average percentage (AAP) was calculated for each site as the relative 
strength of virus activity. Duration of seasonal epidemics were defined as the 
minimum number of months to account for 75% of annual positive samples. 
Based on monthly AAP, IFV and RSV activity was modelled using site-
specific temperature and relative humidity data. A prediction tool was used to 
help estimate local seasonal epidemics of IFV and RSV. Using RSV 
seasonality data in LMICs, the effectiveness and efficiency of different 
candidate approaches of RSV immunisation was compared. A separate 
systematic review was conducted to critically appraise the methodologies 
and findings of existing population studies on the association between viral 
  iv 
infection and subsequent pneumococcal disease. Based on the findings of 
this review, an ecological study was conducted using laboratory-confirmed 
viral and pneumococcal data to assess the association. The attributable 
percentage of invasive pneumococcal disease to IFV, RSV, PIV, and MPV 
was estimated in all ages, <6y, 6–64y, and >64y. 
Results 
IFV had clear seasonal epidemics in winter months in most temperate sites 
but the timing of epidemics was more variable and less seasonal with 
decreasing distance from the equator. Unlike IFV, RSV had clear seasonal 
epidemics in both temperate and tropical regions, starting in late summer 
months in the tropics of each hemisphere, reaching most temperate sites in 
winter months. PIV epidemics were found mostly in spring and early summer 
months in each hemisphere. MPV epidemics occurred in late winter and 
spring in most temperate sites but the timing of epidemics was more diverse 
in the tropics. The prediction model had good predictability of the local 
average epidemic months of IFV and RSV. RSV seasonality was distinct and 
was relatively stable over several years in most LMICs. Compared with a 
year-round approach, seasonal approaches were more supported in LMICs 
with clear seasonality. The systematic review of viral-pneumococcal 
association studies found that failure to account for shared seasonal factors 
between viral and pneumococcal infection was common and that the 
association was likely to differ by virus type, highlighting the needs for viral-
specific analysis. Using laboratory-confirmed viral and pneumococcal data in 
Scotland, IFV and RSV were found to be associated with subsequent 
invasive pneumococcal pneumonia across all age groups. 
Conclusion 
This is the first study to provide global representations of month-by-month 
activity of IFV, RSV, PIV and MPV. The prediction model is helpful in 
predicting the local onset of IFV and RSV epidemics. The seasonality 
information presented in the thesis has important implications for health 
services planning, the timing of RSV passive prophylaxis and the strategy of 
  v 
IFV and future RSV vaccination. A seasonal approach of RSV immunisation 
can be considered for most LMICs with clear RSV seasonality. The viral-
pneumococcal association study finds a consistent support for the 
association between IFV and RSV in all age groups. Future individual-
patient-level studies are warranted to confirm the findings. 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
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Chapter 1 Introduction 
1.1 Common respiratory viruses 
Acute lower respiratory infection (ALRI), which mainly includes pneumonia 
and bronchiolitis, is one of the leading causes of mortality and morbidity in 
young children and older adults worldwide. It is estimated that ALRI caused 
over 2.3 million deaths globally in 2016 (Troeger et al. 2018). Influenza virus 
(IFV), respiratory syncytial virus (RSV), parainfluenza virus (PIV) and 
metapneumovirus (MPV) are the four most common respiratory viruses that 
are related to ALRI (Shi et al. 2015a; Shi et al. 2019) (Table 1-1). Globally, it 
is estimated that in 2016, there were 39.1 million IFV episodes and 24.8 
million RSV episodes, resulting 58.2 thousand deaths and 76.6 thousand 
deaths in all ages, respectively. Currently, there are no global burden 
estimates for ALRI associated with PIV or MPV. 
Table 1-1 The odds ratio (OR) and attributable fraction in the exposed 
(AFE, %) of each respiratory virus in ALRI cases compared with 
asymptomatic controls, from meta-analysis results 
VIRUS CHILDREN UNDER 5  ELDERLY OVER 65 
OR (95%CI) AFE (95%CI)  OR (95%CI) AFE (95%CI) 
IFV 5.1 (3.2–8.1) 80 (69–88)  8.3 (4.4–15.9) 88 (77–94) 
  IFV A 6.0 (3.3–10.8) 83 (70–91)  8.4 (3.9–17.8) 88 (75–94) 
  IFV B 2.7 (0.97–7.5) 63 (–3–87)  NA ~100 
RSV 9.8 (5.0–19.3) 90 (80–95)  8.5 (3.9–18.5) 88 (74–95) 
PIV 3.4 (1.6–7.2) 70 (37–86)  NA ~100 
MPV 3.8 (2.5–5.8) 73 (59–83)  9.8 (2.3–41.0) 90 (57–98) 
ADV 1.1 (0.7–1.8) 12 (–41–44)  NA ~100 
RV 1.4 (1.0–2.0) 30 (3–49)  7.1 (3.7–13.6) 86 (73–93) 
BOV 1.2 (0.4–4.0) 17 (–178–75)  5.6 (1.3–23.7) 82 (25–96) 
COV 1.0 (0.8–1.3) 3 (–25–25)  2.8 (2.0–4.1) 65 (49–76) 
IFV=influenza virus; RSV=respiratory syncytial virus; PIV=parainfluenza 
virus; MPV=metapneumovirus; ADV=adenovirus; RV=rhinovirus; 
BOV=bocavirus; COV=coronavirus; NA=not available 
Global seasonality of respiratory viruses and the association between viral acute 
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1.1.1 Influenza virus 
IFV is a negative-sense, single-stranded RNA virus of the Orthomyxoviruses 
family and has four types—IFV A, IFV B, IFV C and IFV D. Only IFV A, IFV 
B, and IFV C infect human beings. Compared with IFV A and IFV B, IFV C is 
less common in human infections. A recent study tested 3300 human 
respiratory samples from Scotland using polymerase chain reaction (PCR) 
and found 3.2% positive for IFV A, 0.9% for IFV B, 0.2% for IFV C, and none 
for IFV D (D. B. Smith et al. 2016).  
Influenza virus A 
IFV A can be further categorised into subtypes, e.g. IFV A(H1N1) and IFV 
A(H3N2), based on surface glycoproteins, hemagglutinin (HA) and 
neuraminidase (NA). There are 18 different HA subtypes and 11 different NA 
subtypes. Currently, IFV A(H1N1)pdm and IFV A(H3N2) are the two main 
circulating strains. The predominant IFV A subtypes differ each year and 
differ by region. Within IFV A subtypes, there are different strains due to 
IFV’s antigenic change, including antigenic drift and antigenic shift. Antigenic 
drift is more common and is a result of point mutations in the genes encoding 
HA and NA. This may produce seasonal outbreaks of IFV. Antigenic shift is 
rare and is a result of viral assortment of two viruses, creating new virus 
strains. This may trigger an IFV pandemic, as humans are unlikely to have 
immunity to the novel strains. An IFV pandemic may also be triggered when 
an IFV strain that generally infects animals starts to be able to infect humans. 
In the past one hundred years, there were four pandemics that resulted from 
novel IFV strains: the 1918 H1N1 Spanish flu, the 1957 H2N2 Asian flu, the 
1968 Hong Kong flu, and the 2009 swine flu (Table 1-2) (Saunders-Hastings 
and Krewski 2016). 
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Table 1-2 Summary of the four IFV pandemics in the past one hundred 
years 




SPANISH FLU 1918–1920 H1N1 China 40–50 million 
ASIAN FLU 1957–1958 H2N2 China 1–2 million 
HONG KONG FLU 1968–1970 H3N2 China 0.5–2 million 
SWINE FLU 2009–2010 H1N1pdm Mexico up to 0.6 million 
 
Influenza virus B 
Unlike IFV A, IFV B does not have subtypes but can be further broken down 
into lineages and strains. Currently B/Yamagata and B/Victoria are the two 
circulating lineages. According to a recently published systematic review, 
there were very few differences in the clinical presentation of patients 
infected with different influenza subtypes/lineages (Saverio Caini et al. 2018). 
Transmission 
IFV infects and replicates in the epithelial cells of the human respiratory tract. 
The median incubation period, defined as the time between infection and 
symptom onset, is 1.4 days for IFV A and 0.6 days for IFV B (Lessler et al. 
2009). Currently, there are three widely accepted routes of IFV transmission, 
defined as the process where an infectious organism moves from one host to 
another and induces disease: droplets, aerosols and contact (Panel 1-1), but 
it remains unclear regarding the relative significance of these routes 
(Killingley and Nguyen‐Van‐Tam 2013). 
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Panel 1-1 Routes of IFV infection transmission 
Droplets: Droplets refer to particles generally >10 µm. These particles can 
adhere on mucous surfaces in the upper respiratory tract (e.g. mouth and 
nose). They can be inhaled but are too large to reach the lower respiratory 
tract. 
Aerosols: Aerosols are smaller particles (<5 µm). These particles can be 
inhaled and reach the lower respiratory tract, in addition to the upper 
respiratory tract. 
Contact: Contact includes direct contact and indirect contact. The former 
refers to the virus being physically transferred between two persons and the 
latter refers to an indirect transfer via contaminated surface or objects. 
Influenza Vaccine 
Vaccination is the most effective way for the prevention and control of 
IFV. Due to the antigenic drift and shift of IFV, circulating strains vary from 
year to year. Therefore, the vaccine needs to be administrated annually to be 
matched with the circulating strains of the year (World Health Organization 
2018b). Interestingly, cross-lineage protection and residual effects from prior 
vaccination were observed (McLean et al. 2015) and the underlying 
mechanism warranted further investigation.  
Currently, WHO recommends annual vaccination for: 
 pregnant women at any stage of pregnancy 
 children aged between 6 months to 5 years 
 elderly individuals (aged more than 65 years) 
 individuals with chronic medical conditions (e.g. diabetes) 
 health-care workers 
In order to better monitor global IFV activity, The Global Influenza 
Surveillance and Response System (GISRS) has been set up since 1950s. 
WHO recommends seasonal influenza vaccine compositions twice a year for 
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the northern hemisphere and southern hemisphere, in order to match with 
the prevalent IFV strains in each season.  
1.1.2 Respiratory syncytial virus 
Human RSV is a negative-sense, single-stranded RNA virus of the species 
Human orthopneumovirus of the family Pneumovirinae (formerly a subfamily 
within Paramyxoviridae family until 2016 (Afonso et al. 2016)). The RSV 
genome is approximately 15000 nucleotides in length, which encode 11 viral 
proteins including non-structural protein 1 (NS1) and NS2, nucleocapsid 
protein (N), phosphoprotein (P), matrix protein (M), small hydrophobic protein 
(SH), attachment glycoprotein (G), fusion glycoprotein (F), transcription 
regulatory proteins (M2-1 and M2-2), and a large polymerase (L) (Lee et al. 
2012; Schobel et al. 2016). It has two antigenic groups, group A and B, 
based on antigenic and genomic differences found in several viral proteins, 
but especially the G protein.  
RSV was first discovered more than sixty years ago in chimpanzees and then 
the next year in two children with respiratory illness (Chanock et al. 1957). 
Transmission 
RSV replicates in the nasopharyngeal epithelium. The median incubation 
period of RSV is 4.4 days (Lessler et al. 2009). RSV transmission is by direct 
inoculation of contagious secretions or by droplets (>10 µm) into the eyes 
and nose (Hall and Douglas 1981). 
RSV Vaccine 
Currently, there is no licensed RSV vaccine although there are more than 20 
candidate vaccines undergoing clinical trials. The only licensed RSV 
prevention product is Palivizumab, a monoclonal antibody (mAb) providing 
passive immunisation. Palivizumab is short-acting and needs to be given on 
a monthly basis for 5 months starting from the onset of RSV season. 
Palivizumab is expensive. For a baby at 6 months weighing 7.5 kg, the cost 
of one dose of palivizumab is over £1000 (D. Wang et al. 2011). Therefore, 
Palivizumab is almost exclusively used in high-income countries. It is 
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expected that long-lasting mAb will be less expensive and might only need 
one dose at the onset of RSV season (Domachowske et al. 2018). In addition 
to mAb, maternal vaccination could be another option for a future prevention 
strategy. Figure 1-1 below shows a snap shot of RSV vaccines and mAbs, 
which is regularly updated by PATH. More detailed information about RSV 
vaccine progress can be found in a recently published review (Mazur et al. 
2018). Most recently, the topline results from the phase 3 clinical trial of 
maternal RSV vaccine (ResVax) were announced. Although the vaccine did 
not meet its primary efficacy endpoint (39.4%, 97.5%CI, -1.0% to 63.7%), the 
vaccine demonstrated efficacy in preventing RSV-hospitalization (44.4%, 
95%CI, 19.6% to 61.5%) (Anonymous 2019b).
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Figure 1-1 RSV vaccine and mAb snapshot (Updated on 10th December 2018) 
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1.1.3 Parainfluenza virus 
PIV is a negative-sense, single-stranded RNA virus of the subfamily 
Paramyxovirinae in Paramyxoviridae family and has four subtypes, PIV 1–4. 
PIV 1–3 were more frequently reported whereas PIV 4, which could be 
further categorised into PIV 4A and PIV 4B, was less frequently reported, 
partly due to the difficulties in identifying the virus from cell culture (Lau et al. 
2005). 
Transmission 
PIV infects epithelial cells. The median incubation period of PIV is 2.6 days 
(Lessler et al. 2009). Like RSV, PIV transmission is by direct or indirect (i.e. 
through contamination) contact (Henrickson 2003). 
Vaccine 
Currently, there is no licensed PIV vaccine. Several PIV vaccine candidates 
are currently under clinical trials (Schmidt et al. 2011).  
1.1.4 Metapneumovirus 
Human metapneumovirus (hMPV/MPV) is a negative-sense, single-stranded 
RNA virus of the family Pneumovirinae, same family as RSV and has two 
lineages, MPV A and B. MPV was first detected in respiratory specimens 
from children with respiratory tract infections in 2001 (B. G. van den Hoogen 
et al. 2001).  
Transmission 
MPV infects epithelial cells. The incubation period of MPV is around 5 days 
(Lessler et al. 2009). The mode of transmission of MPV is likely to be by 
direct or indirect contact. 
Vaccine 
Similar to PIV, there is no licensed MPV vaccine. Overall, a variety of 
vaccination strategies have been raised and tested in animals but none has 
yet been tested in humans (Ren et al. 2015). 
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1.2 Seasonality of respiratory viruses 
1.2.1 Global seasonality 
IFV and RSV 
There are several reports describing the global seasonality of IFV and RSV. 
A summary of these studies attached below in Table 1-3. Both IFV and RSV 
have seasonal epidemics in winter months in the temperate region. In the 
tropics, IFV tends to have biannual activity or year-round activity; little is 
known about RSV seasonality but was presumed to be similar to IFV based 
on limited data (Bloom-Feshbach et al. 2013). Within IFV, IFV A and IFV B 
have similar seasonality but the peak of IFV A is around 4 weeks earlier than 
that of IFV B in the temperate region. IFV season coincides with lower 
temperature in the temperate region and with rainy seasons in the sub-
tropical or tropical settings (J. D. Tamerius et al. 2013). 
While different studies on IFV tended to have similar findings, the two main 
studies on global RSV seasonality had contradictory conclusions. The first 
study by Bloom-Feshbach et al (Bloom-Feshbach et al. 2013) concluded that 
RSV had weak latitudinal gradients in the timing of epidemics by hemisphere, 
with peaks occurring later with increasing latitude whereas the second study 
by Obando-Pacheco et al (Obando-Pacheco et al. 2018) concluded that RSV 
usually travelled from the south to the north. The inconsistency could be due 
to the lack of global representativeness of RSV data and also the limited 
number of data points in both studies. 
Additionally, the WHO published a “influenza transmission zones” document 
during the 2009 swine flu pandemic, which showed the geographical groups 
of countries, areas or territories with similar influenza transmission patterns 
(World Health Organization 2011). However, this document did not give 
further details regarding the methodology. 
PIV and MPV 
No report was found describing the global seasonality of PIV or MPV. In the 
US, PIV 1 and PIV 2 were most frequently detected in the fall and winter 
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while PIV 3 was mostly detected in the spring. PIV 1 and PIV 2 had biennial 
patterns with increased activity in odd-numbered years (PIV 1)/even-
numbered years (PIV 2) (Steffens et al. 2016). Similar patterns were reported 
in the UK (Zhao et al. 2017). Recently, PIV 4 was more frequently tested than 
the past and its seasonality was found similar to PIV 3 (Maykowski et al. 
2018; Zhao et al. 2017). 
Compared with PIV, seasonality of MPV was less frequently reported as this 
virus was not identified until 2001. In the US, MPV had distinct seasons with 
onsets ranging from November to February and offsets from April to July; 
RSV, IFV and MPV occurred sequentially and the seasonal patterns of MPV 
were similar to RSV (Haynes et al. 2016).  
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Table 1-3 Summary of studies reporting global seasonality of respiratory viruses 












By study site; 
IFV: 77 sites 
from 40 
countries 













IFV and RSV peaked during winter in temperate 
regions, while there was greater diversity in the tropics. 
Several temperate locations experienced semi-annual 
IFV activity with peaks occurring in winter and summer.  
Two annual peaks common in tropical areas of 
Southeast Asia for both viruses.  
Biennial RSV cycles in Northern Europe. 
Both viruses exhibited weak latitudinal gradients in the 
timing of epidemics by hemisphere, with peak 
occurring later with increasing latitude. 












degree of seasonality 
measured by the 
difference between 
highest and lowest 
proportion 
Degree of seasonality positively correlated with 
absolute latitudes 
Latitude negatively correlated with the proportion of 
IFV occurring during May through October 
In the tropics, concordance in seasonality within 
regions and between adjacent countries was limited 
In temperate countries, IFV B peaked 4 weeks after 
IFV A 
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(epidemics) by month, 
number of peaks/year-
round activity 
Average IFV duration: 4.7 months 
Of 118 countries, 85% with one peak season, 13% 
with two, 4% with year-round activity 
 
Deyle et al. 
2016 (Deyle 
et al. 2016) 
By country; 
67 countries 
FluNet Lab-confirmed Degree of seasonality 
measured by the 
correlation between 
IFV and absolute 
humidity 
IFV seasonality could be explained by absolute 
humidity and to a lesser extent, by temperate in both 
temperate and tropic regions. 
Caini et al. 
2016 
(Saverio 














Peak week, duration, 
monthly activity by 
annual percentage 
In tropical countries, IFV lasted longer and the peaks 
of IFV A and B coincided less frequently than in 
temperate countries. 
Temporal characteristics of IFV heterogeneous in the 
tropics. 
Seasons with co-circulation of IFV A and B longer than 
IFV A seasons, especially in the tropics. 
Alonso, et al. 
2015 (Alonso 
et al. 2015) 
By country; 
125 countries 
FluNet  Lab-confirmed, 
≥20 IFV, 
Brazil, India and 
China excluded. 
Peak month,  
heat map of monthly 
virus activity 
IFV peaks in temperate countries well aligned with the 
winter season.  
IFV peaks in tropical countries had little regard for 
hemispheric position. 
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He et al. 




FluNet Lab-confirmed Weekly activity IFV A(H1N1)pdm outbreak did not occur in many 
countries in 2011/12, although occurred the following 
year (“skip-and-resurgence” pattern). 
Tamerius et 
al. 2013 (J. 
D. Tamerius 
et al. 2013) 








≥24 IFV or 
RSV/year. 
Peak month Two types of environmental conditions related to IFV 
peak: “cold-dry” and “humid-rainy”. 
Azziz 
Baumgartner 
et al. 2012 
(Azziz 
Baumgartner 







data ≤6 months 
excluded. 
Peak month, duration, 
n of epidemics, start 
and end 
>1 IFV epidemic period per year more common in 
tropical countries than in temperate countries. 
Year-round activity occurred mostly in subtropical and 
tropical countries. 
High IFV activity was associated with low temperature. 
RSV: two studies 
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Start, peak, end and 
duration 
RSV started in most countries in the southern 
hemisphere from March to June and in countries in  
the northern hemisphere from September to 
December. 
Decrease in RSV observed from August to October in 
the southern hemisphere and from February to May in 
the northern hemisphere. 
5–6 months of duration in most countries. 
Seasonality fairly consistent within most regions from 




et al. 2003) 
By study site; 
n of sites not 
known 
Literature None Month of the onset RSV seasons depended on geographic location and 
altitude and tended to occur in clusters. 
Although RSV seasons varied by continent, they 
usually began in coastal areas. 
* FluNet is a global web-based tool for influenza virological surveillance first launched in 1997.  
IFV=influenza virus; RSV=respiratory syncytial virus; WHO=World Health Organization; PAHO=Pan American Health 
Organization; NIC=national influenza center; n=number; ECDC=European Centre for Disease Prevention and Control. 
 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Introduction  15 
1.2.2 Drivers of seasonality 
It has long been recognised that seasonality of respiratory viruses (e.g. IFV) 
is associated with seasonal meteorological stimuli such as temperature and 
humidity but the underlying mechanism is not well known. It is widely 
believed that there are three mechanisms that help explain the seasonality of 
respiratory viruses: human contact rates, virus survival rates, and human 
immunity levels. 
Human contact rates 
Human contact is an important stimulus of the spread of infectious diseases. 
Transmission is greater among school age children and among adults aged 
20–40, and greater between children and their parents (Del Valle et al. 2013). 
It is noted in Chapter 1.1 that all of the four viruses, IFV, RSV, PIV, and MPV 
can be transmitted by direct/indirect contact. Therefore, seasonal fluctuation 
in human contact rates could drive viral seasonality. School closure/holiday is 
one of the seasonal stimuli that modifies human contact rates (Eames et al. 
2011). Several studies from various regions showed that school closure 
reduced the transmission of IFV (Cauchemez et al. 2008; Cowling et al. 
2008; Jackson et al. 2013). The incidence rate increased when the school 
was reopened, supporting a potential casual role for school closure in the 
reduction in incidence of IFV (Jackson et al. 2013). It was reported in the US 
that winter holidays delayed IFV seasonal epidemic peaks and shifted 
disease risk toward adults because of changes in contact patterns (Ewing et 
al. 2017). A recent study in Belgium had a similar finding for winter holidays 
and even weekends; the authors also reported that changes in travel 
behaviour did not alter the IFV epidemics (Luca et al. 2018). Human mobility, 
e.g. travelling or commuting, is another seasonal stimulus. Several studies in 
the US showed that IFV transmission was dominated by local work 
commutes rather than air traffic (Bozick and Real 2015; Charu et al. 2017). 
However, neither school closure/holiday nor human mobility is specific 
enough to explain the timing of viral seasonality. For example, this does not 
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explain why IFV does not peak in the early autumn when the students are 
back to school from holidays. 
Apart from holidays/work, human contact patterns are also affected by 
meteorological factors (Horanont et al. 2013). For example, people tend to 
stay indoors in cold days (Graham and McCurdy 2004), potentially increasing 
transmission. However, a research study conducted in Belgium found 
general dominance of day-type (weekend, holiday, working day) over 
weather conditions in terms of contact duration, but nonetheless observed an 
increased duration on regular workdays with low temperatures, no 
precipitation and low humidity (Willem et al. 2012). 
Virus survival rates 
In order to survive the transport between humans, virus needs to endure 
certain environmental conditions. In general, virus survives longer on hard 
and nonporous surfaces (e.g. stainless steel) (Bean et al. 1982). Since some 
of the environmental conditions change in seasonal patterns (e.g. 
temperature and humidity), it is possible that viral seasonality is driven by its 
ability to survive. Unlike human contact rates, which uniformly affect all 
viruses, virus survival rates are specific to virus type and have the potential to 
explain the differences of seasonality among viruses.  
In general, IFV, RSV, PIV, and MPV have similar changes in stability in 
response to changing environmental conditions. The survival of IFV was 
most studies among the four viruses. Unlike the other three viruses, IFV can 
also be transmitted through aerosol. Studies have shown that IFV survival 
increases both on surfaces or in aerosols when absolute humidity decreases; 
relative humidity decreases; or temperature increases (McDevitt et al. 2010; 
Myatt et al. 2010; Noti et al. 2013; Shaman and Kohn 2009). Absolute 
humidity was reported to be a better predictor of IFV survival compared to 
relative humidity and temperature (McDevitt et al. 2010; Shaman and Kohn 
2009). In contrast, when in droplets, high humidity can increase the survival 
of IFV, which complicates the interaction between humidity and IFV survival 
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(Paynter 2014). Similar findings were reported for RSV. At room temperature, 
RSV survival rate in droplets was higher at the higher humidity levels over 
the first 5 hours; but over the next 67 hours, survival was higher at the lower 
humidity levels (Paynter 2014). Higher temperature was found to be 
associated with lower survival rate on surfaces for PIV and MPV (Henrickson 
2003; Tollefson et al. 2010). In addition to temperature and humidity, higher 
ultraviolet levels were also found to decrease viral survival rates on surfaces 
(Vasickova et al. 2010). However, the relative contribution of these seasonal 
stimuli on viral seasonality is still unknown. 
Human immunity levels 
Human immunity levels can vary throughout a year and could be a non-
specific contributor to viral seasonality. A recently published study measured 
the expression of immune-system-related genes and proteins found that 
seasonal rhythm existed in human immune system in both hemispheres 
(Dopico et al. 2015). Various predictors have been proposed to be 
associated with human immunity, including temperature, humidity, 
photoperiod (solar radiation), malnutrition, and so on (J. Tamerius et al. 
2011). Seasonal malnutrition is one of the most important contributors to the 
seasonal fluctuation of human immunity levels. The change in food 
availability is reported to be the most important factor influencing the 
seasonality of malnutrition. In rural Ethiopia, acute child under-nutrition was 
relatively higher in the dry season than the wet season (Egata et al. 2013). In 
rural Bangladesh, the periods of greatest nutritional deficit began with the 
monsoon rains (Brown et al. 1982). 
1.2.3 Modelling of global seasonality 
IFV 
The three modelling studies on global seasonality of IFV are summarised in 
Table 1-4. Although using different methods, these three studies all 
supported the role of temperature in shaping IFV seasonality in the 
temperate regions. The studies by Deyle et al and Tamerius et al reinforced 
the role of absolute humidity in influencing seasonality. At higher 
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temperatures, higher humidity was associated with higher IFV activity while 
at lower temperatures; lower humidity was associated with higher IFV 
activity. This corresponds to the so-called “cold-dry” IFV season in most 
temperate regions and “humid-rainy” IFV season in the subtropics and 
tropics. 
RSV 
To my knowledge, there are no modelling studies on global seasonality of 
RSV. Nevertheless, there is one systematic review published in 2014 
summarising country-level or city-level modelling studies on seasonality of 
RSV (Tang and Loh 2014). This reported that RSV activity was consistently 
positively correlated with lower temperature and higher relative humidity in 
the subtropical and temperate regions. In the tropics, the correlation between 
RSV activity and meteorological factors was not consistent. 
PIV and MPV 
Little is known about the seasonal predictors of PIV or MPV.  
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
Introduction  19 
Table 1-4 Summary of modelling studies on global seasonality of IFV 




Modelling Methods Main Findings 
Deyle et al. 
2016 (Deyle 
et al. 2016) 
By country; 
67 countries 





IFV seasonality could be explained by AH and to a 
lesser extent, by T in both temperate and tropic 
regions. 
A U-shaped relationship between AH and IFV was 
found, which was mediated by T (of 75˚F): when 
T<75˚F, AH had negative effects on IFV; when T>75˚F, 
AH had positive effects on IFV. 
Tamerius et 
al. 2013 (J. 
D. Tamerius 
et al. 2013) 





T, RH, rainfall Logistic regression: 
univariate and 
multivariate 
Two types of environmental conditions related to IFV 
peak: “cold-dry” and “humid-rainy”. 
Azziz 
Baumgartner 
et al. 2012 
(Azziz 
Baumgartner 











High IFV activity was only associated with low T, 
adjusted for AH, rainfall and duration of sunlight. 
AH=absolute humidity; RH=relative humidity; T=temperature
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1.3 Interaction between viral respiratory infection and 
pneumococcal disease 
1.3.1 Pneumococcal disease 
Pneumococcal disease refers to disease caused by the bacterium 
Streptococcus pneumoniae (S. pneumoniae), also known as pneumococcus. 
Pneumococcus was first discovered in 1881 from human saliva (D. A. 
Watson et al. 1993). Pneumococcus can infect multiple parts of human body 
and cause many types of diseases, some of which are life-threatening. 
Pneumococcal disease can be invasive, i.e. the infected site is normally 
sterile (e.g. blood, cerebrospinal fluid, and pleural), and non-invasive. 
Common invasive pneumococcal disease includes septicaemia (sepsis), 
meningitis and bacteraemic pneumonia. Common non-invasive 
pneumococcal disease includes non-bacteraemic pneumonia, otitis media, 
sinusitis and bronchitis.  
Pneumococcal disease occurs more frequently in younger children and older 
adults (Ludwig et al. 2012). In young children, pneumococcal pneumonia and 
pneumococcal meningitis are the two major causes of deaths from 
pneumococcal diseases. It is estimated that there were 257000 
pneumococcal pneumonia deaths and 37900 pneumococcal meningitis 
deaths among young children under the age of five globally in 2015 (Wahl et 
al. 2018).  
Pneumococcal disease is vaccine-preventable. There are two types of 
pneumococcal vaccines: pneumococcal conjugate vaccines (PCV) and 
pneumococcal polysaccharide vaccines (PPV). There are three PCVs 
available, PCV-7, PCV-10, and PCV-13 and one PPV, PPV-23. The number 
after PCV/PPV indicates the number of different pneumococcal serotypes 
that the vaccines can cover. PCV can be given to children under the age of 2 
years whereas PPV cannot due to low effectiveness. WHO recommends the 
inclusion of PCVs in childhood immunization programmes worldwide. US 
CDC also recommends PPV for all adults 65 years or older, people 2 through 
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64 years of age with certain medical conditions, and adults 19 through 64 
years old who smoke cigarettes. 
1.3.2 Vaccine as a probe to understand the interaction 
between viral respiratory infection and pneumococcal 
disease 
The impact of PCV on influenza-associated hospitalisation was first 
described in a randomised trial of PCV-9, which achieved 45% (95% CI: 14–
64) reduction in IFV-associated hospitalisation and 31% (95% CI: 15–43) 
reduction in any-virus-associated hospitalisation in South Africa (Madhi et al. 
2004). Similar results were reported in the US in the PCV-7 trial, with a 
reduction of 39–50% in IFV hospitalisation in <2y (Simonsen et al. 2011).  
1.3.3 Viral-pneumococcal interaction during IFV pandemics 
As shown earlier in Table 1-2, the Spanish flu pandemic in 1918 caused 40–
50 million deaths. It was believed that it was not flu alone that caused the 
majority of deaths during the pandemic. According to a historical review 
(Brundage 2006), in the US, there was a large flu outbreak at Camp Funston. 
Five days after the flu outbreak, a wave of pneumonia cases occurred. 
Among 1100 soldiers hospitalised for flu, 22% of them developed 
pneumonia, 20% of whom died. Similar findings were reported in other 
camps and the overall case fatality ratio was estimated to be 4.9%. Bacterial 
culture results in autopsy series from victims of the pandemic showed that at 
least 70% of the samples had positive bacterial culture results and that more 
than 20% of the samples had pneumococcus positive results (Fauci et al. 
2008). 
The 1957 Asian flu and 1968 Hong Kong flu pandemics were reported to be 
less severe, causing up to 2 million deaths each (Table 1-2). Most deaths 
were attributed to bacterial infection, with Staphylococcus aureus being 
predominant — different from in the Spanish flu pandemic (Fauci et al. 2008). 
In the recent 2009 swine flu pandemic, results from large-scale population-
based studies consistently demonstrated that higher incidence of invasive 
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pneumococcal disease was associated with the flu pandemic and that the 
cases with secondary pneumococcal infection were younger than similar 
cases in the inter-pandemic period (Table 1-5). At least 17% of the cases 
were associated with laboratory-confirmed IFV (Nelson et al. 2012). 
Table 1-5 Summary of studies reporting pneumococcal diseases during 
the 2009 swine flu 
Study Setting Main findings 





The incidence of IPD during the 7-week study 
period in 2009 (28.9/million) was statistically 
higher than that observed in 2008 
(19.6/million) and 2010 (14.6/million). 
IPD cases were younger and healthier during 
the 7-week study period in 2009 than 2008 
and 2010. 
Launes et al 




The incidence of IPD during 2009–2010 
season was approximately same as the total 
incidence of two flu seasons before 2009 or 
after 2010. 
IPD cases were younger in 2009–2010 than 
the other four non-pandemic flu seasons 
Fleming-Dutra et 
al (Fleming-Dutra 
et al. 2013) 
9 surveillance 
sites in US 
The pandemic likely resulted in an out-of-
season IPP peak among persons ≥5 
years. (IPP rate per 10 million: 48 vs 9 in 5–
124y, 74 vs 53 in 25–49y, 188 vs 114 in 50–
64y, and 229 vs 187 in 65y–) 
 
Weinberger et al 
(Weinberger et al. 
2012) 
US There was a significant increase in 
pneumococcal hospitalizations during the 
pandemic. 
Individuals aged 5–19y had the largest 
relative increase in pneumococcal 
hospitalizations (ratio=1.6, 95% CI: 1.4–1.7).  
In contrast, there was no excess disease in 
the elderly. 
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Study Setting Main findings 
Nelson et al 




During October 2009, there were 58 IPD 
cases, three times than the usual number in 
October (2004–2008). 
IPD cases in October 2009 were younger 
and more likely to have chronic lung disease 
than IPD cases in February 2009. 
>17% of IPD cases during the pandemic 
were associated with IFV A(H1N1)pdm. 
IPD=invasive pneumococcal disease; IPP=invasive pneumococcal 
pneumonia 
1.3.4 Current understanding of the interaction between viral 
respiratory infection and pneumococcal diseases 
During interpandemic period, the association between seasonal IFV and 
pneumococcal disease as well as the association between other seasonal 
viral infections and pneumococcal disease remain to be studied in detail. 
Murdoch et al. found that IFV and PIV were associated with invasive 
pneumococcal disease; RSV was associated with invasive pneumococcal 
disease only in children under five years old (Murdoch and Jennings 2009). 
In the UK, it is estimated that 6–7.5% and 3–4% of invasive pneumococcal 
disease cases were attributable to IFV and RSV, respectively (Nicoli et al. 
2013). However, a study in Germany found no association between IFV A 
peak and invasive pneumococcal disease peak (Toschke et al. 2008). A 
systematic literature review is warranted in order to better understand the 
existing evidence regarding the association between seasonal respiratory 
viral infection and pneumococcal disease.  
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1.4 Aims of the thesis 
The aims of the thesis are listed below in each sub-section. Specific 
objectives are provided within each aim/sub-section. Briefly, the thesis has 
two parts. The first part focuses on the global seasonality of respiratory 
viruses and the second part focuses on the viral-pneumococcal associations. 
1.4.1 To understand global seasonality of respiratory viruses 
(Chapter 2) 
 To describe the global seasonal patterns of IFV (including all 
subtypes), RSV, PIV, and MPV. 
 To understand the association between meteorological factors (e.g. 
temperature and humidity) and viral seasonality. 
 To predict viral seasonality based on a selected set of meteorological 
factors and to valid the model. 
1.4.2 To understand the role of RSV seasonality on RSV 
prevention strategy planning in lower and middle 
income countries (Chapter 3) 
 To describe the RSV seasonality in lower and middle income countries 
(LMICs) based on the findings of Chapter 2, including the year-to-year 
variations where data are available. 
 To compare the impact of a seasonal administration strategy and a 
year-round administration strategy for both maternal immunisation and 
long-acting mAbs in LMICs. 
1.4.3 To understand existing evidence in the association 
between viral respiratory infection and subsequent 
pneumococcal disease (Chapter 4) 
 To summarise findings from existing population-based studies. 
 To critically review the methods used in existing studies. 
 To summarise gaps in knowledge and inform future studies. 
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1.4.4 To investigate the association between viral respiratory 
infection and subsequent invasive pneumococcal 
disease (Chapter 5) 
 To assess the association using laboratory-confirmed viral data and 
IPD data, both in all ages and by age group. 
 To estimate the percentage of IPD that can be attributable to each 
virus, both in all ages and by age group.
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Chapter 2 Global patterns in monthly activity 
of influenza virus, respiratory 
syncytial virus, parainfluenza virus 
and metapneumovirus: a systematic 
analysis 
2.1 Introduction 
Influenza virus (IFV), respiratory syncytial virus (RSV), parainfluenza virus 
(PIV), and metapneumovirus (MPV) are the four major viral pathogens 
associated with acute respiratory infection (ARI) and these represent a 
significant burden of disease particularly in young children (Shi et al. 2015b) 
and the elderly (Falsey et al. 2005; Shi et al. 2019). Understanding the 
seasonal patterns of these viruses is important for health-care services 
planning. This is particularly relevant to the immunisation strategies of IFV 
and RSV in the near future that rely on local seasonality information. 
However, seasonal patterns of IFV and RSV are still poorly understood in 
tropical and sub-tropical regions; no global reports described seasonal 
patterns of PIV and MPV. 
Therefore, a systematic analysis of global seasonality of IFV, RSV, PIV, and 
MPV was conducted using data from systematic literature search, online 
public data, and unpublished data shared by a group of researchers. This 
work has been published in Lancet Global Health. (Li Y, Reeves RM, Wang 
X, et al. Global patterns in monthly activity of influenza virus, respiratory 
syncytial virus, parainfluenza virus, and metapneumovirus: a systematic 
analysis. Lancet Glob Health. 2019;7(8):e1031-e1045) 
In this publication, I led the systematic literature review with contributions 
from Rachel Reeves (RR) and Xin Wang (XW). I cleaned, analysed, and 
visualised the data. Harish Nair (HN), Harry Campbell (HC) and I led the data 
interpretation. I wrote the first draft with inputs from RR, XW, HN and HC. HN 
and HC conceptualised the study. All other named authors of this publication, 
Quique Bassat, W. Abdullah Brooks, Cheryl Cohen, David P. Moore, Marta 
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Nunes, and Barbara Rath, contributed to collection of unpublished research 
data and interpretation, and critically reviewed the initial manuscript. All group 
authors from RSV Global Epidemiology Network (RSV GEN) contributed to 
data collection, and reviewed the manuscript for intellectual content. All 
authors above read and approved the final draft. 
The full-text of the publication (journal-accepted version) has been attached 
below. Some contents have been reordered to comply with the format of this 
thesis.  
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2.2 “Global patterns in monthly activity of influenza 
virus, respiratory syncytial virus, parainfluenza 
virus, and metapneumovirus: a systematic 
analysis” [version accepted for publication by 
Lancet Global Health] 
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Abstract 
Background: Influenza virus (IFV), respiratory syncytial virus (RSV), 
parainfluenza virus (PIV), and metapneumovirus (MPV) are the most 
common viruses associated with acute lower respiratory infections in young 
children and the elderly. A global report of the monthly activity of these 
viruses is needed to inform public health strategies and programmes for their 
control. 
Methods: We compiled data from systematic literature review, online 
datasets and unpublished research data reporting seasonality of IFV, RSV, 
PIV, and MPV. We calculated monthly annual average percentage (AAP) as 
the relative strength of virus activity. We defined duration of epidemics as the 
minimum number of months to account for 75% of annual positive samples, 
with each component month defined as an epidemic month. Furthermore, we 
modelled monthly AAP of IFV and RSV using site-specific temperature and 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, 
parainfluenza virus and metapneumovirus 30 
relative humidity for the prediction of local average epidemic months. We 
also predicted global epidemic months of IFV and RSV on a 5° by 5° grid. 
Results: We included 246 sites for IFV, 183 sites for RSV, 83 sites for PIV 
and 65 sites for MPV. IFV had clear seasonal epidemics in winter months in 
most temperate sites but timing of epidemics was more variable and less 
seasonal with decreasing distance from the equator. Unlike IFV, RSV had 
clear seasonal epidemics in both temperate and tropical regions, starting in 
late summer months in the tropics of each hemisphere, reaching most 
temperate sites in winter months. In most temperate sites, IFV epidemics 
occurred later than RSV (by 0.3 months, 95% CI: –0.3–0.9) while no clear 
temporal order was observed in the tropics. PIV epidemics were found mostly 
in spring and early summer months in each hemisphere. MPV epidemics 
occurred in late winter and spring in most temperate sites but the timing of 
epidemics was more diverse in the tropics.  IFV epidemics had shorter 
duration (3.8 months, 95% CI: 3.6–4.0) in temperate sites and longer 
duration (5.2 months, 4.9–5.5) in the tropics. Duration of epidemics was 
relatively comparable across all sites for RSV (4.6 months, 4.3–4.8) and MPV 
(4.8 months, 4.4–5.1). By comparison, PIV had longer duration of epidemics 
(6.3 months, 6.0–6.7). Our model had good predictability in the average 
epidemic months of IFV in temperate regions, and RSV in both temperate 
and tropical regions. Through leave-one-out cross validation, the overall 
prediction error in the onset of epidemics was within one month (IFV: −0.2 
months, 95% CI −0.6–0.1; RSV: 0.1 months, −0.2–0.4).  
Interpretation: This is the first study that provides global representations of 
month-by-month activity of IFV, RSV, PIV and MPV. Our model is helpful in 
predicting the local onset month of IFV and RSV epidemics. The seasonality 
information presented in our study has important implications for health 
services planning, the timing of RSV passive prophylaxis and the strategy of 
IFV and future RSV vaccination. 
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2.2.1 Introduction 
Influenza virus (IFV), respiratory syncytial virus (RSV), parainfluenza virus 
(PIV), and metapneumovirus (MPV) are the four major viral pathogens 
associated with acute lower respiratory infection (ALRI) and these represent 
a significant burden of disease particularly in young children (Shi et al. 
2015b) and the elderly (Falsey et al. 2005; Shi et al. 2019). Globally, IFV is 
estimated to be associated with 39.1 million ALRI episodes (30.5–48.4) and 
58 200 ALRI deaths (44 000–74 200) annually; RSV is estimated to be 
associated with 24.8 million ALRI episodes (19.7–31.4) and 76 600 ALRI 
deaths (55 100–103 500) annually (Troeger et al. 2018). To date, no global 
burden estimate has been reported for PIV and MPV. 
Seasonality information of IFV, RSV, PIV, and MPV is important in health-
care services planning and the development of appropriate disease 
prevention and control strategies, including immunisation strategies. The 
demand for a global overview of the seasonal patterns of IFV, RSV, PIV, and 
MPV has been growing steadily as this helps understand the seasonality in 
those under-reported countries or regions where the burden of viral 
respiratory infections is substantial while health-care resources are 
insufficient. For example, the seasonality of one country could be possibly 
estimated given the information of countries in geographic proximity or any 
other global patterns. As a result, several reports (Alonso et al. 2015; Azziz 
Baumgartner et al. 2012; Bloom-Feshbach et al. 2013; Saverio Caini et al. 
2016; Deyle et al. 2016; He et al. 2015; Muscatello 2018; Newman et al. 
2018; Obando-Pacheco et al. 2018; Stensballe et al. 2003; J. D. Tamerius et 
al. 2013) have described the global seasonality of IFV and/or RSV (Table 
1-3). It is noted in these studies that both IFV and RSV circulation peaks 
were well aligned with winter months in temperate regions, while greater 
diversity in timing was observed in the tropics; and both viruses exhibited 
weak latitudinal gradients in the annual timing of epidemics by hemisphere, 
with peaks occurring later with increasing latitude. However, seasonal 
patterns of IFV and RSV are still poorly understood in tropical and sub-
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tropical regions where seasonal patterns could not be well described simply 
by indicators such as peak timing and/or beginning and end of epidemics as 
done in temperate regions. Only three recent studies (Alonso et al. 2015; 
Saverio Caini et al. 2016; Newman et al. 2018) reported monthly country-
level activity of IFV; nevertheless, these reports were unable to characterise 
any within-country variations that could help understand the latitudinal 
gradient of viral activity. In addition to the seasonal patterns reported, some 
studies (Azziz Baumgartner et al. 2012; Deyle et al. 2016; J. D. Tamerius et 
al. 2013) reported pronounced correlations between meteorological factors 
such as temperature and humidity, and IFV epidemics, suggesting the 
possibility in prediction of viral epidemics on a global scale. However, issues 
related to data availability impeded these studies from further looking into the 
prediction of viral epidemics.  
In order to address the data gaps in global seasonality of IFV, RSV, PIV, and 
MPV, we compiled data from systematic literature review, online datasets 
and unpublished research data at both country level and sub-country level, 
and conducted a systematic analysis of global monthly activity of IFV, RSV, 
PIV, and MPV. Furthermore, with the compiled dataset, we aimed to model 




We collected viral activity data for IFV, RSV, PIV, and MPV from a range of 
sources including systematic literature search, online public datasets, and the 
research datasets shared by the collaborators from RSV Global 
Epidemiology Network (RSV GEN)(Shi et al. 2017). 
Systematic literature search 
We searched three bibliographic databases, Medline, Embase, and Global 
Health, for articles reporting activity of IFV, RSV, PIV, or MPV using a 
tailored search strategy. The literature search used the following terms (with 
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synonyms and closely related words): "Influenza virus”, “respiratory syncytial 
virus”, “parainfluenza virus”, “human metapneumovirus”, “acute lower 
respiratory infection” combined with "seasonality" , “surveillance”, 
“periodicity”, and "temporal variation"  (Appendix A2). In the present study, 
records related to all-cause ALRI without including any of the four viruses 
above were not included. We limited the literature search to the period of 1st 
Jan 2001 to 31st Dec 2017. We did not include studies published before 2000 
because seasonality could change in the long term and our objective was to 
report on current global seasonality. References cited in retrieved articles 
were also examined for eligibility. No language restrictions were applied. The 
protocol for this systematic literature search was registered on PROSPERO 
(registration number: CRD42018091628). 
Inclusion criteria 
 Studies reporting laboratory-confirmed incidence data of human 
infection of IFV, RSV, PIV and/or MPV for at least 12 consecutive 
months (or 52 weeks equivalent). 
 Studies with stable testing practice throughout all years reported (e.g. 
studies should be able to conduct IFV tests both in and out of IFV 
season with no interruption). 
 Studies reporting virus results among residents in well-defined 
geographic locations. 
 Studies reporting aggregated virus results at least on a monthly basis 
or, if possible, more frequently. 
Exclusion criteria 
 Studies reporting respiratory infections only among those under 
special medical conditions (e.g. patients with chronic obstructive 
pulmonary disease or patients infected with human immunodeficiency 
virus). 
 Studies only reporting influenza during the 2009-2010 influenza 
pandemic period. 
 Studies only reporting nosocomial infections. 
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 Studies reporting publicly available datasets (e.g. FluNet by World 
Health Organization, WHO), secondary data, commentary, or reviews. 
(corresponding original source of data was assessed for eligibility) 
 Studies only reporting all-cause ALRI. These studies were excluded in 
the phase of full-text screening (i.e. they were still retained during title 
and abstract screening). 
Data from online public sources and RSV GEN 
We included open-access online data from the following sources: WHO 
FluNet (World Health Organization 2018a), Pan America Health Organization 
FluID (Pan American Health Organization 2018), Japan National Institute of 
Infectious Diseases (National Institute of Infectiou Disease Japan 2015), 
Hong Kong Department of Health (Department of Health Hong Kong 2018), 
Canada FluWatch (Government of Canada 2018), and New Zealand Ministry 
of Health (Ministry of Health New Zealand 2018). The detailed information 
about these data can be found in Appendix A3  
We also included viral activity data shared by RSV GEN which is a 
collaboration of more than 70 investigator groups primarily in low-income and 
middle-income countries that was initially established to estimate RSV-ALRI 
disease burden (Shi et al. 2017). The detailed information of RSV GEN data 
can be found in Appendix A4. 
Data extraction 
Data extraction was conducted independently by YL and jointly by RR and 
XW through a three-stage process as detailed below. Any discrepancies 
were resolved through discussion among YL, RR, and XW. 
During the first stage, general information of each study was collected 
including site, country, coordinates (extracted from Google Map), data 
source, diagnosis, virus type and subtype, specimen, test method, subject 
age, dates of data availability, number of total specimens tested, number of 
total positive tests, time interval of aggregated data (e.g. weekly and 
monthly), format of seasonality data presented (e.g. graph, table and 
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dataset), and measurement of seasonality data presented (e.g. case number, 
proportion positive, and incidence rate).  
During the second stage, an assessment of accessibility of seasonality data 
was conducted in each included article. This assessment evaluated whether 
the seasonality data reported in the articles were extractable as aggregated 
number of cases per time interval (i.e. not proportion positive, incidence rate 
or any other proportional measures). Where seasonality data were not 
extractable, we attempted to contact the authors for gaining access to these 
data. We excluded studies when seasonality data were neither extractable 
nor accessible.  
During the third stage, seasonality data were extracted. The extraction was 
done by site and virus with each record extracted referring to one virus in one 
site. The viruses extracted include IFV, IFV A, IFV B, IFV A(H1N1), IFV 
A(H3N2), IFV A(H1N1)pdm, RSV, PIV, and MPV. We did not extract 
subtypes of RSV, PIV or MPV due to the very limited number of studies with 
those data available. For IFV, IFV A, IFV A(H1N1), and IFV A(H1N1)pdm, 
data between April 2009 and August 2010 inclusive were excluded due to the 
irregular seasonality of these viruses during the influenza pandemic period. 
In each study, we only extracted full-year (i.e. 12 months, 24 months, etc.) 
data for appropriate comparisons among months. When two or more studies 
were available for the same virus at the same site, we only extracted and 
included the one with the highest number of positive cases. Additionally, we 
excluded any data with <25 positive tests for each virus in total. For articles 
where seasonality data were reported in graphs, we utilised the software 
WebPlotDigitizer to facilitate data extraction (Rohatgi 2018). 
Quality assessment 
For each article included in the systematic literature review, a quality 
assessment was independently conducted by YL and jointly by RR and XW. 
The quality assessment comprised three brief questions regarding data 
representativeness, test practice, and timely reporting (questionnaire in the 
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Appendix A5). Data representativeness indicated if the seasonality reported 
in the study could be representative of the seasonality in that given site. Test 
practice indicated if there were any changes in terms of viral testing during 
the study period that could affect the reported seasonality. Timely reporting 
indicated if issues related to the timing of reporting test positives affected the 
seasonality results. Any disagreement was addressed through discussion. 
Any study with any “D” (bad) rated in the quality assessment was excluded. 
Data transformation 
In order to acquire seasonality results comparable across all sites, we added 
the number of cases by month across all years reported for each data record. 
We converted any weekly data to monthly data by using the R package 
“wktmo” before we added these data by month (Li 2017). 
Data analysis 
Definitions of geographical region and meteorological season 
We defined geographical regions as follows: temperate region (latitude < –
23.5 or > 23.5), and tropical region (latitude between –23.5 and 23.5). We 
defined meteorological seasons as follows: spring (March–May in the 
northern hemisphere; September–November in the southern hemisphere), 
summer (June–August in the northern hemisphere; December–February in 
the southern hemisphere), autumn (September–November in the northern 
hemisphere; March–May in the southern hemisphere), and winter 
(December–February in the northern hemisphere; June–August in the 
southern hemisphere). 
Description of monthly activity 
For each month, we calculated annual average percentage (AAP) as a 






100%, where i denotes the month i and n denotes the number of cases. We 
plotted heat maps displaying the activity of IFV, RSV, PIV, and MPV in each 
site sorted by latitude.  
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Duration of epidemics 
In the main analysis, we estimated the duration of epidemics by the minimum 
number of months to account for a total AAP of 75%, a modified method 
based on Caini et al (Saverio Caini et al. 2016). The modified method could 
account for sites with more than one season per year. This was done by first 
sorting monthly AAP into descending order and then identifying the first n 
months to account for AAP of 75%, with each month being an “epidemic 
month” and n being the duration of epidemics. The onset month of epidemics 
at each site was defined by the first month of the longest consecutive 
epidemic months. Pearson’s correlation was applied to assess the correlation 
between the onset month and latitude/longitude of the sites. In order to 
present the relationship between latitude and duration of epidemics, we 
plotted duration of epidemics against the latitude of the sites using local 
regression (LOESS) smoothing by virus, with the parameter span in LOESS 
set as 0.60.   
Subgroup analysis 
We conducted subgroup analyses determined a priori to compare the 
duration of epidemics of viruses of interest, using the same method as stated 
above. We pre-specified the following three comparison groups, IFV 
subtypes (IFV A vs IFV B), IFV vs RSV, and RSV vs MPV. For each 
comparison group, we conducted the analyses only among those sites with 
complete data of the viruses in the comparison group.  
In order to study the relationship between seasonal timing of the viruses, we 
conducted cross-correlation analyses for each site between IFV A and B, 
between IFV and RSV, and between RSV and MPV, using −5 to 5 months of 
lag (a total of 11 correlation analyses). In consideration of the multiple 
correlation analyses within each site, we adjusted the significance level to 
0.004 using the Bonferroni method (0.05/11≈0.004). If statistically significant 
correlation results were observed at a site, we reported the lag that 
maximised the correlation coefficient as the difference in timing between the 
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viruses. We also calculated the monthly overlapping AAP between each pair 
of viruses stated above and the overall annual overlapping AAP. 
Prediction model of viral epidemics 
For each site included, we extracted meteorological data from the site’s 
nearest weather station provided by the US National Centers for 
Environmental Information using R package “GSODR” (Sparks et al. 2017).  
We modelled monthly AAP of virus using mean-centred monthly temperature 
and relative humidity as predictors in a LOESS model. This model is based 
on the assumption that for each month, the relative strength of viral activity 
(i.e. AAP) is associated with the relative measurements of the selected 
meteorological factors (i.e. mean-centred temperature and relative humidity). 
Details of model assumption, data preparation, model comparison, and 
model assessment are attached in the Appendix A6. The model-predicted 
AAP values for each site were then used to determine the epidemic months 
(i.e. a dichotomous result for each month, epidemic or non-epidemic). We 
required a minimum of 120 sites with ≥100 positives per virus for more robust 
models. With the available data, we were able to model IFV (including IFV 
subtypes) and RSV only.  
To assess the model performance, we predicted the monthly AAP at each 
site using the model trained by data from the remainder sites (i.e. “leave-one-
out” method) as the first step; based on the predicted AAP, we then 
determined the epidemic months and assessed the agreement between the 
predicted epidemic months and the observed epidemic months by calculating 
Cohen’s kappa, sensitivity, specificity, positive predictive value, and negative 
predictive value. We also calculated the mean difference in months between 
the predicted and the observed onset of epidemics (i.e. prediction error) and 
its 95% confidence interval. 
Based on the model, we estimated the global epidemic months of IFV and 
RSV on a 5° by 5° scale using gridded temperature and relative humidity 
data in 2013–2017 from the HadISDH dataset (4.0.0.2017f) (A. Smith et al. 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, 
parainfluenza virus and metapneumovirus 39 
2011; Willett et al. 2014). Moreover, using the R package “Shiny”,(Chang et 
al. 2017) we developed an online interactive tool for the prediction of local 
epidemic months of IFV and RSV. This tool is available freely in 
http://resceu.ecdf.ed.ac.uk/shiny/ShinyPred/. The user manual of this tool is 
in the Appendix A7. 
All data analyses were conducted using R software (version: 3.4.3) (R Core 
Team 2017). The seasonality data and key R functions developed for the 
analysis are available through the Edinburgh DataShare 
(https://doi.org/10.7488/ds/2531). 
Role of the funding source  
This study was supported by Respiratory Syncytial virus Consortium in 
EUrope (RESCEU). RESCEU has received funding from the Innovative 
Medicines Initiative 2 Joint Undertaking under grant agreement Nº 116019. 
This Joint Undertaking receives support from the European Union’s Horizon 
2020 research and innovation programme and The European Federation of 
Pharmaceutical Industries and Associations (EFPIA). The funder had no role 
in study design, data collection, data analysis, data interpretation, or writing 
of the report. The corresponding author had full access to all the data in the 
study and had final responsibility for the decision to submit for publication.  
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2.2.3 Results 
After excluding duplicates, the systematic literature search identified 21065 
records and 1081 records were assessed in full-texts. Of these records, 542 
studies were further checked for availability of monthly data and for any 
duplicates. A total of 185 studies were included at the final stage of the 
literature review (flow chart, details of these studies, and their quality 
assessment results are attached in Appendix A8. Table 2-1 demonstrates 
the number of sites, number of positives and length in years of data from the 
published literature and other sources that were collected in our analysis. 
Compared with data from the published literature, data from other sources 
had greater number of positive samples and were collected over a longer 
time span. Figure 2-1 demonstrates the geographical distribution of the sites 
included by virus (IFV subtypes in Appendix A9). IFV A(H1N1) was not 
included in the analysis due to the limited number of sites included (n sites = 
39). 
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RSV PIV MPV 
All A B A(H1N1) A(H3N2) A(H1N1)pdm 
Number of 
sites 
All 246 209 200 39 183 165 183 83 65 
Literature 104 77 76 8 61 42 111 44 39 



























































All 4[3–6] 4[3–6] 5[3–7] 4[2–6] 5[3–7] 4[3–6] 3[2–7] 4[2–8] 4[2–7] 
Literature 3[2–4] 4[2–4] 5[2–5] 4[1–4] 5[2–5] 4[4–4] 3[2–6] 3[1–5] 2[1–4] 
Dataset† 6[3–7] 6[3–7] 6[4–9] 4[2–7] 7[4–9] 6[3–7] 4[3–8] 8[4–8] 8[4–8] 
IFV=influenza virus; MPV=metapneumovirus; PIV=parainfluenza virus; RSV=respiratory syncytial virus. 
*Median[1QR–3QR].  
†From online public source and from research data shared by RSV GEN collaborators. 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, 
parainfluenza virus and metapneumovirus 42 
 
Figure 2-1 Study sites included in the analysis 
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Global monthly activity of IFV, RSV, PIV and MPV 
Figure 2-2 and Figure 2-3 demonstrate the global monthly activity of IFV, 
RSV, PIV and MPV by latitude (results of IFV subtypes in Appendix A10). 
Animated figures of global monthly activity of these four viruses can be found 
in the ShinyApp at http://resceu.ecdf.ed.ac.uk/shiny/ShinyGIF/. Distinct 
seasonality of virus activity was observed in most sites for the four viruses. 
Latitudinal variations of the onset month of epidemics were also observed, 
although patterns varied by virus. Detailed results of epidemic months 
grouped by country are attached in Appendix A11. 
IFV epidemics occurred consistently during January–March in most 
temperate sites in the northern hemisphere and during June–August in most 
temperate sites in the southern hemisphere. These patterns became less 
pronounced closer to equator, with the emergence of summer epidemics in 
some sites. Variable timing of epidemics was observed in tropical sites. In 
both hemispheres, the onset of the major IFV epidemics was later with 
increasing latitudes (northern hemisphere: r=0.36, P<0.001; southern 
hemisphere: r=0.47, P=0.003) 
RSV activity showed a latitudinal gradient in the timing of epidemics in each 
hemisphere. In the northern hemisphere, RSV activity was initiated in July in 
tropical sites. The activity was initiated later with increasing latitude until it 
reached high-latitude sites in around January. Subsequently, the RSV activity 
started to wane before another round of activity was initiated in around July in 
tropical sites. Similar patterns were observed in the southern hemisphere, 
where RSV activity was initiated around January in tropical sites first and in 
June in high-latitude sites. Interestingly, in the tropics, the timing of RSV 
epidemics was similar within each hemisphere but differed greatly between 
hemispheres, with only a few exceptions in equatorial sites; this pattern was 
not observed with any IFVs. In both hemispheres, the onset of major RSV 
epidemics was later with increasing latitudes (northern hemisphere: r=0.50, 
P<0.001; southern hemisphere: r=0.54, P<0.001). 
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In addition to latitudinal gradients in IFV and RSV onset month, we observed 
longitudinal patterns in Europe where most sites had comparable latitudes 
but different longitudes. The onset month of both IFV and RSV epidemics 
was observed to be later in the east (i.e. higher longitudes) than the west 
(IFV: r=0.46, P=0.006; RSV: r=0.45, P=0.025) while no significant latitudinal 
patterns were observed in this region (IFV: r=0.07, P=0.694; RSV: r=0.11, 
P=0.610). The average difference in the timing of onset between west and 
east of Europe (defined geographically by 20˚E) was 0.6 months for IFV and 
0.8 months for RSV. 
Seasonality of PIV was not as distinct as IFV or RSV. PIV epidemics were 
found mostly in spring and early summer months in both the northern and 
southern hemispheres. MPV epidemics occurred in late winter and spring in 
most temperate sites but the timing of epidemics was more diverse in the 
tropics.  
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Figure 2-2 Heat map of global monthly activity of influenza virus and 
respiratory syncytial virus, sorted by latitude.  
“+” denotes the onset month of virus epidemics. 
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Figure 2-3 Heat map of global monthly activity of parainfluenza virus 
and metapneumovirus, sorted by latitude 
“+” denotes the onset month of virus epidemics 
Duration of epidemics 
Overall, virus-specific latitudinal patterns were observed in duration of 
epidemics (Figure 2-4). PIV had longer duration of epidemics (6.3 months, 
95% CI: 6.0–6.7) compared with the other three viruses. The duration of IFV 
epidemics varied greatly by latitude, with shorter duration (3.8 months, 95% 
CI: 3.6–4.0) in temperate sites and longer duration (5.2 months, 95% CI: 4.9–
5.5) in the tropics. Within IFV subtypes, IFV A(H1N1)pdm had the shortest 
duration of epidemics (3.3 months, 95% CI: 3.1–3.5), followed by IFV 
A(H3N2) (4.2 months, 95% CI: 3.9–4.4) and IFV B (4.5 months, 95% CI: 4.3–
4.8), regardless of the latitudes; the durations of IFV A(H1N1)pdm, A(H3N2) 
and B demonstrated similar latitudinal patterns. Compared with IFV, the 
duration of epidemics of RSV and MPV was relatively stable (RSV: 4.6 
months, 95% CI: 4.3–4.8; MPV: 4.8 months, 95% CI: 4.4–5.1). Subgroup 
analyses using site-matched data replicated the results of the comparisons 
above (Appendix A12). 
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Figure 2-4 Latitudes of sites and duration of epidemics 
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Co-circulation of viruses 
Results from subgroup analysis using sites with complete data of IFV A and 
B demonstrated that IFV A and B activity were statistically correlated in 78% 
of temperate sites (67/86) and 55% of tropical sites (55/100). In the 
temperate region, IFV A epidemics occurred 0.6 months (95% CI: 0.3–0.9) 
earlier than IFV B. In the tropics, no clear temporal order was observed 
(lag=0, 95% CI: −0.5, 0.5) and this was largely due to the greater variability in 
the timing of epidemics in the northern tropics. (Panel A in Figure 2-5) 
IFV and RSV activity were statistically correlated in 67% of temperate sites 
(28/42) and 59% of tropical sites (28/47). IFV epidemics occurred later than 
RSV in most temperate sites with the average lag of 0.3 months (95% CI: 
−0.3, 0.9) while no clear temporal order was observed in the tropics (lag=0.1, 
95% CI: −0.9, 1.2). (Panel B in Figure 2-5) 
RSV and MPV activity were statistically correlated in 83% of temperate sites 
(29/35) and in 62% of tropical sites (14/22). In the temperate region, MPV 
epidemics occurred 1.7 months (1.1–2.3) later than RSV while no clear 
temporal order was observed in the tropics (lag=0.2, 95% CI: −0.9, 1.3). 
(Panel C in Figure 2-5) 
We found that 61.2% (95% CI: 58.6–63.9) of IFV A and B activity overlapped 
annually, that 59.5% (95% CI: 55.4–63.6) of IFV and RSV overlapped, and 
that 60.3% (95% CI: 55.6–65.0) of MPV and RSV overlapped. The 
percentages did not differ significantly between the temperate and tropical 
region. (Appendix A13) 
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Figure 2-5 Latitudes of sites and difference in timing of epidemics 
between A. influenza virus A and B, B. influenza virus and respiratory 
syncytial virus, and C. metapneumovirus and respiratory syncytial virus 
by subgroup analyses 
Positive lag indicates the former virus occurred after the latter; negative lag 
indicates the former virus occurred before the latter. 
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Prediction model of IFV and RSV 
The model with mean-centred temperature and mean-centred relative 
humidity was selected for our main analysis (results of model comparison 
and selection in Appendix A6). 
Figure 2-6 demonstrates the model predicted monthly virus activity against 
mean-centred temperature and relative humidity (observed activity against 
temperature and relative humidity in Appendix A14). Lower temperature was 
associated with higher IFV and RSV activity. When temperature was lower 
than the annual average, higher relative humidity was also associated with 
higher RSV activity but not with higher IFV activity. When temperature was 
higher than the annual average, higher relative humidity was associated with 
higher IFV activity, especially for IFV A(H3N2), whereas this pattern was not 
observed for RSV.  
Regarding the predictability of the model, the results of “leave-one-out” cross 
validation are demonstrated in Table 2-2. Overall, the model had good 
precision across all viruses in predicting local epidemic months. Better 
predictability was observed in the temperate regions than the tropics, 
especially for IFV. Regarding the prediction of the onset month of epidemics, 
the model prediction error was –0.2 months (95% CI: –0.6–0.1) for IFV, and 
0.1 months (95% CI: –0.2–0.4) for RSV. 
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Figure 2-6 Monthly activity of influenza virus and respiratory syncytial 
virus against mean-centred temperature and relative humidity: model-
predicted output 
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Table 2-2 Agreement on epidemic months between observed data and model prediction by leave-one-out cross 
validation 
 Number of sites Cohen’s kappa 
with 95% CI 
Agreement* SEN* SPE* PPV* NPV* Prediction error in the month of 
onset with 95% CI† 
Global         
    IFV 200 0.36 [0.32, 0.40] 70 63 74 60 76 –0.2 [–0.6, 0.1] 
    IFV A 172 0.35 [0.31, 0.39] 70 62 73 55 79 –0.3 [–0.7, 0.1] 
    IFV B 127 0.37 [0.32, 0.42] 70 66 72 60 77 –0.7 [–1.0, –0.3] 
    IFV A(H1N1)pdm 129 0.39 [0.34, 0.44] 73 69 74 51 86 –0.6 [–1.0, –0.2] 
    IFV A(H3N2) 135 0.33 [0.29, 0.38] 68 67 68 55 78 –0.4 [–0.8, 0.1] 
    RSV 146 0.47 [0.42, 0.51] 75 65 81 69 78 0.1 [–0.2, 0.4] 
Temperate Region         
    IFV 97 0.59 [0.54, 0.64] 82 74 86 71 87 –0.4 [–0.8, –0.1] 
    IFV A 81 0.57 [0.51, 0.63] 82 72 86 68 88 –0.5 [–0.8, –0.1] 
    IFV B 73 0.49 [0.43, 0.55] 78 70 81 62 86 –1.0 [–1.3, –0.6] 
    IFV A(H1N1)pdm 61 0.61 [0.55, 0.68] 85 82 86 63 94 –0.7 [–1.0, –0.4] 
    IFV A(H3N2) 68 0.48 [0.42, 0.54] 77 73 78 59 87 –0.3 [–0.8, 0.3] 
    RSV 85 0.55 [0.49, 0.60] 79 66 87 75 82 0.5 [0.1, 0.8] 
Tropical Region         
    IFV 103 0.15 [0.09, 0.20] 58 55 60 52 63 –0.1 [–0.7, 0.5] 
    IFV A 91 0.16 [0.13, 0.23] 59 57 60 48 68 –0.1 [–0.8, 0.5] 
    IFV B 54 0.17 [0.10, 0.25] 59 62 55 58 59 –0.2 [–1.0, 0.5] 
    IFV A(H1N1)pdm 68 0.21 [0.14, 0.27] 62 61 62 44 76 –0.5 [–1.2, 0.2] 
    IFV A(H3N2) 67 0.17 [0.11, 0.24] 58 63 55 51 66 –0.5 [–1.2, 0.2] 
    RSV 61 0.35 [0.28, 0.42] 68 64 71 63 72 –0.4 [–0.9, 0.1] 
CI=confidence interval; IFV=influenza virus; NPV=negative predictive value; PPV=positive predictive value; RSV=respiratory 
syncytial virus; SEN=sensitivity; SPE=specificity. 
*in %.  
†in month; a negative value indicates the onset predicted is earlier than the observed. 
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Moreover, based on the model, we present the estimated global epidemic 
months of IFV and RSV on a 5° by 5° scale. We also highlight the onset of 
the epidemic months for readers’ reference. (Figure 2-7 and Figure 2-8) 
 
Figure 2-7 Global maps of the estimated average epidemic months of 
influenza virus during 2013–2017 on a 5° by 5° scale 
  
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Global patterns in monthly activity of influenza virus, respiratory syncytial virus, 
parainfluenza virus and metapneumovirus 54 
 
Figure 2-8 Global maps of the estimated average epidemic months of 
respiratory syncytial virus during 2013–2017 on a 5° by 5° scale 
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2.2.4 Discussion 
To our knowledge, this is the first systematic analysis of global monthly 
activity of IFV, RSV, PIV and MPV at national and sub-national levels. With 
strict criteria, we compiled laboratory-confirmed viral activity from literature 
review, online surveillance datasets, and shared datasets by collaborators. 
We present global maps of monthly virus activity for IFV (including types and 
subtypes), RSV, PIV and MPV, demonstrating the distinct seasonal patterns 
for each virus. We found that latitudinal patterns in duration of epidemics 
were diverse among the four viruses. Furthermore, we modelled monthly 
virus activity using site-specific temperature and relative humidity for the 
prediction of epidemic months; developed an interactive tool for predicting 
the local epidemic months of IFV and RSV; and estimated the gridded global 
epidemic months of IFV and RSV on a 5° by 5° scale for the years 2013 
through 2017.  
Our results suggest that the global seasonal patterns of IFV and RSV are 
different in terms of both timing and duration of epidemics. At most temperate 
sites, IFV epidemics occurred later than RSV (by 0.3 months, 95% CI: −0.3, 
0.9); in the tropics, RSV epidemics occurred in late summer and autumn 
months while timing of IFV epidemics varied greatly, and as a result, no clear 
temporal order was observed (lag=0.1 months, 95% CI: −0.9, 1.2). However, 
in a previous global review by Bloom-Feshbach et al (Bloom-Feshbach et al. 
2013), the authors concluded that seasonal patterns of IFV and RSV were 
broadly similar in timing. The difference between the results of our study and 
those of Bloom-Feshbach et al (Bloom-Feshbach et al. 2013) is likely due to 
the smaller number of sites included in their review compared with the 
present study (IFV: 246 sites vs 77 sites; RSV: 183 sites vs 96 sites). With 
regard to duration of epidemics, IFV was more seasonal in the temperate 
region (duration of epidemics: 3.8 months, 3.6–4.0) than in the tropical region 
(5.2 months, 4.9–5.5) while RSV seasonality was weaker than IFV in the 
temperate region but stronger than IFV in the tropical region. This finding was 
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consistent with the review by Bloom-Feshbach et al (Bloom-Feshbach et al. 
2013), despite different definitions for the duration of epidemics. 
Our study found statistically significant positive correlations between the 
onset of epidemic months and absolute latitudes in each hemisphere, for 
both IFV and RSV. This is similar to the findings by Bloom-Feshbach et al 
(Bloom-Feshbach et al. 2013) using peak month instead of onset month. In 
addition to the latitudinal gradient stated above, we found a significant west-
to-east gradient in the onset month for IFV and RSV in Europe, similar to 
country-level studies (S. Caini et al. 2017; Obando-Pacheco et al. 2018). The 
average difference in the timings of onset between west and east of Europe 
(defined geographically by 20˚E) was 0.6 months for IFV and 0.8 months for 
RSV. 
Our study also found that seasonality was slightly different among IFV types 
and subtypes, similar to the findings from previous country-level regional 
reports (S. Caini et al. 2017; Finkelman et al. 2007). In our study, IFV A 
epidemics occurred 0.6 months (95% CI: 0.3–0.9) before IFV B in the 
temperate sites but no clear temporal order was seen in the tropical sites 
(lag=0, 95% CI: −0.5, 0.5). Moreover, we identified some interesting patterns 
not having been reported in previous reports; the latitudinal patterns of 
epidemic duration were similar among IFV subtypes, with IFV A(H1N1)pdm 
being the most seasonal virus (duration of epidemics=3.3 months, 95% CI: 
3.1–3.5), followed by IFV A(H3N2) (4.2 months, 95% CI: 3.9–4.4) and IFV B 
(4.5 months, 95% CI: 4.3–4.8), regardless of the latitudes. 
Compared with IFV and RSV, year-round laboratory-confirmed data of MPV 
and PIV are scarce and there is no global report on the seasonality of these 
two viruses. In the present study, we found that PIV epidemics occurred most 
often in the spring and early summer months in each hemisphere; MPV 
epidemics occurred in late winter and spring in most temperate sites but the 
peaks were more diverse in the tropics. PIV had longer duration of 
epidemics, which could be explained by the different circulation timings in 
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each PIV subtype (Fry et al. 2006; Mizuta et al. 2012). MPV had similar 
patterns to RSV in duration of epidemics, which may reflect known genetic 
similarities between the two viruses (Bernadette G. van den Hoogen et al. 
2002). However, these two viruses did not co-circulate at most sites. In the 
temperate regions, MPV occurred 1.7 months (95% CI: 1.1–2.3) after RSV; in 
the tropics, no clear temporal order was observed. This indicates possible 
interference between these two viruses warranting further study. 
The mechanisms that shape the global seasonal patterns of IFV, RSV, PIV 
and MPV remain unclear. Possible mechanisms include contact rates 
between susceptible and infected hosts, virus survival, and host immunity. 
Possible seasonal stimuli include temperature, humidity, precipitation, solar 
radiation, travel/work flows amongst other factors (J. Tamerius et al. 2011). In 
our study, all four viruses had different global patterns of timing and duration 
of epidemics; these patterns are unlikely to be well explained by non-virus-
specific factors alone and one should be aware of potential spurious 
correlations between any non-virus-specific factors and virus activity. For 
example, travelling pattern is a potential factor that affects transmission but is 
not likely to explain the observed seasonal patterns well due to its non-virus-
specific nature. Therefore, we did not select non-virus-specific factors in our 
candidate models. The two predictors that we included, temperature and 
relative humidity, were found to be associated with the seasonality of IFV and 
RSV in different ways. Although lower temperature was associated with 
higher activity of both IFV and RSV, higher relative humidity was associated 
with higher IFV activity when temperature was above annual average, and 
was associated with higher RSV activity when temperature was below annual 
average. Experimental studies on the transmission and survival of these 
viruses are needed in order to confirm our findings. Our findings regarding 
the predictors of IFV were similar to the two types of IFV peaks, “cold-dry” 
and “humid-rainy”, proposed by Tamerius et al (J. D. Tamerius et al. 2013) 
However, the model by Tamerius et al (J. D. Tamerius et al. 2013) was 
based on the activity of IFV of a dichotomous nature, i.e. peak and non-peak. 
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In our study, we modelled the activity of IFV and RSV of a continuous nature, 
thus allowing for more flexibility in our prediction.  
Based on the gridded dataset of monthly temperature and relative humidity 
on a 5° by 5° scale (A. Smith et al. 2011; Willett et al. 2014), we mapped the 
global average epidemic months in 2013–2017. The results indicated that for 
those countries with a wide range of climate patterns, the viral epidemics 
varied within the country. For example, IFV and RSV epidemics occurred 
earlier in northern Australia than southern Australia. Moreover, given the 
global climate changes in the last few decades, we compared our prediction 
for 2013–2017 with our prediction for 1973–1977 but did not observe 
significant change in the predicted seasonal patterns for IFV and RSV. 
Our study provides global maps of monthly virus activity, which have 
important implications for public health strategy. For IFV, vaccination is the 
most effective way to prevent disease.(World Health Organization 2018c) 
Seasonality data from existing country-level surveillance help inform the 
timing and composition of IFV vaccines but such surveillance is unable to 
account for any within country variations and under-sampled areas. By 
incorporating data from published and unpublished studies, our study 
potentially fills the data gap at sub-national level and for countries with no 
surveillance programme. This is particularly important for geographically 
large countries and tropical regions where great variations of virus activity 
may exist, as found in our study. For RSV, the seasonality information is 
important for immunisation strategy. In high-income countries, the 
administration of palivizumab prophylaxis, an RSV-neutralizing monoclonal 
antibody mainly used among high-risk infants, needs to be timed according to 
the local RSV season given the limited duration of its protection. For middle- 
and lower-income countries, RSV seasonality information is important for the 
development of affordable biologic equivalents of palivizumab and any 
vaccines with limited duration of protection (Q. Zhu et al. 2017). Moreover, 
the length of an RSV season defined by the duration of epidemics in our 
study is relatively stable at 4–5 months across all sites, in contrast to IFV, 
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which has irregular seasonality or year-round activity in the tropics. This 
could help optimise immunisation programmes by focusing on the pre-
defined RSV seasons in both temperate and tropical regions. Unlike IFV for 
which surveillance data are widely available, RSV surveillance data are still 
lacking and WHO is in the process of implementing a global RSV 
surveillance programme (World Health Organization 2017). To this end, our 
prediction model estimates the local epidemic months for RSV epidemics, 
including the onset of epidemics, on a global scale. This information would be 
beneficial for lower and middle income countries. For all the viruses, the 
seasonality information is helpful in health-care services planning, especially 
when viruses co-circulate and impose pressure on hospital beds. It is also 
important for the patients’ clinical management and for the appropriate use of 
antibiotics in the context of increased antimicrobial resistance and limited 
health resources in some settings (Sabuncu et al. 2009). 
This study, however, is not without its limitations. First, like most studies of 
this type, the accuracy of the global activity data reported could be limited by 
the variety of methodologies applied in the studies and surveillance systems 
included. We were also unable to account for the variability regarding the age 
groups and severity of viral infections included at each site. While we aspired 
to have good geographical representativeness, we applied strict inclusion 
criteria and conducted additional quality assessment to exclude studies 
where the reported seasonality was likely to be biased by study subjects, 
testing practice, or reporting practice. Second, for better comparison across 
different sites, we calculated monthly AAP by aggregating multi-year data to 
determine virus activity. Although multi-year surveillance data suggest that 
the year-to-year change of IFV and RSV onset is within one month for most 
sites (Alonso et al. 2015; Obando-Pacheco et al. 2018), aggregating multi-
year data could obscure the seasonal patterns of those sites with more 
notable year-to-year changes in seasonality. In particular, we were unable to 
identify multi-year periodicity of RSV activity which has been reported in 
some of countries in northern Europe (Broberg et al. 2018). Third, we were 
unable to report global seasonal patterns of any subtypes of RSV, PIV or 
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MPV due to a lack of relevant data reported; this could obscure the 
seasonality results of RSV, PIV and MPV, particularly PIV since the seasonal 
patterns were reported to differ greatly by type (Fry et al. 2006; Mizuta et al. 
2012). Fourth, compared to IFV and RSV, there were fewer sites which 
reported data on MPV and PIV, thus limiting the representativeness of the 
results. Fifth, we were only able to summarise the global seasonality on a 
monthly basis instead of on a weekly basis. This was due to the scarcity of 
weekly data (e.g. only 20% of RSV data in our study were originally weekly 
aggregated), and methodologic challenges in order to accommodate the 
different definitions for “week” (e.g. a week can start with Saturday, Sunday 
or Monday by different definitions). Sixth, due to the lack of granularity of our 
training data, our prediction model might not be able to reflect the possible 
changes of viral epidemics induced by subtle short-term climate changes. 
However, such prediction is possible with data that are more granular in 
future (e.g. multi-year weekly data). Finally, our model is limited in its ability 
to predict the IFV epidemic months in the tropical region, partly due to the 
lack of clear seasonality and the failure to establish association between viral 
activity and meteorological factors. In the tropics, multi-year viral activity data 
from more countries are warranted and factors related to host immunity (e.g. 
seasonal fluctuation of nutritional status (Hillbruner and Egan 2008)) can be 
considered in future modelling studies. 
Given the substantial health-care burden caused by IFV, RSV, PIV and MPV, 
their seasonal patterns described in our study are important for related health 
services planning. The model developed in our study is helpful in predicting 
the onset months of local IFV and RSV epidemics. This, together with the 
seasonality results presented, helps with the optimisation of any RSV 
immunisation strategies that rely on the information of local RSV season, 
especially in most middle- and lower- income countries where there may be 
no routine RSV surveillance. However, the model is limited regarding its 
performance on predicting IFV epidemics in the tropics, partly due to the lack 
of clear seasonality and the failure to establish association between IFV and 
meteorological factors. Besides, data gaps remain in PIV (including all 
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subtypes) and MPV and we are unable to model the epidemics of these two 
viruses. Future studies should consider describing and modelling the activity 
of IFV, RSV, PIV and MPV on a multi-year scale and should take into 
consideration the effects of climate change on respiratory viral epidemic 
seasonality. 
2.3 Conclusion 
The seasonality information of IFV, RSV, PIV and MPV is key for health 
services planning. The prediction tool developed in this study is helpful in 
predicting the onset months of local IFV and RSV epidemics, and serves as a 
supplement to existing surveillance. This, together with the summarised 
seasonality information, will help with the optimisation of RSV immunisation 
strategies that rely on the information of local RSV season, especially in most 
middle- and lower- income countries where routine RSV surveillance is not 
available. These implications will be further discussed in the next chapter.  
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Chapter 3 The role of RSV seasonality on 
national planning of introduction of 
RSV prevention strategies 
3.1 Introduction 
As noted in Chapter 1, several RSV prevention products are currently under 
clinical development and will hopefully be introduced in a few years. 
Currently, the only licensed RSV prevention product is Palivizumab, which is 
a short-acting mAb, exclusively administered in high income countries. 
Palivizumab is given every month for 5 months from the onset of the RSV 
season for infants in their first year of life and therefore, needs local RSV 
seasonality information. It is expected that future long-acting mAbs, will rely 
on RSV seasonality information (similar to Palivizumab). This is also the case 
for maternal RSV vaccine, which is designed to protect young infants during 
the first three to four months of their life.  
Before this thesis, there have been no reports on RSV seasonality in LMICs. 
The data from existing RSV surveillance in high-income countries are not 
appropriate to use as a guide as they are all in temperate settings whereas 
the majority of LMICs are in the tropics. It remains unclear whether the 
seasonal approach, as adopted by the high income countries for 
Palivizumab, is suitable for LMICs; or alternatively, it might be suitable to 
adopt year-round administration if RSV is less seasonal in LMICs. The 
impact of various RSV prevention strategies for both long-acting mAb and 
maternal RSV vaccine needs to be estimated and compared in LMICs.  
Therefore, based on the RSV data in Chapter 2, this chapter is aimed to 
understand the RSV seasonality in LMICs, including the year-to-year 
variations; and to assess and compare the impact of different RSV 
prevention strategies in LMICs. 
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3.2 Method 
3.2.1 RSV seasonality in LMICs 
The data on RSV seasonality in LMICs are a subset of the data described in 
Chapter 2. In order to understand the multi-year variation of RSV 
seasonality, I restricted the analysis to sites where multi-year data were 
available. To be eligible for multi-year data, the site should have at least 
three consecutive calendar years of monthly or weekly RSV positive cases 
and each year should have at least 25 positive cases.  
For multi-year data, I calculated annual percentage (AP) similar to AAP. The 
duration of epidemics, epidemic month, and onset month for multi-year data 
are defined as was done for the annual average data in Chapter 2. If the 
duration of RSV epidemic was longer than five months, it was defined as 
“year-round” activity; otherwise, it was defined as “clearly seasonal”. The cut-
off of 5 months was based on the typical protection length of current mAb, 
Palivizumab (i.e. 5 doses * 1 month/dose of protection) and a mAb candidate, 
MEDI8897 (expected to have 5 months of protection per dose) 
(Domachowske et al. 2018). 
3.2.2 Assessment of the impact of RSV prevention 
programmes in LMICs 
The schematic figure of the analysis in this section is attached in Figure 3-1. 
The following subsections introduce the detailed methods of each main step. 
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Figure 3-1 Schematic figure presenting the workflow of assessing the 
impact of RSV prevention strategies 
RSV=respiratory syncytial virus; ALRI=acute lower respiratory infection; 
m=month; mAb=monoclonal antibody; mV=maternal vaccine. 
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sALRI refers to ALRI with chest wall indrawing; BCG refers to the birth dose 
of Bacillus Calmette–Guérin vaccine; HepB refers to the birth dose of 
Hepatitis B vaccine; ANC4+ refers to pregnant women attending antenatal 
clinics at least 4 times during pregnancy. 
 
Candidate approaches 
I considered both long-acting mAb (hereinafter referred to as “mAb”) and 
maternal RSV vaccine (hereinafter referred to as “mV”) programmes. mAb 
programme is aimed at newborns and mV programme is aimed at pregnant 
women at their third trimester. For mAb programme, five candidate 
approaches were considered, namely Seasonal Approach 1–4, and Year-
Round Approach. All the four seasonal approaches were based on the 
epidemic months as defined previously in this thesis. In Seasonal Approach 
1, mAb is administered before each epidemic month. In Seasonal Approach 
2, 3, and 4, mAb is administered before a month if at least two epidemic 
months are anticipated in the upcoming 3, 4, and 5 months, respectively. 
Compared to Seasonal Approach 1, Seasonal Approach 2–4 was conceived 
to address the issues in Seasonal Approach 1 that an infant born several 
months before the season could not be immunised but would be exposed to 
high load of RSV during RSV season in very early months of life. In Year-
Round Approach, mAb is administered all year round, regardless of RSV 
epidemic months. Similarly, two seasonal approaches and one year-round 
approach were considered for mV. There was no Seasonal Approach 3 or 4 
for mV, due to the shorter protection duration of mV compared to mAb. 
Figure 3-2 and Figure 3-3 below present all the approaches for mAb and mV 
in Bolivia as an example. 
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
The role of RSV seasonality on countries planning of introduction of RSV 
prevention strategies 66 
 
Figure 3-2 Schematic figure presenting the five candidate approaches 
for mAb using Bolivia as an example 
mAb=monoclonal antibody. The red bar denotes the administration of mAb; 
the shaded area denotes protection by mAb. 
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Figure 3-3 Schematic figure presenting the three candidate approaches 
for mV using Bolivia as an example 
mV=maternal vaccine. Red bar denotes the administration of mV; shaded 
area denotes protection by mV. 
Calculation of monthly RSV incidence by age group 
The country-specific estimates of overall RSV-ALRI incidence in children 
under five years old were taken from a modelling study using six risk factors 
of RSV-ALRI as predictors, including prematurity, low birth weight, siblings in 
the household, maternal smoking, paediatric human immunodeficiency virus 
infection, and crowding (Shi et al. 2017). Both estimates for RSV-ALRI and 
RSV-severe ALRI in <5y were extracted. It was noted that severe ALRI was 
defined as ALRI with chest wall indrawing in the modelling study. To estimate 
RSV incidence in finer age bands for children aged <1y, the incidence rate 
ratios were calculated using the data in that study between <5y and each of 
the following age groups: 0-2m, 3-5m, 6-8m, and 9-11m (details of IRR in 
Appendix A15). For each country, the RSV monthly proportion was used to 
calculate the monthly RSV incidence. If more than one site was available for 
a country, the nearest site to the country’s geographical centre was used. 
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Coverage and efficacy of mAb and mV 
As birth dose was considered for mAb, I used the coverage data of existing 
vaccination programmes that had a birth dose, Bacillus Calmette–Guérin 
(BCG) vaccine and Hepatitis B (Hep B) vaccine. The coverage data of BCG 
and Hep B in LMICs in the year of 2017 were obtained from WHO website 
(Organization 2019). Where available, the coverage of BCG was applied as 
the coverage of mAb. For countries where BCG coverage was not available, 
Hep B coverage was applied. 
For mV, there were little data on the maternal vaccine for IFV which is 
believed to provide the most suitable estimate of the potential coverage for 
RSV mV. As an alternative, antenatal care (ANC) visit data were used 
(WHO/RHR ANC4+ Global Database March 2019, personal communication). 
The ANC dataset contained the percentage of women aged 15–49 years who 
attended ANC at least four times during pregnancy. As the fourth ANC visit 
occurs in the third trimester, the percentage of women with at least four times 
of ANC visits is proposed as an acceptable proxy estimate of the coverage of 
RSV mV. 
The efficacy of the long-acting mAb was obtained from the phase 2b trial 
results of MEDI8897: 70.1% (95% CI: 52.3–81.2) for medically attended ALRI 
and 78.4% (95% CI: 51.9–90.3) for ALRI hospitalisation on day 150 of 
administration. The efficacy of mV was obtained from the recent results of the 
phase-3 clinical trial of the Novavax RSV vaccine, ResVax; the efficacy was 
estimated to be 39.4% (95% CI: 5.3–61.2) for ALRI and 44.4% (95% CI: 
19.6–61.5) for severe ALRI, at the age of 3 months (Anonymous 2019b). 
Measures of effectiveness and efficiency 
For each outcome, i.e. RSV-ALRI or RSV-severe ALRI, the proportion of 
incidence averted in <1y as the measure of effectiveness and the proportion 
averted per dose was calculated as the measure of efficiency. The results 
were then compared among different approaches. As it was anticipated that 
the duration of RSV epidemics would be associated with the efficiency of 
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seasonal approaches, all country-specific results were sorted by the duration 
of RSV epidemics as defined in the previous chapter. 
All data analyses were conducted using R software (version: 3.4.3) (R Core 
Team 2017). 
3.3 Results 
3.3.1 RSV seasonality in LMICs 
Data availability 
RSV seasonality data were available in 110 sites from 46 LMICs (34% of 
LMICs). Multi-year RSV seasonality data were available in 36 sites from 23 
LMICs (17% of LMICs). Figure 3-4 below shows the distribution of data 
availability across LMICs. Only two sites from Turkey were available for the 
European region. The Americas had the best coverage among the six WHO 
regions, with 75% (18/24) of the countries having RSV seasonality data and 
72% (13/18) of them having multi-year RSV data. Detailed information about 
data source and availability is attached in Appendix A16. 
 
Figure 3-4 Data availability of RSV seasonality in LMICs 
Annual average seasonality 
More than two thirds (76/110, 69%) of the sites had clear RSV seasonality. 
Figure 3-5 below shows the distribution of duration of RSV epidemics in the 
temperate and tropical regions. There was no statistical difference in terms of 
the distribution of RSV duration of epidemics between temperate and tropical 
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regions (P>0.05; Appendix A17). The mean duration was 4.51 months [95% 
CI: 4.03–4.99] in the temperate region and 4.82 months [95% CI: 4.45–5.20] 
in the tropical region. Figure 3-6 shows the detailed monthly activity of RSV 
in LMICs. Sites with similar latitudes were more likely to have similar RSV 
seasonality. 
 
Figure 3-5 The distribution of duration of RSV epidemics (in months) in 
the temperate and tropical regions 
The dashed line denotes mean duration.  
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
The role of RSV seasonality on countries planning of introduction of RSV 
prevention strategies 71 
Solid line=equator, dashed lines=tropics of Cancer and Capricorn 
  
Figure 3-6 Annual average monthly activity of RSV in LMICs 
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Year-to-year variation of RSV seasonality 
Figure 3-7 on the next page shows the RSV monthly activity for the 36 sites 
with multi-year data available. Twenty-two of these 36 sites (61%) had clear 
seasonality when averaging the activity across the years. Within the 22 sites, 
when taking a closer look at the individual years per site, there was clear 
RSV seasonality during most years (106/115 site-years, 92.2%). Detailed 
results of duration of RSV epidemics are displayed in Table 3-1. 
Table 3-1 The distribution of duration of RSV epidemics measured by 
site-years 
 Duration of epidemics per site-year 
 Clear seasonality Year-round activity Total 
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Figure 3-7 Monthly activity of RSV in sites with multi-year data 
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Among the 22 sites with clear seasonality, I then assessed the year-to-year 
variation in terms of the onset of RSV epidemics. 36.5% (42/115) of the site-
years had the same onset as the average onset. The variation of the RSV 
onset was within 1 month for most of the site-years (86/115, 74.8%) and was 
within 2 months for more than 90% of the site-years (104/115, 90.4%). 
Detailed results are displayed in Table 3-2. I also assessed the year-to-year 
variation in terms of the proportion of RSV cases that could be covered by 
the average RSV season defined for each site. The results in Table 3-3 show 
that most site-years (71/115, 61.7%) covered more than 80% of annual RSV 
positive cases during the average RSV season and that more than three 
quarters of the site-years covered more than 70% of annual RSV positive 
cases during the average RSV season.  
Table 3-2 The distribution of year-to-year variation in the onset of RSV 
epidemics among sites with clear seasonality, measured by site-years 
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Table 3-3 The distribution of RSV coverage by the average RSV season 













































































3.3.2 Effectiveness and efficiency of different approaches 
A total of 44 countries were included in the analysis. Overall, mAb had 
greater proportion averted and proportion averted per dose than mV, largely 
owing to the longer duration of protection and better coverage (the 
distribution of coverage in Appendix A18). For either mAb or mV, the 
proportion averted and proportion averted per dose was greater in RSV-
severe ALRI cases than RSV-ALRI cases. Seasonal Approach 4 of mAb and 
Seasonal Approach 2 of mV performed well in terms of both effectiveness 
and efficiency. Detailed results are displayed in Figure 3-8 and Figure 3-9 
below. 
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Figure 3-8 Proportion of RSV incidence averted by different approaches 
of RSV immunisation 
S1–S4 denotes each seasonal approach; YR=year-round approach; 
mAb=monoclonal antibody; mV=maternal vaccine. 
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Figure 3-9 Proportion of RSV incidence averted per dose by different 
approaches of RSV immunisation 
S1–S4 denotes each seasonal approach; YR=year-round approach; 
mAb=monoclonal antibody; mV=maternal vaccine. 
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Country-specific results 
Compared with the year-round approach, the proportion averted per dose 
increased with decreasing duration of RSV epidemics. In terms of dose-
efficiency, seasonal approaches were favoured in countries with ≤5 months 
of RSV epidemic duration (i.e. countries with clear seasonality) for both mAb 
and mV (Figure 3-10 and Figure 3-11).  
Country-specific results considering year-to-year variations 
A total of 22/44 countries had multi-year level data that enabled evaluation of 
the performance of seasonal approaches given the year-to-year change of 
RSV seasonality. As shown in Figure 3-12 and Figure 3-13, although year-
to-year variations were observed in seasonal approaches, the advantage of 
seasonal approaches over the year-round approach remained in most 
countries with clear seasonality. Additionally, for each country, I plotted the 
proportion averted and proportion averted per dose in one plot as I 
anticipated that a “trade-off” between effectiveness and efficiency would likely 
to be of more interest to the policy makers from each country (Appendix 
A19, A20, A21, and A22). 
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Figure 3-10 Country-specific comparisons of different mAb administration approaches, sorted by duration of RSV 
epidemics 
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Figure 3-11 Country-specific comparisons of different mV administration approaches, sorted by duration of RSV 
epidemics 
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Figure 3-12 Country-specific comparisons of different mAb administration approaches, sorted by duration of RSV 
epidemics, considering multi-year variations 
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Figure 3-13 Country-specific comparisons of different mV administration approaches, sorted by duration of RSV 
epidemics, considering multi-year variations  
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3.4 Discussion 
This study described the RSV seasonality in LMICs and found that RSV 
seasonality was distinct and was relatively stable over years in most LMICs. 
Compared with the year-round approach, seasonal approaches were more 
suitable in LMICs with clear seasonality (~two thirds of LMICs included) for 
both long-acting monoclonal antibody immunisation (mAb) and maternal RSV 
vaccine (mV). The findings were consistent in the subgroup analysis 
including only countries with multi-year RSV data.  
As discussed in Chapter 2, unlike IFV in most LMICs, especially in the 
tropical region (Saverio Caini et al. 2016), RSV seasonality was distinct in 
most LMICs and sites with similar latitude tended to have similar RSV 
seasonality. Further to the analysis in Chapter 2, this study focused more on 
the multi-year variations of RSV in LMICs. For sites with clear seasonality, I 
found that these sites were very likely to have clear RSV seasonality for each 
year, and that the variation of the onset was within 1 month for most sites. 
Using the same average RSV season, more than 70% of the annual RSV 
cases could be covered in each year for most sites. These results suggest 
that a static seasonal approach can be considered for countries with clear 
seasonality and with no active RSV surveillance. 
To further assess and compare different approaches (i.e. seasonal 
approaches vs year-round approach), several seasonal approaches were 
considered for mAb and for mV, separately. The different seasonal 
approaches differed mainly by the starting month. For example, while 
Seasonal Approach 1 only protected infants born right before an RSV 
epidemic month, Seasonal Approach 4 aimed to protect those infants born up 
to 3 months before an RSV epidemic month. This was limited to 3 months 
prior to onset of RSV epidemic so as to confer at least 2 months of protection 
during early infancy. For mV, only Seasonal 1 and 2 were considered as the 
duration of protection by mV was not suitable for the other two seasonal 
approaches.  
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
The role of RSV seasonality on countries planning of introduction of RSV 
prevention strategies 84 
For mAb, all the approaches were based on the strategy of birth dose only, 
for several reasons. First, birth-dose is logistically more feasible for LMICs; 
RSV mAb can be given to the newborns as soon as they are born (along with 
BCG and HepB), avoiding a separate visit. By contrast, immunising infants 
later can be challenging as immunisation coverage decreases with 
subsequent doses for vaccines in Expanded Programme on Immunisation 
(EPI) and organising catch-up campaigns can be challenging for the already 
weak and over-burdened health systems in LMICs (Hoest et al. 2017). 
Second, the incidence of RSV-severe ALRI is highest in infants aged 3–5m 
(Appendix A15) and the birth dose of mAb can protect infants for the first 
five months of life. Third, the phase 3 trial of the long-acting mAb will be 
initiated later in 2019. Although the protocol has not been registered publicly 
at the time of writing, the phase 3 trial is likely to be conducted among 
healthy newborns and the mAb will be given at birth (personal 
communication).  
The results of the comparisons suggest that Seasonal Approach 4 for mAb 
had the highest effectiveness and efficiency among all the four seasonal 
approaches in countries with clear seasonality. When comparing this 
seasonal approach with the year-round approach in these countries, the 
Seasonal Approach 4 was favoured as it had comparable effectiveness to the 
year-round approach but much higher dose efficiency. Similarly, Seasonal 
Approach 2 for mV had the highest effectiveness and efficiency in countries 
with clear seasonality and had advantages in dose-efficiency over the year-
round approach. These results supported the use of a seasonal approach in 
most LMICs with clear RSV seasonality when considering the introduction of 
long-acting mAb and/or maternal vaccine. The results from further subgroup 
analyses from sites with multi-year data consistently supported the seasonal 
approach, indicating that a fixed seasonal approach could be applied to 
LMICs with clear seasonality and with limited resources to conduct active 
RSV surveillance. 
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However, there are some limitations in this study. First, the estimate of 
proportion averted in each country could be biased due to various reasons. 
For mAb, the use of BCG or Hep B coverage could overestimate the 
coverage of mAb as the introduction of a new prophylaxis may not receive 
the same level of acceptance as the current vaccines . Even though being 
given at the same time as BCG, parents may still have concerns about 
having another injection to their fragile babies. Nevertheless, the potentially 
biased estimate of mAb coverage is not expected to affect the comparisons 
between different seasonal approaches and the year-round approach. For 
mV, there are several uncertainties around the estimate. According to the 
phase 3 trial results of the maternal vaccine, the efficacy of the late 
vaccination group (i.e. after 33 weeks of gestation) was lower than the 28–32 
weeks group (Anonymous 2019b). In my study, the ANC data did not indicate 
the exact gestational week of the fourth visit so it was not possible to account 
for this factor. Therefore, the overall efficacy was applied to this study. Apart 
from the timing of the vaccination, prematurity is an important factor that 
could bias the estimate. On the one hand, prematurity reduces the placental 
transfer of RSV antibody and affects the vaccine effectiveness (Okoko et al. 
2001). On the other hand, as the maternal vaccine is timed assuming a term 
delivery for the seasonal approaches, an earlier birth could leave the infants 
unprotected when the RSV season comes later. This could lead to an 
overestimate of the effectiveness and efficiency of the seasonal approaches. 
Given the high prevalence of preterm births in LMICs (Blencowe et al. 2012), 
one should interpret the results for mV with caution. 
Second, this study only included 46 countries with available RSV seasonality 
data (only 23 having multi-year RSV data) and the seasonality results might 
not be representative of all LMICs. Same issues apply to the comparisons 
between seasonal approaches and year-round approach in mAb and mV 
programmes. Third, this study was conceived as a first-phase comparison of 
different immunisation approaches and no formal cost-effectiveness analysis 
was conducted. Such analysis is warranted in future studies. 
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In conclusion, there are still data gaps in RSV seasonality in LMICs. Most 
LMICs included in this study have clear and stable seasonality over time. The 
results of evaluating the effectiveness and efficiency of different RSV 
immunisation programmes are supportive of a seasonal approach for both 
long-acting monoclonal antibody and maternal vaccine in LMICs with clear 
seasonality. Further work is needed on the evaluation of different maternal 
vaccine strategies.
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Association of seasonal viral acute respiratory infection with pneumococcal 
disease: a systematic review  87 
Chapter 4 Association of seasonal viral acute 
respiratory infection with 
pneumococcal disease: a 
systematic review 
4.1 Introduction 
Pneumococcal disease is a major cause of communicable disease burden 
globally. It has been suggested by animal and in vitro studies that preceding 
viral acute respiratory infection can predispose to pneumococcal infection. In 
population-based studies, it is estimated that 6–7.5% of cases of invasive 
pneumococcal disease are attributable to influenza and 3–4% attributable to 
RSV in the UK (Nicoli et al. 2013) and that 20% of pneumococcal pneumonia 
cases are attributable to RSV among infants <1y in the US (Weinberger et al. 
2015). These findings suggest prevention of VARI can yield additional benefit 
for the control of PD. However, evidence from population-based studies is 
not accordant. These studies differed substantially in study design, data 
sources and methods, making it difficult to compare and interpret the results 
across the studies.  
Therefore, a systematic review of population-based studies about the 
association of viral acute respiratory infection with pneumococcal disease 
was conducted and this work in this chapter has been published in BMJ 
Open journal. (Li Y, Peterson ME, Campbell H, et al Association of seasonal 
viral acute respiratory infection with pneumococcal disease: a systematic 
review of population-based studies BMJ Open 2018;8:e019743) 
In this published work, I conducted the systematic literature review; extracted 
the data, drafted the manuscript and revised the manuscript according to the 
comments from the journal’s peer review. Meagan Peterson conducted the 
second extraction independently and revised the manuscript for intellectual 
content. Prof. Harish Nair and Prof. Harry Campbell conceived and oversaw 
the work, and revised the manuscript for intellectual content. 
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Abstract 
Objective: Animal and in vitro studies suggest that viral acute respiratory 
infection (VARI) can predispose to pneumococcal infection. These findings 
suggest that the prevention of VARI can yield additional benefits for the 
control of pneumococcal disease (PD). In population-based studies, 
however, the evidence is not in accordance, possibly due to a variety of 
methodological challenges and problems in these studies. We aimed to 
summarise and critically review the methods and results from these studies 
in order to inform future studies. 
Methods: We conducted a systematic review of population-based studies that 
analysed the association between preceding seasonal VARI and subsequent 
PD. We searched MEDLINE, Embase and Global Health databases using 
tailored search strategies. 
Results: A total of 28 studies were included. After critically reviewing the 
methodologies and findings, 11 studies did not control for seasonal factors 
shared by VARI and PD. This, in turn, could lead to an overestimation of the 
association between the two illnesses. One case–control study was limited 
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by its small sample size (n case=13). The remaining 16 studies that 
controlled for seasonal factors suggested that influenza and/or respiratory 
syncytial virus (RSV) infections were likely to be associated with the 
subsequent occurrence of PD (influenza: 12/14 studies; RSV: 4/5 studies). 
However, these 16 studies were unable to conduct individual patient data-
based analyses. Nevertheless, these studies suggested the association 
between VARI and subsequent PD was related to additional factors such as 
virus type and subtype, age group, comorbidity status, presentation of PD 
and pneumococcal serotype. 
Conclusions: Population-based studies do not give consistent support for an 
association between preceding seasonal VARI and subsequent PD 
incidence. The main methodological challenges of existing studies include 
the failure to use individual patient data, control for seasonal factors of VARI 
and PD, or include other factors related to the association (eg, virus, age, 
comorbidity and pneumococcal serotype). 
4.2.1 Introduction 
Both viral acute respiratory infection (VARI) and pneumococcal disease (PD) 
account for a substantial disease burden worldwide, especially in young 
children and the elderly (Drijkoningen and Rohde 2014; O'Brien et al. 2009; 
H. Wang et al. 2016). The association of VARI and subsequent PD was not 
well recognised until the catastrophic 1918 influenza pandemic, which 
resulted in an estimated 40–50 million deaths;(McCullers 2006) it has been 
suggested that pneumococcus may have been a major cause of death 
(Chien  et al. 2009). Most recently, it was observed that the incidence of PD 
was higher during 2009 influenza H1N1 pandemic period than the same 
period in prepandemic (Fleming-Dutra et al. 2013; Launes et al. 2014; Nelson 
et al. 2012; Pedro-Botet et al. 2014; Weinberger et al. 2012) and 
postpandemic years (Launes et al. 2014; Pedro-Botet et al. 2014; 
Weinberger et al. 2012). 
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During interpandemic periods, the associations of seasonal influenza and 
other seasonal respiratory viruses such as respiratory syncytial virus (RSV), 
human metapneumovirus and parainfluenza virus (PIV) with PD incidence 
are poorly understood and remain unclear. In animal and in vitro studies, it 
has been suggested that viral respiratory infection could predispose to 
pneumococcal infection and might facilitate pneumococcal transmission; in 
turn, this coinfection could induce a lethal synergism that is much more 
severe than infection with either pathogen alone (a brief summary of findings 
is displayed in supplementary Table 4-4). However, these studies are all 
relatively small-scale studies and may be subject to publication bias 
favouring reporting of positive findings. In population-based studies, the 
findings were inconsistent. These studies differed substantially in study 
design, data sources and methods, making it difficult to compare and 
interpret the results across the studies. We conducted a systematic review of 
population-based studies on the association of preceding VARI on the 
occurrence of PD to summarise the methodology and results, critically review 
the findings and present recommendations for future studies. 
4.2.2 Methods 
Search strategy and selection criteria 
We searched MEDLINE, Embase and Global Health databases using tailored 
search strategies (search strategies in supplementary Panel 4-1, Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
flow chart in Figure 4-1). We restricted the search to studies published 
between 1 January 1990 and 31 December 2017. We included population-
based studies with clinically diagnosed PD cases (see next for detailed 
definition). In terms of VARI exposure, we accepted the following studies: (1) 
those with laboratory-confirmed viral infections; (2) those with the 
International Classification of Diseases (ICD) code for influenza and/or RSV 
infection and (3) those with case definition of influenza-like illness (ILI) and 
bronchiolitis as proxies for influenza and RSV, respectively. We excluded 
animal studies and theoretical studies where no population data were 
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applied. We focused our review on the association of seasonal VARI and PD 
and thus excluded studies that reported pandemic influenza cases only. No 
language restrictions were applied. The reference lists of eligible studies 
were also checked to identify additional studies for inclusion. For all included 
studies, quality assessment was conducted using tailored Critical Appraisal 
Skills Programme checklists for case–control studies and cohort studies 
(online supplementary file S1 available at: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914779/bin/bmjopen-2017-
019743supp003.pdf). The review was conducted and reported according to 
the PRISMA guidelines. The protocol for this systematic review was 
registered on PROSPERO (registration number: CRD42017064760. 
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Figure 4-1 PRISMA flow diagram of the literature search 
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Definition of PD 
We defined PD as any disease caused by Streptococcus pneumoniae 
(pneumococcus). Since this definition contains a broad range of diseases 
and symptoms, including some that are trivial to our review, we adopted a 
narrower definition. This narrowed definition includes invasive pneumococcal 
disease (IPD) and pneumococcal pneumonia (PP). We defined IPD as 
detection of pneumococcus in typical sterile sites (e.g., blood, pleural and 
cerebrospinal fluid). A detailed category of PD for our review is displayed in 
Figure 4-2. Additionally, we used the term ‘non-pneumonic invasive 
pneumococcal disease (npIPD)’, which referred to all IPD without diagnosis 
of pneumonia, in order to differentiate from both invasive and non-invasive 
PP. 
 
Figure 4-2 Category of pneumococcal disease in the present review 
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Definition of VARI 
We defined VARI as a respiratory tract infection with viral aetiology. ILI was 
viewed as a proxy for influenza infection in the present review. We defined ILI 
as a symptomatic cough and fever ≥38°C with onset within 7 days. 
Data extraction 
We used a standardised data extraction template to extract relevant data 
from the eligible full-text studies, including study design, data source, 
methods, results and conclusion. The principle summary measures of the 
association between VARI and PD include correlation coefficients, risk ratios, 
rate ratios, ORs and attributable percentage of PD to VARI. YL and MP 
independently extracted the data. HN or HC arbitrated any disagreement with 
the extraction. 
Data analysis 
Since it was expected that methodology would differ substantially between 
studies and a quantitative meta-analysis would not be appropriate, a 
narrative synthesis was conducted. Studies were summarised according to 
methodology to allow for more appropriate comparisons of the results. 
In addition, because of the concern of multiple testing, we determined the 
number of tests conducted in each study, so a Bonferroni correction could be 
applied where applicable; only the tests relevant to the association between 
VARI and pneumococcal infection were included as part of the correction. 
The Bonferroni-adjusted significance level was calculated as 0.05 divided by 
the number of relevant statistical tests within a study. 
Patient and public involvement 
No patients or public were involved in the present study. 
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4.2.3 Results 
A total of 28 studies (Allard et al. 2012; Ampofo et al. 2008; Burgos et al. 
2015; Ciruela et al. 2016; Dangor et al. 2014; Domenech de Cellès et al. 
2017; Edwards et al. 2011; Grabowska et al. 2006; Hendriks et al. 2017; 
Jansen et al. 2008; Kim et al. 1996; Kuster et al. 2011; Murdoch and 
Jennings 2009; Nicoli et al. 2013; O'Brien et al. 2000; Opatowski et al. 2013; 
Peltola et al. 2011; Shrestha et al. 2013; Stensballe et al. 2008; Talbot et al. 
2005; Toschke et al. 2008; Walter et al. 2010; M. Watson et al. 2006; 
Weinberger et al. 2013, 2014b; Weinberger et al. 2014a; Weinberger et al. 
2015; Zhou et al. 2012) were eligible and included in the review. We noticed 
a variety of study designs, exposures and outcomes of interest and analytical 
methods in these studies (summarised in supplementary Table 4-5). Due to 
the variety, we summarised the studies and displayed the results according 
to study design and methods. 
Individual patient data-based studies 
Individual patient data-based studies during the interpandemic period are 
sparse. Only three studies(Edwards et al. 2011; O'Brien et al. 2000; 
Stensballe et al. 2008) were identified (Table 4-1), including two cohort 
studies(Edwards et al. 2011; Stensballe et al. 2008) and one small case-
control study by O’Brien et al.(O'Brien et al. 2000) The reported results 
consistently supported the role of preceding VARI on the occurrence of PD. 
However, the two cohort studies did not attempt to control the seasonal risk 
factors of VARI and PD that could potentially bias the estimated effect size. 
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Abbreviations: d, day(s); IFV, influenza virus; ILI, influenza-like illness; IPD, 
invasive pneumococcal disease; OR, odds ratio; PD, pneumococcal disease; 
PP, pneumococcal pneumonia; RR, relative risk; RSV, respiratory syncytial 
virus; VARI, viral acute respiratory infection; w, week(s); y, year(s). 
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Ecological studies 
In our review, 25(Allard et al. 2012; Ampofo et al. 2008; Burgos et al. 2015; 
Ciruela et al. 2016; Dangor et al. 2014; Domenech de Cellès et al. 2017; 
Grabowska et al. 2006; Hendriks et al. 2017; Jansen et al. 2008; Kim et al. 
1996; Kuster et al. 2011; Murdoch and Jennings 2009; Nicoli et al. 2013; 
Opatowski et al. 2013; Peltola et al. 2011; Shrestha et al. 2013; Talbot et al. 
2005; Toschke et al. 2008; Walter et al. 2010; M. Watson et al. 2006; 
Weinberger et al. 2013, 2014b; Weinberger et al. 2014a; Weinberger et al. 
2015; Zhou et al. 2012) of the 28 studies were ecological studies. 16(Allard et 
al. 2012; Burgos et al. 2015; Ciruela et al. 2016; Domenech de Cellès et al. 
2017; Grabowska et al. 2006; Hendriks et al. 2017; Kuster et al. 2011; 
Murdoch and Jennings 2009; Nicoli et al. 2013; O'Brien et al. 2000; 
Opatowski et al. 2013; Walter et al. 2010; M. Watson et al. 2006; Weinberger 
et al. 2013, 2014b; Weinberger et al. 2014a; Weinberger et al. 2015) out of 
the 25 ecological studies controlled for seasonal patterns of VARI and PD 
(supplementary Table 4-5). Additionally, the study by Stensballe et al 
(Stensballe et al. 2008) analysed data at both population and individual levels 
but did not control for the seasonal patterns.  
Correlation analyses with no control for seasonal patterns 
Table 4-2 shows a summary of 11 studies (Ampofo et al. 2008; Burgos et al. 
2015; Ciruela et al. 2016; Jansen et al. 2008; Kim et al. 1996; Murdoch and 
Jennings 2009; Nicoli et al. 2013; Peltola et al. 2011; Stensballe et al. 2008; 
Talbot et al. 2005; M. Watson et al. 2006) using correlation analyses without 
controlling for seasonal patterns of VARI and PD. Since all studies conducted 
multiple tests in analysing the correlation (e.g., across age groups, viruses 
and lag time between VARI and PD), the Bonferroni method was applied to 
adjust the significance level. The correlation between PD and influenza or 
RSV was statistically significant in all five studies (Ciruela et al. 2016; 
Murdoch and Jennings 2009; Nicoli et al. 2013; Stensballe et al. 2008; Talbot 
et al. 2005) that analysed population data of all ages (correlation coefficient r: 
0.40–0.71 for influenza at no time lag, 0.47–0.77 for RSV at no time lag).  
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<18y, IPD coded by ICD-9 
IFV: 0.23c (0), 0.24c (2w), 0.18c (4w); 
RSV: 0.31a (0), 0.35a (2w), 0.34a (4w); 
PIV: 0.03 (0), −0.01 (2w), −0.03 (4w); 
ADV: 0.01 (0), −0.05 (2w), −0.08 (4w); 
hMPV: 0.31a (0), 0.39a (2w), 0.37a (4w) 














lab data, monthly 
Spearman 
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IFV: 0.71a (0), 0.64a (1m); 
RSV: 0.77a (0), 0.80a (1m); 
ADV: 0.61a (0), 0.39a (1m) 
(similar results for age-stratified analysis 
of IFV and RSV; results of ADV were 















0–4y, 5–17y, ≥18y 
IFV-PB: 0.24b, 0.21b, 0.62b 
IFV-PM: 0.23b, 0.14b, 0.39b 
RSV-PB: 0.29b, 0.12b, 0.59b 
RSV-PM: 0.36b, —, 0.44b 
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IFV: 0.46a (0), 0.35c (4w) 
RSV: 0.56a (0), 0.54a (4w) 
ADV: 0.25c (0), 0.29c (4w) 
non-IFV: 0.38a (0), 0.35c (4w) 
<18y 
IFV: 0.08 (0), 0.23c (4w), 0.47a (8w) 
RSV: 0.13 (0), 0.28c (4w), 0.32c (8w) 
ADV: 0.31c (0), 0.55a (4w), 0.24c (8w) 





















IFV A: 0.44a (0), 0.37a (1m) 
IFV B: 0.23c (0), 0.13 (1m) 
RSV: 0.52a (0), 0.47a (1m) 
ADV: 0.27a (0), 0.33a (1m) 
PIV 1/2: 0.24c (0), 0.31a (1m) 
PIV 3: 0.34a (0),  0.17c (1m) 
(correlations were stronger in 5–65y and 
>65y) 
















All ages, Pearson 
IFV: 0.54a 
RSV: 0.47a 
All ages, Spearman 
IFV: 0.67a 
RSV: 0.63a 
(correlations were stronger in 15–64y 
and ≥65y than 0–4y and 5–14y) 
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RSV: 0.56a (0), 0.60a (1w), 0.59a (2w), 
0.57a (3w), 0.55a (4w) 
IFV: 0.40a (0), 0.41a (1w), 0.34a (2w), 
0.33a (3w), 0.26a (4w) 
(correlations were stronger in ≥18y than 
<18y) 
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IFV: not significant 
RSV: not significant 
PIV: not significant 
RSV or IFV: 0.48c 
Time lag indicates the time difference between preceding VARI and subsequent PD incidence. 
Abbreviations: ADV, adenovirus; EV, enterovirus; IFV, influenza virus; IPD, invasive pneumococcal disease; m, month(s); 
MPV, metapneumovirus; PB, pneumococcal bacteraemia; PD, pneumococcal disease; PIV, parainfluenza virus; PM, 
pneumococcal meningitis; RSV, respiratory syncytial virus; RV, rhinovirus; VARI, viral acute respiratory infection; w, week(s); 
y, year(s). 
Correlation coefficients in bold were statistically significant as originally reported in the study (P<0.05); correlation coefficients 
ending with “a” were statistically significant after Bonferroni adjustment (P< 0.05/number of relevant tests) or when the 
Bonferroni correction was deemed unnecessary; correlation coefficients ending with “b” did not have enough information to 
apply the Bonferroni correction; correlation coefficients ending with “c” were not statistically significant after Bonferroni 
adjustment.  
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Regression analyses controlling for seasonal patterns 
Table 4-3 shows the summary of the 15 studies (Allard et al. 2012; Burgos et 
al. 2015; Ciruela et al. 2016; Domenech de Cellès et al. 2017; Grabowska et 
al. 2006; Kuster et al. 2011; Murdoch and Jennings 2009; Nicoli et al. 2013; 
Opatowski et al. 2013; Walter et al. 2010; Weinberger et al. 2013; 
Weinberger et al. 2014a; Weinberger et al. 2015; Zhou et al. 2012) that 
controlled for seasonal patterns by regression analysis. Results were 
inconsistent among the studies. In all-age population studies, preceding 
influenza infection was likely to be associated with IPD (12 studies(Burgos et 
al. 2015; Ciruela et al. 2016; Domenech de Cellès et al. 2017; Grabowska et 
al. 2006; Kuster et al. 2011; Murdoch and Jennings 2009; Nicoli et al. 2013; 
Walter et al. 2010; Weinberger et al. 2013; Weinberger et al. 2014a; 
Weinberger et al. 2015; Zhou et al. 2012) reported an association and two 
studies(Allard et al. 2012; Weinberger et al. 2014a) reported no association). 
According to two studies (Murdoch and Jennings 2009; Nicoli et al. 2013) 
that reported age-stratified results, the association between influenza and 
IPD was more likely to exist among older people than among young children. 
In terms of preceding RSV infection, four (Ciruela et al. 2016; Nicoli et al. 
2013; Weinberger et al. 2014a; Weinberger et al. 2015) out of five studies 
(Ciruela et al. 2016; Murdoch and Jennings 2009; Nicoli et al. 2013; 
Weinberger et al. 2014a; Weinberger et al. 2015) observed an association of 
RSV with PD incidence. Specifically, one study (Ciruela et al. 2016) found the 
association between RSV and IPD only existed among children <5 years. 
Studies reporting other viruses such as ADV and PIV were sparse (two 
(Ciruela et al. 2016; Murdoch and Jennings 2009) and one (Murdoch and 
Jennings 2009) studies, respectively). Five studies (Ciruela et al. 2016; 
Murdoch and Jennings 2009; Nicoli et al. 2013; Weinberger et al. 2014a; 
Weinberger et al. 2015) that reported two or more viruses demonstrated that 
the association differed by the type of virus. Moreover, the association could 
differ among virus subtypes (e.g. influenza A vs influenza B (Kuster et al. 
2011) and PIV 1/2 vs PIV 3 (Murdoch and Jennings 2009)). Notably, there 
are other factors that could influence the strength of the associations 
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reported in these studies. For instance, the association could vary by 
presentation of PD (invasive pneumococcal pneumonia, IPP vs npIPD 
(Walter et al. 2010; Weinberger et al. 2014a) and PP vs pneumococcal 
sepsis, PSe (Weinberger et al. 2015)); preceding VARI was more likely to be 
associated with the occurrence of pneumonia than other clinical 
presentations. Additionally, the results from studies in Denmark, where 
comorbidity status and pneumococcal serotype were available, demonstrated 
that influenza had a greater influence on the incidence of low-invasiveness 
serotypes than medium- or high- invasiveness among the low comorbidity 
group; among the high comorbidity group, the pattern was reversed 
(Weinberger et al. 2013; Weinberger et al. 2014a).  
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trends of IPD 
All ages 
IFV A: 1.01 (0), 1.00 
(1w), 1.00 (2w), 0.99 
(3w), 1.00 (4w), 1.00 
(5w) 
IFV B: 1.01 (0), 1.01 
(1w), 1.00 (2w), 1.01 


























IFV: 1.23a [1.03–1.47] 
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IFV: 1.26b [1.03–1.54] 
(0), 1.09 [0.87–1.36] 
(1m) 
RSV: 1.15 [0.89–1.48] 
(0), 1.81b [1.36–2.41] 
(1m) 
ADV: 1.58 [0.88–2.74] 
(0), 1.32 [0.68–2.42] 
(1m) 
<5y 
IFV: 1.16 [0.90–1.50] 
(0), 1.06 [0.80–1.42] 
(1m) 
RSV: 1.41 [1.00–1.97] 
(0), 
2.57b [1.78–3.71] (1m) 
ADV: 2.47b [1.38–
4.53] (0), 1.00 [0.59–
1.68] (1m) 
(not significant in 5–
64y or ≥65y) 
 
(Domenech 
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All ages 
ILI: median 4.9% across all 
study years (1w) 
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trends of IPD 
All ages 
IFV: 1.03 [0.93–1.15] 
(0), 1.11 [1.00–1.23] 
(1w), 1.11 [0.99–1.22] 
(2w), 1.14c [1.02–
1.26] (3w),  1.12c 
[1.01–1.23] (4w) 
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IFV A&B: 1.09a [1.05–
1.14] (1w), 0.93c 
[0.89–0.98] (3w) 
IFV A: identical to IFV 
A&B 
IFV B: not significant 
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IFV: 1.38c [1.02–1.85] 
(0), 1.20 [0.91–1.58] 
(1m) 
RSV: 1.15 [0.87–1.52] 
(0), 0.90 [0.68–1.18] 
(1m) 
PIV 1/2: 1.04 [0.82–
1.30] (0), 1.04 [0.84–
1.29] (1m) 
PIV 3 outside IFV 
season: 1.64a [1.18–
2.30] (0), 1.49c [1.07–
2.08] (1m) 
ADV: 0.97 [0.78–1.20] 
(0), 1.26c [1.02–1.54] 
(1m) 
(similar in 5–65y, 
>65y; not significant in 
<5y)  
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All ages, 0–4y, 5–14y, 15–
64y, ≥65y controlling for 
temperature, multiplicative 
model 
IFV: 5.6%b [0.2–23.8%] , 
−0.4% [−1.8–0.0%], 2.9%c 
[0.0–13.6%], 1.8%c [0.1–
7.4%], 3.2%b [0.0–14.7%] 
RSV: 2.9%b [0.1–14.2%], 




(no significant results in 
time lag analyses) 
(Opatowski 
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Northeast, all ages 
IFV-IPP: 4.9%c [4.5–5.3%] 
(1w) 
South, all ages 
IFV-IPP: 5.4%b [5.0–5.9%] 
(1w) 
West, all ages 
IFV-IPP: 5.2%c [4.8–6.0%] 
(1w) 
(not significant for IFV-
npIPD) 
(Weinberger 





































(not significant for IFV) 
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Covariates RR [95% CI] (time lag) AP [95% CI] (time lag) 
(Weinberger 































≥40y, low comorbidity and 
low serotype invasiveness 
ILI: 17.9%a [13.6–21.9%] 
(1w) 
≥40y, low comorbidity and 
high serotype invasiveness 
ILI: 6.7%a [3.8–11.7%] 
(1w) 
≥40y, medium/high 
comorbidity and low 
serotype invasiveness 
ILI: 1.3% [−1.6–5.4%] (1w) 
≥40y, medium/high 
comorbidity and high 
serotype invasiveness 
ILI: 8.9%a [6.6–11.8%] 
(1w) 
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
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(Weinberger 
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Covariates RR [95% CI] (time lag) AP [95% CI] (time lag) 
(Weinberger 





















trends of PD, 
PCV periods,  
IFV or RSV, 
state 







0–2m, 3–11m, 0–11m, 12–
23m 
IFV-PP: 2.1% [−4.5–1.4%], 











0.3%], 1.9%a [1.1–2.6%] 
RSV-PSe: 15.0%a [13.1–
17.1%], 0.1% [−4.9–5.0%], 
7.2%a [5.3–9.0%], 3.8%a 
[2.5–5.2%] 
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Covariates RR [95% CI] (time lag) AP [95% CI] (time lag) 































p values for the 
likelihood ratio test 












Time lag indicates the time difference between VARI and subsequent PD incidence. 
Abbreviations: ADV, adenovirus; AP, attributable percentage; CI, confidence interval; IFV, influenza virus; h, hour(s); ILI, 
influenza-like illness; IPD, invasive pneumococcal disease; IPP, invasive pneumococcal pneumonia; IR, incidence rate; npIPD, 
non-pneumonic invasive pneumococcal disease; PCV, pneumococcal conjugate vaccine; PD, pneumococcal disease; PIV, 
parainfluenza virus; PP, pneumococcal pneumonia; PSe, pneumococcal sepsis; RR, relative risk; RSV, respiratory syncytial 
virus;  UV index, clear-sky ultraviolet index; VARI, viral acute respiratory infection; w, week(s); y, year(s).  
Relative risk or attributable percentage in bold were statistically significant as originally reported in the study (P<0.05); relative 
risk or attributable percentage ending with “a” were statistically significant after Bonferroni adjustment (P<0.05/number of 
relevant tests) or when the Bonferroni correction was deemed unnecessary, those ending with “b” did not have enough 
information to apply the Bonferroni correction; relative risk or attributable percentage ending with “c” were not statistically 
significant after Bonferroni adjustment.
Global seasonality of respiratory viruses and the association between viral acute 
respiratory infection and subsequent pneumococcal disease 
Association of seasonal viral acute respiratory infection with pneumococcal 
disease: a systematic review  114 
Studies utilising other analyses 
Seven ecological studies (Dangor et al. 2014; Domenech de Cellès et al. 
2017; Hendriks et al. 2017; Kuster et al. 2011; Opatowski et al. 2013; 
Shrestha et al. 2013; Toschke et al. 2008) utilised other analytical methods 
(). Except for studies by Hendriks et al. (Hendriks et al. 2017) and Toschke et 
al. (Toschke et al. 2008), all studies reported an association between VARI 
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Abbreviations: IFV, influenza virus; IPD, invasive pneumococcal disease; PD, 
pneumococcal disease; PM, pneumococcal meningitis; PP, pneumococcal 
pneumonia; VARI, viral acute respiratory infection; w, week(s); y, year(s). 
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4.2.4 Discussion 
In our review, we summarised population-based studies that evaluated the 
association of seasonal VARI and subsequent PD. To our knowledge, this is 
the first review that summarises the methodology and findings of existing 
epidemiological studies on this topic.  
    We found that reported associations between VARI and subsequent PD 
were inconsistent among the 28 included studies. Only three studies 
(Edwards et al. 2011; O'Brien et al. 2000; Stensballe et al. 2008) analysed 
the association using individual patient data. The two cohort studies 
(Edwards et al. 2011; Stensballe et al. 2008) did not account for the shared 
risk factors between VARI and PD that influenced their seasonality, 
substantially limiting the inferences that can be made from these data while 
the case-control study (O'Brien et al. 2000) was limited by its small sample 
size (n case=13). In ecological studies, only 16 (Allard et al. 2012; Burgos et 
al. 2015; Ciruela et al. 2016; Domenech de Cellès et al. 2017; Grabowska et 
al. 2006; Hendriks et al. 2017; Kuster et al. 2011; Murdoch and Jennings 
2009; Nicoli et al. 2013; Opatowski et al. 2013; Walter et al. 2010; 
Weinberger et al. 2013; Weinberger et al. 2014a; Weinberger et al. 2015; 
Zhou et al. 2012) of the 25 (Allard et al. 2012; Ampofo et al. 2008; Burgos et 
al. 2015; Ciruela et al. 2016; Dangor et al. 2014; Domenech de Cellès et al. 
2017; Grabowska et al. 2006; Hendriks et al. 2017; Jansen et al. 2008; Kim 
et al. 1996; Kuster et al. 2011; Murdoch and Jennings 2009; Nicoli et al. 
2013; Opatowski et al. 2013; Peltola et al. 2011; Shrestha et al. 2013; Talbot 
et al. 2005; Toschke et al. 2008; Walter et al. 2010; M. Watson et al. 2006; 
Weinberger et al. 2013; Weinberger et al. 2014a; Weinberger et al. 2015; 
Zhou et al. 2012) ecological studies accounted for seasonal patterns. In 
these studies, we found that influenza and/or RSV infections were likely to be 
associated with the subsequent occurrence of PD. For influenza, the 
association was stronger among younger populations compared to older 
adults (Murdoch and Jennings 2009; Nicoli et al. 2013) while the pattern was 
reversed for RSV (Ciruela et al. 2016). Data from multiple studies suggested 
that virus type (five studies (Ciruela et al. 2016; Murdoch and Jennings 2009; 
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Nicoli et al. 2013; Weinberger et al. 2014a; Weinberger et al. 2015)) and 
subtype (two studies (Kuster et al. 2011; Murdoch and Jennings 2009)), 
comorbidity status (two studies (Weinberger et al. 2013; Weinberger et al. 
2014a)) and pneumococcal serotype invasiveness (one study (Weinberger et 
al. 2013)) could influence the association. However, these 16 ecological 
studies had various population characteristics (e.g. age, comorbidity, 
immunity status), PD datasets, VARI datasets and analytical methods. As 
such, heterogeneity among the studies, along with their ecological nature, 
limits the amount of valid inferences that can be made from the data (as 
summarised above).  
Nevertheless, these studies provide important clues for the potential factors 
related to the association between VARI and subsequent PD, and thus could 
help with the conception and design of future studies. Ideally, in order to 
understand whether a particular preceding VARI can predispose an individual 
to PD, a prospective cohort study that monitors each individual for VARI and 
pneumococcal infection would be utilised, allowing analyses at both 
individual and population levels. However, such a design would not be 
feasible or affordable as inter alia pneumococcal infections are rare. 
Alternatively, utilisation of large-scale routine health data and reliable data 
linkage (through unique individual identifiers) from sources such as 
surveillance data and hospitalisation datasets may be feasible in many 
industrialised countries. An example of such data linkage in our review is the 
study by Stensballe and colleagues (Stensballe et al. 2008) that linked 
information from four Danish population-based registries. While the authors 
conducted individual-level analysis, the results were based on cases tested 
for both the presence of respiratory viruses and pneumococcal infection. The 
true number of VARI-associated PD cases is likely to be significantly higher 
due to incomplete testing of cases; the untested viral-pneumococcal cases 
could represent a crucial source of selection bias. Community-based active 
surveillance can likely address the issue of missing cases but such 
surveillance would be labour intensive and less cost-effective to conduct. 
Another option is a case-control study, which is affordable and practical, but 
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not without its limitations. In addition to challenges in designing such studies, 
defining the history of VARI is likely to be inaccurate since the timing of viral 
serology may be less accurate (information bias) (Peltola et al. 2011). In the 
case-control study by O’Brien and colleagues, (O'Brien et al. 2000) the 
authors used influenza-strain specific convalescent serology as evidence for 
preceding influenza infection. The authors also conducted telephone 
interviews to investigate ILI history but they did not mention whether 
interviewers and interviewees were blind to case or control status. Moreover, 
the value of this case-control study is limited by its very small sample size (n 
case = 13). 
Compared with individual patient data based studies, ecological studies are 
more feasible, and thus the most common study design included in our 
review (25/28). However, there are some caveats when interpreting results 
from ecological studies. First, causality can never be inferred from such 
studies. Second, the results should be interpreted at a population level and 
cannot be generalised to the individual level. Since ecological studies used 
data aggregated into broad categories, the potential biases introduced by the 
aggregation should be taken into account. For instance, while 16 out of 25 
ecological studies used weekly data, others used fortnightly or monthly data. 
This may lead to misclassification as the time window of the association of 
VARI on PD susceptibility can be as short as one week (McCullers and Rehg 
2002; Sun and Metzger 2008). Moreover, data from different sources in 
ecological studies should represent the same population. 
Apart from the study design, one further challenge of analysing the 
association is accounting for the influence of seasonal factors of VARI and 
PD (confounding). Both VARI and PD have similar seasonal patterns, and 
thus are likely to correlate as indicated by the correlation results from 
ecological studies. The increased risk of PD during an epidemic season 
could be caused by VARI or by seasonal risk factors or by both. In the 
present review, 11 studies (Ampofo et al. 2008; Dangor et al. 2014; Edwards 
et al. 2011; Jansen et al. 2008; Kim et al. 1996; Peltola et al. 2011; Shrestha 
et al. 2013; Stensballe et al. 2008; Talbot et al. 2005; Toschke et al. 2008; M. 
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Watson et al. 2006) did not attempt to control for seasonal confounders, likely 
leading to biased estimations of the association. For example, the study by 
Edwards and colleagues (Edwards et al. 2011) reported a relative risk as 
high as 112.5 when not adjusting any seasonal factors. One way to address 
this problem in such studies would be to match the individuals with the onset 
timing of pneumococcal infection, keeping the risk of PD comparable 
between VARI cases and non-VARI cases; for ecological studies, regression 
analysis adding seasonal terms or climatic factors (such as temperature and 
humidity), or cross-correlation analysis of time series controlling for seasonal 
patterns could be considered. 
Our review suggests that the association of VARI and subsequent PD 
could vary by virus type (Ciruela et al. 2016; Murdoch and Jennings 2009; 
Nicoli et al. 2013; Weinberger et al. 2013; Weinberger et al. 2014a) and even 
by subtype (Kuster et al. 2011; Murdoch and Jennings 2009). Studies using 
combinations of viral infections such as all virus, influenza + RSV, non-
influenza, or non-RSV could give biased estimations of the association. 
However, it is not always practical to analyse the association by virus type. In 
ecological studies, different types of viruses might co-circulate and thus be 
highly correlated in incidence, making it difficult to determine the role for each 
virus. In terms of PD, most studies used IPD as the outcome of interest. 
However, studies that categorised IPD into IPP and npIPD found that the 
association was more pronounced in IPP than in npIPD (Walter et al. 2010; 
Weinberger et al. 2014a). A similar finding, that the association was stronger 
in PP than PSe, was reported in another study (Weinberger et al. 2015). 
These results suggest VARI is more likely to be associated with pneumonic 
pneumococcal infections than non-pneumonic infections. In our review, we 
excluded studies using information other than clinical diagnosis as a proxy for 
PD (e.g. prescription data and carriage data). Pneumococcal carriage could 
have a fundamental role in the transmission and incidence of PD (Simell et 
al. 2012). In a study analysing the impact of pneumococcal carriage and viral 
activity, Weinberger and colleagues (Weinberger et al. 2014a) found npIPD 
was associated with carriage prevalence, whereas IPP was associated with 
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bronchiolitis (as a proxy for RSV). The authors also proposed that preceding 
VARI increased susceptibility but did not enhance transmission (indicated by 
carriage prevalence) in children. However, more studies are needed to 
confirm these findings. 
The association could also vary by population characteristics. According to 
two studies that displayed age-stratified results (Murdoch and Jennings 2009; 
Nicoli et al. 2013), the association of influenza and subsequent IPD was 
more likely to exist among older people than among young children. Studies 
by Weinberger et al.(Weinberger et al. 2013; Weinberger et al. 2014a) 
gauged the association in different comorbidity and pneumococcal serotype 
groups among Denmark populations. The results showed that influenza had 
a stronger impact on the incidence of low-invasiveness serotypes than 
medium- or high- invasiveness ones in the low comorbidity group, while the 
pattern reversed in the high comorbidity group. Another study that analysed 
clinical records of 919 patients with PP found that infrequently colonising 
pneumococcal serotypes were more likely to cause PP after preceding VARI, 
particularly in patients with immunodeficiency or chronic lung diseases (Song 
et al. 2014). These findings suggest the need for future studies to analyse the 
association by age group, pneumococcal serotype and comorbidity status. 
Moreover, the recent introduction of pneumococcal vaccines has brought 
changes in the incidence of serotype-specific PD (Shiri et al. 2017), making 
the association of VARI and PD more complicated to understand. As a result, 
future studies should consider the possible serotype-specific influence that 
pneumococcal vaccines have on both individual immunity and herd immunity 
when analysing the association. 
    In addition to the factors discussed above, additional factors may influence 
the estimates of the association. The first is the change over time in the 
methodology of data collection, including changes in test method or 
diagnosis, clinical practice and health-seeking behaviour. The second is the 
possible delay in measurement, which happened most often in passive 
hospital-based studies. Thirdly, for ecological studies using aggregated data, 
“holiday spikes” could occur due to more social gatherings (Walter  et al. 
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2009); besides, weekends and holidays might influence timely tests or 
diagnosis as well as the health-seeking behaviour of patients. 
To our knowledge, this is the first review to summarise and critically 
appraise the methods and results of population-based studies about the 
association between seasonal VARI and subsequent PD. However, this 
review is not without its limitations. First, due to a variety of study designs, 
data sources and analytical methods in the studies included, no meta-
analysis was conducted in the review. As such, we were unable to provide a 
quantitative measure of the association of seasonal VARI and PD. Second, 
no unpublished data sources were included in the review, which could mean 
the data reported favours positive associations due to publication bias. Thus, 
caution should be taken when interpreting the results. Thirdly, we found 
many studies tended to conduct multiple statistical tests using different 
subgroups and time periods (e.g. age group, virus, time lag between VARI 
and PD) without specifying the primary study question a priori or making 
proper statistical adjustments to account for multiple testing. This could give 
rise to an increased risk of reporting false positive results. In this review, we 
applied Bonferroni corrections to adjust for the multiple tests where deemed 
necessary. Since the Bonferroni method is conservative and we are unable 
to adjust for studies where P values were not given, the adjustment in our 
review is intended for readers’ reference and as caveats for future studies. 
Given the substantial burden of VARI across the world,(H. Wang et al. 
2016) even a modest association between VARI and subsequent PD could 
lead to a substantial burden of disease in terms of VARI-related PD cases. If 
proper anti-bacterial interventions could be applied to those with higher risk 
of PD due to a preceding VARI, subsequent pneumococcal infections could 
be prevented. The interventions would be more effective / better targeted if 
we could estimate the risk (i.e. the strength of association) according to 
timing of infection by week/month of a year, age, comorbidity status, virus 
type and status of immunity. In turn, understanding the association between 
VARI and subsequent pneumococcal infection can help evaluate the full 
impact of viral vaccine programs. 
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In conclusion, the role of seasonal VARI on subsequent PD incidence 
remains controversial in population-based studies. Nevertheless, these 
studies provide valuable information and can help with the conception of 
future well-designed studies. Future work could explore the association by 
timing of infection, age, comorbidity status, virus type, pneumococcal 
serotype and presentation, and thus would identify potentially susceptible 
populations with VARI for preventive interventions. 
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4.3 Supplementary files to the publication 
“Association of seasonal viral acute respiratory 
infection with pneumococcal disease: a 
systematic review of population-based studies” 
Table 4-4 Summary of findings from animal and in vitro studies 
Study Material Exposure Main findings 
(Diavatopoulos 
et al. 2010) 
Mice 
(n=~10 per group) 
influenza A + 
pneumococcus 
(3d later) 
On day 3 of 
pneumococcus challenge, 
pneumococcus numbers 
increased in the 
nasopharynx (50-fold, 
P=0.0002) and the lungs 
(300-fold, P=0.0005) in 





littermates was dependent 
on infection with influenza 
A. 










After RSV infection of the 
monolayers, an increased 
adherence (2–10 fold) was 
observed among all 
serotypes compared with 
uninfected monolayers. 
(J. M. Hament et 
al. 2005) 
Mice 
(n=7 per group) 
RSV + 
pneumococcus (0 
or 4d later) 
At 24h of pneumococcus 
challenge, mice infected 
with RSV 0 or 4d before 
pneumococcus challenge 
had higher levels of 
bacteremia than control 
group. 
(Kukavica-Ibrulj 
et al. 2009) 
Mice 






on day 7 of 
pneumococcus challenge: 
5×102 CFU/lung in mock 
infection, 107 CFU/lung in 
hMPV group and 108 
CFU/lung in influenza A 
group. 
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Study Material Exposure Main findings 
(LeVine et al. 
2001) 
Mice (n=3 per 
group) 






colony counts 24h and 
48h following 
pneumococcus challenge. 
(Ludewick et al. 
2011) 






Only mice infected with 
influenza A demonstrated 
an 8% weight loss 72h 
following pneumococcus 
challenge while hMPV 




Mice (n=20 per 
group) 
influenza A + 
pneumococcus (0 
or 7d later) 
60% of mice died 2–11d 
after pneumococcus 
challenge in influenza A 
group compared with 15% 
in mock group; reversal of 
the order of challenge led 
to protection from 
influenza; challenge of 
influenza and 
pneumococcus on the 
same day led to 100% 
mortality. 
(McCullers et al. 
2010) 
Ferrets (n=5 per 
group) and Mice 
(n=~5 per group) 
influenza A + 
pneumococcus 
(7d later) 
Prior influenza infection 
enhanced pneumococcal 






et al. 2016) 
Mice (n=3–5 per 
group) 
influenza A + 
pneumococcus 
T4, 19F or 7F (7d 
later) 
Pneumococcal coinfection 
during the acute phase of 
influenza A infection 
increased degree of 
pneumonia and mortality 
for all tested 
pneumococcal strains. 
However, the incidence 
and kinetics of systemic 
dissemination remained 
strain dependent. 
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Study Material Exposure Main findings 




epithelial cells and 




Following incubation with 
RSV, pneumococcus 
demonstrated a significant 
increase in the 
inflammatory response 
and bacterial adherence to 
human ciliated epithelial 
cultures and increased 
virulence in mice model. 
(Stark et al. 
2006) 






at 24h of pneumococcus 
challenge: 7.45×105 
CFU/lung in RSV group, 
5.9×103 CFU/lung in mock 
group. 
The number in brackets in the column material refers to the number of 
animals observed under each experiment condition; number of animals used 
in transmission models (used by some studies) were not displayed.  
Abbreviations: CFU, colony-forming units; d, day(s); h, hour(s); hMPV, 
human metapneumovirus; RSV, respiratory syncytial virus. 
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Panel 4-1 Search strategy 
Medline 
1. Meningitis, Pneumococcal/ or Pneumonia, Pneumococcal/ or exp 
Pneumococcal Infections/ or pneumococc*.mp.  
2. exp Streptococcus pneumoniae/ or Streptococcus pneumoniae.mp.  
3. virus.mp. or exp Viruses/  
4. exp Virus Diseases/ or virus disease*.mp.  
5. correlat*.mp.  
6. associat*.mp.  
7. interact*.mp.  
8. relat*.mp.  
9. 1 or 2  
10. 3 or 4  
11. 5 or 6 or 7 or 8  
12. 9 and 10 and 11  
13. limit 12 to yr="1990 -Current" 
1,664 results by 27 Apr 2017 
1,888 results by 31 Dec 2017 
EMbase 
1. exp pneumococcal infection/ or pneumococc*.mp.  
2. Streptococcus pneumoniae.mp. or exp Streptococcus pneumoniae/  
3. exp virus/ or virus*.mp.  
4. exp virus infection/ or virus infection*.mp. or virus disease*.mp.  
5. exp correlational study/ or exp correlation analysis/ or correlat*.mp.  
6. associat*.mp.  
7. interact*.mp.  
8. relat*.mp.  
9. 1 or 2  
10. 3 or 4  
11. 5 or 6 or 7 or 8  
12. 9 and 10 and 11  
13. limit 12 to yr="1990 -Current" 
4,778 results by 27 Apr 2017. 
5,098 results by 31 Dec 2017. 
Global Health 
1. Streptococcus pneumoniae.mp. or exp Streptococcus pneumoniae/  
2. pneumococc*.mp.  
3. virus*.mp. or viruses/  
4. virus disease*.mp. or viral diseases.sh. or virus infection*.mp.  
5. exp correlation/ or correlation analysis/ or correlat*.mp.  
6. associat*.mp.  
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7. interact*.mp.  
8. relat*.mp.  
9. 1 or 2  
10. 3 or 4  
11. 5 or 6 or 7 or 8  
12. 9 and 10 and 11  
13. limit 12 to yr="1990 -Current" 
1,164 results by 27 Apr 2017 
961 results by 31 Dec 2017 
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Exposure Outcome Data Analysis at POP level Seasonality 
Adjustment IFV RSV Others PD IPD PP Others IDNV POP CORR REGR Others 
(Allard et al. 2012) 
Yes, multiple 
methods 
            
(Ampofo et al. 2008) 
Yes, IF and 
culture 
            
(Burgos et al. 2015) Yes, IF and PCR             
(Ciruela et al. 2016) 
Yes, multiple 
methods 
            
(Dangor et al. 2014) 
Yes, IF and 
culture 
            
(Domenech de Cellès 
et al. 2017) 
No             
(Edwards et al. 2011) 
Yes, method not 
known 
            




            
(Hendriks et al. 2017) No             
(Jansen et al. 2008) 
Yes, multiple 
methods 
            
(Kim et al. 1996) Yes, culture             
(Kuster et al. 2011) 
Yes, culture and 
DAT 
            
(Murdoch and 
Jennings 2009) 
Yes, IF and 
culture 
            
(Nicoli et al. 2013) 
Yes, multiple 
methods 
            
(O'Brien et al. 2000) Yes, serology             
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Exposure Outcome Data Analysis at POP level Seasonality 
Adjustment IFV RSV Others PD IPD PP Others IDNV POP CORR REGR Others 
(Opatowski et al. 2013) No             
(Peltola et al. 2011) 
Yes, multiple 
methods 
            
(Shrestha et al. 2013) No             
(Stensballe et al. 2008) No             
(Talbot et al. 2005) 
Yes, culture and 
RAT 
            
(Toschke et al. 2008) Yes, PCR             
(Walter et al. 2010) 
Yes, method not 
known 
            
(M. Watson et al. 
2006) 
Yes, DAT             
(Weinberger et al. 
2014a) 
No             
(Weinberger et al. 
2013) 
No             
(Weinberger et al. 
2014a) 
No             
(Weinberger et al. 
2015) 
No             
(Zhou et al. 2012) 
Yes, method not 
known 
            
CORR, correlation; DAT, direct antigen test; IF, immunofluorescence; IFV, influenza virus; INDV, individual; IPD, invasive 
pneumococcal disease; PCR, polymerase chain reaction; PD, pneumococcal disease; POP, population; PP, pneumococcal 
pneumonia; REGR, regression; RAT, rapid antigen test; RSV, respiratory syncytial virus; VARI, viral acute respiratory 
infection.  
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4.4 Conclusion 
This is the first review that critically reviewed the methods and the findings of 
population-based studies that reported an association between VARI and 
PD. This review would serve as a comprehensive summary of existing 
studies on this topic, and thus assist in designing future studies that aim to 
understand the role of VARI on the occurrence of PD. Additionally, 
understanding the association between VARI and subsequent pneumococcal 
infection can help evaluate the full impact of viral vaccine programs. This is 
particularly relevant as novel vaccines for respiratory viruses (e.g. RSV) are 
being developed and likely to be introduced into national programmes in the 
next 5-7 years. 
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Chapter 5 Association between respiratory 
virus activity and subsequent 
invasive pneumococcal disease 
5.1 Introduction 
Association between respiratory virus activity and subsequent invasive 
pneumococcal disease (IPD) is long recognised. As introduced in Chapter 3, 
the systematic review (Li et al. 2018) reported that IFV and RSV infections 
were likely to be associated with the subsequent occurrence of 
pneumococcal diseases (IFV: 12/14 studies; RSV 4/5 studies). However, 
only a few of the studies were able to assess the association using 
laboratory-confirmed evidence of viral infection. For example, influenza-like 
illness was used in studies as a proxy of IFV infection and clinical 
bronchiolitis was used as a proxy of RSV infection. This would obscure the 
underlying viral-pneumococcal association. The present study aims to assess 
the association using laboratory-confirmed evidence of respiratory viral 
infection and invasive pneumococcal disease. 
5.2 Method 
5.2.1 Data sources 
Laboratory-confirmed infection data of IFV, RSV, PIV, and MPV were 
obtained from the Electronic Communication of Surveillance in Scotland 
(ECOSS) dataset. In ECOSS, the samples tested for virus could originate 
from patients seeking medical attention in either primary or secondary care 
settings. Only respiratory samples were included for the current study. The 
date of the sample was recorded as the date when respiratory samples were 
taken. Data were available from 2009 to 2017 and aggregated on a weekly 
basis, stratified by age group: <6y, 6–64y, and >64y.  
IPD data were obtained from the Scottish Pneumococcal Invasive Disease 
Enhanced Reporting (SPIDER) scheme from 2009 to 2017. This surveillance 
scheme is based on the local and reference laboratory test reports of 
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pneumococcus from invasive body sites. Similarly to the laboratory-confirmed 
viral data, the SPIDER data were aggregated by week and by age group. 
Apart from ECOSS data and SPIDER data, I also included the Scottish 
Morbidity Record (SMR) data in the sensitivity analysis. I extracted ICD-10-
coded IFV, RSV and pneumococcal pneumonia data from 2001 to 2016 and 
aggregated them by week and by pre-specified age groups (as stated for 
ECOSS and SPIDER data). Details regarding the ICD-10 codes used are in 
Appendix A23. No individually identifiable data were used throughout this 
study. 
When presenting the age distribution (i.e. in <6y, 6–64y, and >64y) of IPD 
and viral cases, I also extracted age-specific Scottish population data from 
National Records of Scotland for comparison (Anonymous 2018). The 
population at the midpoint of the study period was used, i.e. the mid-2013. 
The proportion of population in <6y, 6–64y, and >64y was 6.6%, 75.6%, and 
17.8%, respectively. 
5.2.2 Data analysis 
In the main analysis, I used weekly time series data of IPD and laboratory-
confirmed viruses, including IFV, RSV, PIV, and MPV. Negative binomial 
regression analysis rather than Poisson regression was conducted to 
account for overdispersion (formula in Panel 5-1). For the convenience of 
description, week 0 is defined as the week of viral infection; week 1 is defined 
as one week after the week of viral infection, etc. For the dependant variable 
IPD, a range of lags (from 1 week to 6 weeks) between viral infection and 
subsequent IPD were explored, which were based on the choices in pre-
existing population studies. To account for shared risk factors between viral 
infection and IPD, I included simultaneously all the four viruses and IPD at 
week 0. This can also account for the auto-correlation in IPD. Akaike 
information criterion (AIC) was applied to select the optimal lag in the model. 
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Panel 5-1 Negative binomial regression for main analysis 
𝐼𝑃𝐷𝑖  ~ 𝐼𝐹𝑉 + 𝑅𝑆𝑉 + 𝑃𝐼𝑉 + 𝑀𝑃𝑉 + 𝐼𝑃𝐷0 
Where i indicates the week index; week 0 is the week of viral infection. 
i = 1, 2, 3, 4, 5, 6. Akaike information criterion (AIC) was applied for the 
selection of i. 
The attributable percentage (AP) of IPD to each virus was calculated based 
on the corresponding model coefficient, using the same approach as 
Weinberger et al (Weinberger et al. 2015). This is a four-step approach: I first 
obtained the estimate of the predicted weekly IPD incidence using the model 
above, with independent variables set as the observed weekly values. 
Secondly, I obtained the estimate of the predicted weekly IPD incidence, 
using the same model (i.e. without refitting the model), with one of the viruses 
of interest (e.g. IFV) set as zero and the rest (i.e. RSV, PIV, and MPV) set as 
the observed weekly values. Thirdly, I summed all the weekly IPD incidence 
with all viruses set as observed values and all the weekly IPD incidence with 
one of the viruses (e.g. IFV) set as zero, to obtain the overall incidence of 
IPD and the overall incidence of IPD without one of the viruses (e.g. IFV), 
respectively. Then, as the final step, the overall incidence of IPD attributable 
to each virus could be obtained by subtracting the overall incidence of IPD 
without that virus from the overall incidence of IPD and the AP of IPD to each 
virus was calculated by the viral attributable incidence divided by the total 
incidence. 95% confidence intervals of AP were estimated using a yearly 
block bootstrap with 1000 replicates. The AP of a virus was arbitrarily set as 
zero if the coefficient of that virus in the model was not statistically significant.  
The above analysis was conducted in all ages, <6y, 6–64y, and >64y. 
Sensitivity analysis 
A series of sensitivity analyses were conducted using different data for 
comparison with the main analysis as detailed above. Four sets of sensitivity 
analysis were conducted (Panel 5-2). The first set only included post-PCV-13 
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period (i.e. after 2011 in Scotland) to preclude the potential effect of the 
former PCV-7. The second set replaced laboratory-confirmed data with ICD-
10-coded data. The third set replaced laboratory-confirmed IPD with ICD-10-
coded pneumococcal pneumonia and the fourth set replaced all data with 
ICD-10-coded data.  
Similar to the main analysis, all sets of sensitivity analysis were conducted in 
all ages, <6y, 6–64y, and >64y. 
Panel 5-2 Sensitivity Analyses (negative binomial regression) 
Sensitivity analysis 1: 𝐼𝑃𝐷𝑖  ~ 𝐼𝐹𝑉 + 𝑅𝑆𝑉 + 𝑃𝐼𝑉 + 𝑀𝑃𝑉 (𝐴𝑓𝑡𝑒𝑟 2011) 
Sensitivity analysis 2: 𝐼𝑃𝐷𝑖  ~ 𝐼𝐹𝑉(𝐼𝐶𝐷) + 𝑅𝑆𝑉(𝐼𝐶𝐷) 
Sensitivity analysis 3: 𝑃𝑃𝑖(𝐼𝐶𝐷)~ 𝐼𝐹𝑉 + 𝑅𝑆𝑉 + 𝑃𝐼𝑉 + 𝑀𝑃𝑉 
Sensitivity analysis 4: 𝑃𝑃𝑖(𝐼𝐶𝐷)~ 𝐼𝐹𝑉(𝐼𝐶𝐷) + 𝑅𝑆𝑉(𝐼𝐶𝐷) 
Where i indicates the week index; week 0 is the week of viral infection. 
i = 1, 2, 3, 4, 5, 6. Akaike information criterion (AIC) was applied for the 
selection of i. 
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5.3 Results 
5.3.1 Study characteristics  
From 2009 to 2017, I included 5130 cases of IPD, 31788 cases of IFV, 25138 
cases of RSV, 10939 cases of PIV, and 6732 cases of MPV. With regard to 
the distribution across age groups, IPD and all viral infections were less 
frequently observed among 6–64y. Over 80% of the RSV cases and over 
50% of the PIV and MPV cases were seen in young children. IFV was more 
frequently found in <6y and 6–64y. On the other hand, IPD was most 
prevalent among older adults. More detailed results are attached below in 
Table 5-1. Yearly number of IPD and viral infection cases are attached in 
Appendix A24. 
Table 5-1 Number of IPD and viral infection cases included in the main 
analysis by age group 
Age Group 
(% population) 

















































IPD=invasive pneumococcal disease; IFV=influenza virus; RSV= respiratory 
syncytial virus; PIV=parainfluenza virus; MPV=metapneumovirus; y=year(s) 
5.3.2 Seasonality of IPD and viral-infections 
As shown in Figure 5-1, IFV and RSV had one annual seasonal peak, 
without any secondary peaks before or after the primary peak. The only 
exception was for IFV during the swine flu pandemic in 2009. The peak 
timing of the three viruses were slightly different. RSV peak was before the 
end of each calendar year whereas seasonal IFV peak was at the beginning 
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of each calendar year. PIV had two annual seasonal peaks, one primary 
peak in early summer and one secondary peak in later autumn. PIV was also 
prevalent out of season, which was different from IFV or RSV. MPV had one 
annual peak in spring in generally but sometimes had secondary peaks 
before or after the primary peak. IPD had one primary peak at the beginning 
of each calendar year but it also had multiple peaks throughout other time of 
a year and was prevalent all year round. Seasonality of IPD and all the four 
viruses was similar among different age groups Figure 5-2.  
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Figure 5-1 Time series of number of cases in IPD and each viral 
infection, presented as 3-week moving average 
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Figure 5-2 Time series of number of cases in IPD and each viral 
infection by age group, presented as 3-week moving average 
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5.3.3 Association between IPD and viral infection 
In all ages, there was significant association between viral infection and 
subsequent IPD and the time lag was 1 week. The AP of IPD attributable to 
IFV, RSV, PIV, and MPV was 7.5%, 10.8%, 11.6%, and 11.1%, respectively. 
In age-group-stratified analysis, IFV and RSV were consistently associated 
with subsequent IPD with the time lag of 1–2 weeks. The AP of IPD to IFV 
and RSV was higher in young children than other age groups. PIV was 
associated with IPD in both young children and older adults whereas MPV 
was associated with IPD in the middle age group (i.e. 6–64y). 
Table 5-2 Percentage of IPD attributable to each virus by age group in 
the main analysis 
Age Group Lag* (wk) 
Attributable Percentage of IPD 


































*Time lag between viral infection and subsequent IPD.  
**Separate models were used for each age group so the estimates of AP in 
all ages might not vary. IPD=invasive pneumococcal disease; wk=week; 
IFV=influenza virus; RSV=respiratory syncytial virus; PIV=parainfluenza 
virus; MPV=metapneumovirus; y=year(s) 
Sensitivity analysis 
In all sensitivity analyses, the optimal time lag between viral infection and 
subsequent IPD was generally consistent (1–2 weeks across all age groups). 
In the sensitivity analysis with viral data replaced by ICD-coded IFV and RSV 
hospitalisations data, the results were generally consistent with the main 
analysis (Appendix A25). In the sensitivity analysis only including data in 
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post-PCV-13 period, while most estimates were similar to the main analysis, I 
observed a significant increase in the AP to PIV in the group of all ages 
(20.3% vs 11.6%) (Table 5-3). 
However, in the two sensitivity analyses that replaced IPD with clinically 
diagnosed PP, the results were different from all the other analyses (i.e. one 
main analysis and two sensitivity analyses) that used IPD data (Appendix 
A26 and Appendix A27).  
Table 5-3 Percentage of IPD attributable to each virus by age group in 
post-PCV-13 period as a sensitivity analysis 
Age Group Lag* (wk) 
Attributable Percentage of IPD 

































An arrow (↑ up or ↓ down) indicates a significant difference in the attributable 
percentage, compared with corresponding estimate in the main analysis. 
*Time lag between viral infection and subsequent IPD; IPD=invasive 
pneumococcal disease; wk=week; IFV=influenza virus; RSV=respiratory 
syncytial virus; PIV=parainfluenza virus; MPV=metapneumovirus; y=year(s) 
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5.4 Discussion 
Using laboratory-confirmed IPD and viral data in Scotland from 2009 to 2017, 
I found statistically significant associations between viral infection, including 
IFV, RSV, PIV, and MPV, and subsequent IPD incidence among all-age 
group. The time lag between viral infection and IPD incidence was estimated 
to be 1–2 weeks. It was estimated that 7.5%, 10.8%, 11.6%, and 11.1% of 
IPD cases could be attributable to IFV, RSV, PIV, and MPV, respectively. 
Results of age-group-stratified analysis showed that IFV and RSV were 
consistently associated with subsequent IPD across all age groups whereas 
the results of PIV and MPV were more variable and further study on PIV and 
MPV is warranted. 
Although for the association between IFV and RSV, and IPD, the findings of 
this study were generally consistent with previous studies (Li et al. 2018). the 
estimate of AP of IPD attributable to IFV and RSV in all ages was statistically 
higher than some estimates in previous studies. More detailed comparisons 
are presented in Table 5-4. Only the study by Nicoli et al conducted further 
age-stratified analysis (Nicoli et al. 2013). However, the confidence intervals 
of the age-stratified estimates in that study were too wide and not very 
informative. In the age-stratified analysis of my study, the AP of IPD to IFV 
and RSV was higher in young children than other age groups. This is 
consistent with the findings by Weinberger et al (Weinberger et al. 2013, 
2014b) that the AP due to influenza-like illness was higher in people with low 
comorbidity status than middle or high comorbidity status. This is also 
consistent with the experience from most historic pandemics of IFV that 
young people are more likely to be affected by the subsequent 
pneumococcal infection during pandemic IFV (summarised in Section 1.3.3). 
For young children, the findings of this study are also relevant to the 
evaluation of the immunisation programmes of IFV and RSV as prevention of 
IFV and RSV has potential effects on the prevention of subsequent 
pneumococcal infection. 
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Table 5-4 Comparison of findings between previous studies and my 
study in the AP of IPD attributable to IFV and RSV among all ages 
Study Setting Virus IPD AP (95% CI) 
(Domenech de Cellès 
et al. 2017) 
France ILI (as 
IFV) 
IPD 4.9%*↓ 
(Grabowska et al. 
2006) 
Sweden IFV IPD 6% (1–12) – 
(Nicoli et al. 2013) England & Wales IFV IPD 5.6% (0.2–23.8) – 
(Nicoli et al. 2013) England & Wales RSV IPD 2.9% (0.1–14.2) ↓ 
(Walter et al. 2010) North-eastern US IFV IPP 4.9% (4.5–5.3) ↓ 
(Walter et al. 2010) Southern US IFV IPP 5.4% (5.0–5.9) – 
(Walter et al. 2010) Western US IFV IPP 5.2% (4.8–6.0) ↓ 
AP=attributable percentage; CI=confidence interval; IPD=invasive pneumococcal 
disease; IFV=influenza virus; RSV=respiratory syncytial virus; ILI=influenza-like 
illness; IPP=invasive pneumococcal pneumonia 
* No confidence interval was reported. 
↓ Estimate lower than the lower confidence interval of the estimate of my study. 
– Estimate within the confidence interval of the estimate of my study. 
In terms of the association between PIV and MPV, and IPD, few studies 
explored this in details, partly due to the lack of comprehensive laboratory 
testing of these two viruses and the lack of acceptable proxies for these two 
viruses. One study conducted in New Zealand found that PIV 3 outside of the 
IFV season was associated with IPD among all ages (Murdoch and Jennings 
2009). No age-stratified analysis was done in that study. Therefore, I was not 
able to further compare the results by age group between the two studies. 
The sensitivity analyses conducted in my study suggest that the results for 
PIV and MPV might not be robust enough and the insufficient power could be 
a major reason for this (the number of PIV cases was less than half of IFV or 
RSV; the number of MPV cases was less than a quarter of IFV or RSV). 
Future studies with more sufficient samples of PIV and MPV are needed.  
The sensitivity analysis of this study replacing IPD with clinically diagnosed 
PP showed different association results from the main analysis using IPD. 
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The difference could be due to the lack of microbiological evidence in these 
clinical diagnoses. Therefore, one should interpret the results of similar 
studies using ICD-coded pneumococcal diseases with caution. By contrast, 
the sensitivity analysis replacing laboratory-confirmed viral infection with ICD-
coded viral infection had generally similar results as the main analysis. 
In Scotland, IPD plus all of the four viruses, IFV, RSV, PIV, and MPV have 
their distinct seasonal patterns. For each virus, overlaps can be found 
between viral peaks and IPD peaks, which corresponds to the association 
between viral infection and IPD. However, there were other features of viral 
and IPD seasonality that did not support the association. For example, not 
every IFV peak was followed by an IPD peak (i.e. IFV is not sufficient for 
IPD); and an IPD peak could happen without a prior IFV peak (i.e. IFV is not 
necessary for IPD). This is also observed for during the past IFV pandemics. 
Unlike the 1918 Spanish flu, the 1957 Asian flu and 1968 Hong Kong flu had 
fewer secondary pneumococcal infections than 1918 Spanish flu. This raises 
the question whether viral strains modifies the viral-pneumococcal 
association. 
In addition, other important questions about viral-pneumococcal association 
have not been well studied. First, it is not well understood whether co-
seasonality exists in tropical and sub-tropical regions as the existing studies 
have focused almost exclusively on the temperate regions (Li et al. 2018). 
This question is relevant as the common seasonal risk factors (e.g. low 
temperature) between viral infection and pneumococcal infection could 
confound their association. These factors could be “naturally” controlled for in 
the tropics and perhaps in the subtropics. If no co-seasonality is observed 
there, then the association would not exist, at least at the population level. 
Nevertheless, if co-seasonality is observed, this does not indicate the 
association as one cannot rule out the possibility that other common 
seasonal risk factors than temperature in the tropics/subtropics confound the 
association. Second, it is not well understood whether the association exists 
at the individual-patient level. Although there were three existing individual-
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patient based studies (Edwards et al. 2011), they all had methodological 
issues that biased the association (details discussed in the review in Chapter 
3). Third, it is not well understood what the time lag between viral infection 
and pneumococcal infection is. In the current study, I found that 1–2 weeks of 
lag had the best model fit. From the experience of past IFV pandemics, the 
time lag was likely to be 1 week after the IFV symptoms. Active surveillance 
is warranted in order to confirm the findings from this study. 
This study has several advantages. First of all, I used laboratory confirmed 
data for both IPD and all the four respiratory viruses, IFV, RSV, PIV, and 
MPV. Second, owing to the large number of laboratory-confirmed infections, 
this study was able to compare the viral-pneumococcal association among 
different age groups (i.e. <6y, 6–64y, and >64y). Thirdly, by modelling 
comparison among of lag periods, the study was able to identify the lag 
period that resulted in the best model fit of the viral-pneumococcal 
association. Fourthly, by conducting several sets of sensitivity analyses, the 
study was able to understand the robustness of the results under different 
scenarios. 
This study is not without its limitations. First, all the results should be 
interpreted on a population-level basis, due to the ecological nature of the 
study. Second, it is nearly impossible to assess the uncertainty induced by 
the various choices in the time series approach (e.g. the choice of distribution 
of the residuals, the choice of covariates, the choice of seasonal smoothers, 
etc.) Thirdly, as indicated by the sensitivity analysis, the results regarding PIV 
and MPV in this study were not robust enough, partly due to the insufficient 
number of tests and therefore, should be interpreted with caution. Fourth, the 
study only included data in the post-PCV period and therefore was not able 
to assess the effect of the introduction of PCV on the viral-pneumococcal 
association.  
In conclusion, the study suggests that there is association between infection 
of IFV and RSV and subsequent IPD among all broader age groups. The 
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time lag between the two infections is likely to be 1 to 2 weeks. Future 
individual-patient based studies are needed in order to confirm the findings of 
this study.
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Chapter 6 Discussion 
This thesis can be divided into two parts. The first part describes and models 
the global seasonality of the four respiratory viruses, IFV, RSV, PIV, and 
MPV (Chapter 2), and furthermore assesses the role of RSV seasonality in 
LMICs planning for the introduction of RSV immunisation products (Chapter 
3). Global seasonality is different among the four viruses, IFV, RSV, PIV, and 
MPV: IFV has clear seasonal epidemics in winter months in most temperate 
sites but the timing of epidemics is more variable and less seasonal with 
decreasing distance from the equator. Unlike IFV, RSV has clear seasonal 
epidemics in both temperate and tropical regions, starting in late summer 
months in the tropics of each hemisphere, reaching most temperate sites in 
winter months. PIV epidemics are mostly in spring and early summer months 
and MPV epidemics are in late winter and spring in most temperate sites but 
the timing of epidemics is more diverse in the tropics. Based on the 
association between the monthly activity of IFV and RSV, and temperature 
and relative humidity, an online prediction tool was developed to predict local 
seasonal epidemics of IFV and RSV. Most LMICs have clear and stable RSV 
seasonality over time. A seasonal approach for RSV prophylaxis is found to 
achieve higher dose-efficiency and relative high effectiveness in LMICs with 
clear seasonality, compared with a year-round approach. 
The second part includes a systematic review that critically reviews the 
existing literature reporting on the association between seasonal viral acute 
respiratory infection and subsequent pneumococcal disease (Chapter 4), 
and includes a population-based study using Scottish laboratory-confirmed 
data (Chapter 5). Both IFV and RSV are likely to be associated with 
subsequent IPD incidence among all broad age groups (i.e. <6y, 6–64y, and 
>64y). It is estimated that 7.5%, 10.8%, 11.6%, and 11.1% of IPD cases are 
attributable to IFV, RSV, PIV, and MPV, respectively. The time lag between 
the viral and pneumococcal infections is estimated to be 1 to 2 weeks. 
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6.1 Strengths 
6.1.1 Inclusion of unpublished data 
For the global seasonality of respiratory viruses work, I included unpublished 
viral data from RSV GEN research group, which was originally formed to 
estimate the global burden of RSV (Shi et al. 2017). On the basis of the 
original RSV GEN group, during my PhD, I added 26 more new members, 
identified from published literature and from academic conferences who were 
willing to share the viral seasonality data using the tailored template designed 
for this project. These shared data filled in the gaps in seasonality in lower-
resource settings and added substantially to the geographical 
representativeness of the seasonality dataset. 
6.1.2 Novel approach of modelling seasonality 
Novelty 1: inclusion of monthly full-year data for modelling 
Some seasonality modelling approaches had strict restrictions on the viral 
data. For example, a time-series modelling approach generally requires 
multi-year weekly viral data (Deyle et al. 2016). However, such data were 
only accessible in higher-income countries, which were almost exclusively in 
the temperate regions. Moreover, in order to have enough positive tests, 
researchers had to work on national-level datasets (e.g. FluNet), which 
compromised the geographical granularity. Other modelling studies, by 
contrast, went for the other extreme by including only the peak timing of a 
virus in the model while assuming a uniform distribution in all non-peak 
months (J. D. Tamerius et al. 2013). This did not provide enough information 
for understanding viral seasonality, e.g. no information on the onset was 
available. In this thesis, I used a novel approach as a trade-off between the 
two existing approaches. Instead of utilising data on viral peaks, I used 
monthly viral data to ensure that a general overview of viral seasonality was 
possible. Instead of excluding sites that did not provide multi-year data, I also 
included shorter-period data as long as they had at least one full-year of 
seasonality profile (i.e. 12 data points of viral activity, each for a month). In 
this way, I was able to include more sites, and more importantly, sub-
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national-level datasets in the model, while ensuring that important 
seasonality information was still retained.  
Novelty 2: conversion of meteorological data to mean-centred values 
Unlike other modelling studies of this kind, I converted the monthly absolute 
values of each meteorological factor into mean-centred values (i.e. for a 
month, mean-centred value = absolute value – annual mean). The 
transformation was based on the assumption that change in viral activity 
depends on the relative change of meteorological factors in an annual circle. 
The relative measures of meteorological factors (i.e. mean-centred values) 
were expected to fit the relative measures of viral activity (i.e. monthly 
average percentage) better. For example, RSV peak was in December in 
England, which had the lowest temperature of the year, 3.4˚C (6.4˚C below 
the annual mean temperature, also noted as –6.4˚C) whereas in Alaska US, 
the temperature of RSV peak month was –14.5˚C (11.9˚C below the annual 
mean temperature, noted as –11.9˚C). Compared with absolute temperature, 
mean-centred temperature was less variable and thus was more suitable for 
modelling the fluctuation of viral activity.  
6.1.3 Prediction of local IFV/RSV seasonal epidemics 
Based on the viral seasonality model, the prediction tool developed as part of 
this thesis allows for predicting local IFV/RSV monthly epidemics if the local 
monthly temperature and relative humidity are provided. This is the first study 
that provides such a prediction tool for IFV/RSV activity. This tool provides 
important seasonality information for those countries where routine tests of 
IFV or RSV are not possible. As presented in Chapter 3, only about one third 
of the LMICs had RSV monthly activity data. The prediction tool could be 
useful for the rest LMICs if they plan to introduce RSV immunisation products 
in future do not have data from local RSV surveillance. 
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6.1.4 Inclusion of laboratory-confirmed IPD and viral infection 
data 
In assessing the association between viral acute respiratory infection and 
IPD, both laboratory-confirmed pneumococcal infection and viral infection 
were included. This helps minimise the measurement error in terms of both 
exposure (i.e. viral infection) and outcome (i.e. IPD). In the sensitivity 
analysis that replaced IPD with clinically diagnosed PP, the association 
results changed significantly. The results highlighted the importance of 
including laboratory-confirmed data when assessing the association. 
6.2 Limitations 
6.2.1 Heterogeneity in viral activity data globally 
In the study of global seasonality of respiratory viruses, heterogeneity in viral 
activity data was an important limitation. The viral activity data came from 
various sources including literature review, online datasets, and RSV GEN. 
These data were originally collected and reported for different research 
purposes. The study population (e.g. age group and respiratory 
symptoms/diagnoses) and methodology (e.g. respiratory samples and test 
approach) varied greatly among these data. The difficulty or challenge in 
extracting data also differed, depending on the data sources. About one third 
(440/1373, 32%) of the viral data points (i.e. data point = per virus per site) 
were extracted from the graphs in the original publications, which is more 
prone to errors.  
Although, as an inclusion criterion, the viral data should be representative of 
the corresponding site, comparisons between sites using heterogeneous 
data should be interpreted with caution. The same caution should also be 
applied to the seasonality model and prediction model that pooled all viral 
activity data and treated them as if they were homogeneous. 
6.2.2 Year-to-year variability in viral activity 
Limited by the lack of multi-year data in most sites, all viral activity data were 
summed across the years in this study in order to have larger amount of 
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positive tests, averaging the possible year-to-year variability in viral activity. 
This could obscure the multi-annual patterns in some of the sites, e.g. the 
biannual RSV patterns in both timing and intensity in northern Europe 
(Broberg et al. 2018). This also limits the implications of the prediction model 
to predicting the “average” viral seasonality of a site rather than predicting 
viral seasonality for a specific year for a site. 
6.2.3 Limited seasonality data of PIV and MPV 
In the global seasonality work, although a total of 83 sites were included, PIV 
subtypes data were only available in a few studies in the US and in some 
European countries. According to the results from overall PIV data, PIV 
epidemics were found mostly in spring and early summer months in each 
hemisphere. These results, however, should be interpreted with caution as 
they were weighted by the prevalence of each PIV subtype. Regarding MPV, 
this work included a total of 65 sites globally, far fewer than the number of 
sites for IFV (246 sites) and RSV (183 sites). As a result, modelling was not 
possible for PIV or MPV. 
6.2.4 Lack of comorbidity and IPD serotype information 
In the viral-pneumococcal association study, the weekly time series of IPD 
and the four viruses, IFV, RSV, PIV, and MPV, were stratified by three broad 
age groups, <6y, 6–64y, and >64y. This allows for a stratified analysis by age 
group. However, no data were available on comorbidity, which was reported 
to be a key factor that modified the association (Weinberger et al. 2013, 
2014b). Moreover, the study by Weinberger et al suggest that influenza-like 
illness was associated with the greatest increases in the incidence of disease 
caused by serotypes with lower invasive potential. Unfortunately, serotype 
data were not available for analysis as part of the thesis to confirm this 
finding using laboratory-confirmed viral infection. 
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6.3 Comparisons among definitions of viral seasonal 
epidemics 
In order to describe viral seasonality on a global scale, a method is much 
needed that can be applicable to a variety of seasonal patterns globally. 
Table 6-1 below is a summary of definitions used in existing global and 
regional reports of viral seasonality. In general, these definitions were based 
on one of the two types of viral activity measure, annual positive proportion 
(APP) or test positive proportion (TPP). APP is derived from positive tests 
only whereas TPP is derived from both positive and negative tests. Detailed 
comparisons between APP and TPP are attached below in Table 6-2.  
In this work, APP was used to measure viral activity with several 
considerations. First, compared with TPP, APP requires only positive tests 
for each month. This is important in order to be able to include more sites 
worldwide, as a number of medical or laboratory records only had positive 
tests—negative tests would be left blank as if no tests had been done. 
Second, APP only focuses on specific viral positive tests and thus is not 
affected by the competing effects by other co-circulating viruses as TPP. 
Third, TPP is sensitive to the viral detection methods. For example, a study in 
the US compared the weekly TPP of RSV between the antigen-detection 
method and the PCR method, and found that weekly TPP of PCR was much 
lower than weekly TPP of antigen-detection method (Curns et al. 2017). 
Using APP can minimise the bias induced by the high heterogeneity of viral 
detection methods among different data sources. 
In Table 6-1, two APP-based methods in defining viral seasonal epidemics 
have been presented: one, which was more commonly used, is based on a 
weekly/monthly threshold and the other is based on a cumulative 
(consecutive) threshold (Saverio Caini et al. 2016). In the current work, a new 
definition was proposed based on the cumulative non-consecutive threshold. 
These three methods are compared in Table 6-3. All of the three methods 
can define viral seasonal epidemics well in strong seasonality settings. 
However, the cumulative consecutive threshold cannot account for multiple 
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seasons in one year and the weekly/monthly threshold cannot define 
seasons well in weak seasonality settings. The proposed method in this 
work, i.e. cumulative non-consecutive threshold, is able to address all the 
scenarios above. Examples using real-world data are attached below to help 
demonstrate the performance of the three methods in defining seasons under 
different scenarios (Figure 6-1).  
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Definition of Onset Definition of Offset 
(Azziz 
Baumgartner 
et al. 2012) 
 
IFV Monthly Global 
Periods when TPP* 
exceeded annual mean 
The first month when 
TPP* exceeded annual 
mean 
The first month after 
an epidemic when 
TPP* remained below 
annual mean 
IFV Weekly Global 
Periods when TPP exceeded 
annual mean for ≥3 weeks* 
The first week when 
TPP exceeded and 
remained annual mean 
for ≥3 weeks* 
The first week after an 
epidemic when TPP 
remained below 
annual mean for ≥3 
weeks* 
(Bloom-





Months with ≥ 5%/10% of 
APP 
Not defined Not defined 
IFV, 
RSV 
Weekly Global Weeks with ≥ 1.2% of APP Not defined Not defined 
(Broberg et al. 
2018) 
RSV Weekly Europe Weeks with ≥ 1.2% of APP 
The first week with ≥ 
1.2% of APP 
The first week after an 
epidemic when APP 
fell below 1.2% 
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Definition of Onset Definition of Offset 
(Saverio Caini 
et al. 2016) 
IFV Weekly Global 
Minimum number of 
consecutive months to have 
≥80% of APP 
Not defined Not defined 





Model: log(TPP(1-TPP)) ~ 
year + month 
Periods when predicted TPP 
exceeded annual median for 
≥2 months 
Not defined Not defined 






Months with ≥10% of APP in 
at least 2 of 6 years (2010–
2015) 





Model: log(TPP(1-TPP)) ~ 
year + month 
Periods when predicted TPP 
exceeded annual median for 
≥2 months 




median for ≥2 months 
The first month after 
an epidemic when 
predicted TPP fell 
below annual median 
(Newman et al. 
2018) 
IFV Monthly Global 
Months with ≥10% of APP in 
at least 2 of 6 years (2011–
2016) 
Not defined Not defined 
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Definition of Onset Definition of Offset 
(Obando-
Pacheco et al. 
2018) 
RSV Weekly Global 
Periods when TPP was ≥10%  
for ≥2 weeks 
The first week when 
TPP was ≥10% for ≥2 
weeks 
The first week after an 
epidemic when TPP 
was <10% for ≥2 
weeks 
APP = annual positive proportion; IFV = influenza virus; RSV = respiratory syncytial virus; TPP = test-positive proportion 
*When TPP is not available, APP is applied instead. 
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Table 6-2 Comparisons between annual positive proportion and test-
positive proportion 
Data type APP TPP 
Definition The proportion of positive 
tests during an interval* to 
annual positive tests  
The proportion of positive 










i: interval i 
Prerequisite(s) Number of positive tests for 
the full year 
Number of positive and 
negative tests for the interval 
Advantage Does not require the number 
of negative tests 
Does not require the number 
of tests for other intervals of 
the year 
Disadvantage Results of an interval can be 
affected by other intervals of 
the year, thus requiring stable 
test practice all year round 
Results can be affected by 
the co-circulation of other 
viruses 
Results are more sensitive to 
test methods 
APP=annual positive proportion; TPP=test-positive proportion 
*An interval is the smallest unit of aggregation of number of tests, usually a 
week or a month. 
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Cumulative threshold  
(non-consecutive) 
Example (Bloom-Feshbach et al. 2013) etc. (Saverio Caini et al. 2016) This study 
Definition of seasonal 
epidemics 
Months with APP ≥ 5%/10% 
Weeks with APP ≥ 1.2%/2.5% 
Minimum number of consecutive 
months to have ≥80% of APP 
Minimum number of months to 
have ≥75% of APP 




No, due to the consecutiveness 
required by this method 
Yes 
Detection of strong 
seasonality 
Yes Yes Yes 
Detection of weak 
seasonality 
No. Choice of threshold makes 
great difference. High threshold 
results in few or even no seasonal 
epidemics while low threshold 
results in all months/weeks being 
epidemic. 
Yes Yes 
APP=annual positive proportion 
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Figure 6-1 Comparisons among APP-based definitions for viral seasonal epidemics 
Scenario 1: strong seasonality (RSV in Colorado, US) 
Scenario 2: weak seasonality (RSV in El Salvador) 
Scenario 3: two seasons in one year (IFV in Thailand) 
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6.4 Issues regarding controlling for shared seasonal 
risk factors between viral infection and PD 
As proposed in previous studies, the shared seasonal risk factors can 
confound the association between viral infection and PD (Figure 6-2A). For 
example, lower temperature could be one of the shared risk factors of both 
viral infection and pneumococcal infection. To account for the shared 
seasonal factors, two different approaches had been used. The first 
approach is to control for common risk factors per se, e.g. temperature, 
rainfall, and/or humidity. The second approach is to add additional terms, e.g. 
annual and/or semi-annual harmonic terms, to the model as a proxy of all the 
shared seasonal risk factors. However, these shared seasonal factors are not 
all easy to control for. Both approaches might have the issue of residual 
confounding, i.e. factors that are not accounted for (e.g. human contact), or 
factors that are not well captured by the harmonic terms. 
In this work, I proposed a new approach in order to control for the seasonal 
factors. In the new approach, PD is further divided into PD at the time of viral 
infection (i.e. week 0) and subsequent PD (i.e. week i), the outcome of 
interest (Figure 6-2B). The method is designed to control for PD at week 0, 
which can indirectly control for the shared seasonal factors that are normally 
difficult to control for. Then the results can be interpreted as how much of IPD 
at week i can be explained given the viral infection and pneumococcal 
infection at week 0. However, this method is not without its limitations. The 
method ignores the potential association between the shared seasonal 
factors at week 0 and PD at week i, which can confound the observed 
association presented in this work. 
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Figure 6-2 Causal diagrams for the association between viral infection 
and subsequent pneumococcal disease (A. simple version; B. time-lag 
version) 
Squared outline indicates controlling for the corresponding factor in the 
statistical model. 
  
Viral Infection PD 





at week 0 
Shared seasonal factors: 
e.g. temperature 
PD 
at week 0 
PD 
at week i 
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6.5 Implications for RSV immunisation strategies 
As introduced in Chapter 1, RSV represents a substantial burden of disease 
and health-care globally in young children, especially in the LMICs. In high 
income countries, Palivizumab, a short-acting mAb, is currently being 
administered during RSV season to young children at high risk, e.g. preterm 
children, children with congenital heart disease, and children with chronic 
lung diseases. There are two promising candidates that are expected to be 
available at vaccine-like pricing and could be considered for use in LMICs— 
the maternal vaccine ResVax and the long-acting mAb MEDI8897. Both 
candidates provide limited duration of protection and RSV seasonality is 
important to help decide on the immunisation strategy. 
6.5.1 Maternal vaccine — ResVax 
At the end of February 2019, Novavax announced the topline phase-3 trial 
results of ResVax (Anonymous 2019b). Although the final reports of the 
results have not yet been published at the time of writing, there are some 
important results in the initial slides released by Novavax: 1). The vaccine did 
not meet its primary endpoint, medically significant RSV lower respiratory 
tract infection (efficacy: 39.4%, 97.5% CI, –1.0% to 63.7%). 2). The vaccine 
did show efficacy in preventing RSV hospitalisation and RSV with 
hypoxemia. 3). The efficacy results showed that gestational age at the time of 
vaccination affected efficacy; earlier vaccination group (<33 weeks of 
gestation) had higher efficacy. 4). Compared to rest of the world, efficacy in 
US was low and it was speculated by the presenters that this seemed to be 
“related to timing of immunisation, including the negative effects of late 
gestational age immunization and short intervals to birth”.  
From my point of view, the vaccine seems to be effective even though the 
primary endpoint has not been met. Apart from the selection of the primary 
endpoint, which is academically contestable, I think the overall results were 
highly influenced by the results from US (US contributed one fourth of total 
data). It becomes important to identify the reasons for the low efficacy in US. 
While I agree that late timing of immunisation in US could explain the 
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observed low efficacy to some degree, this could not explain the results 
among <33 weeks of gestation vaccination group where the efficacy in US 
children was still lower (US: –9.7 [–259.2, 66.5]; South Africa: 55.4 [19.5, 
75.3]; All: 41.4 [4.1, 64.2]) (Anonymous 2019b). One of the other reasons 
that could explain the low efficacy in the US is the failure to match the timing 
of vaccination with the local RSV seasonality. As a result, fewer RSV cases 
were captured and the power of the trial was reduced. Due to the nature of 
maternal immunisation, there were some inherent challenges in matching 
with the local RSV season. On the one hand, the actual date of delivery is 
never known at the time of vaccination; certain assumptions for both the date 
of delivery and the onset of the upcoming RSV season have to be made in 
order to determine eligibility. On the other hand, the susceptibility to RSV 
infection differs by gestational age at birth and could modify the protection 
conferred by the vaccine. Further investigations into the lower efficacy of this 
trial in the US are warranted. 
6.5.2 Long-acting mAb — MEDI8897 
MEDI8897 is a long-acting mAb that targets prefusion-F protein. The results 
of phase-2b trial showed a favourable safety profile in healthy preterm 
infants and an extended half-life of the mAb (Domachowske et al. 2018). In 
early 2019, MEDI8897 received fast track designation from both U.S. 
Food and Drug Administration (FDA) and European Medicines Agency 
(EMA). Some topline results of the efficacy of MEDI8897 from the phase-
2b trial were presented recently in the 37th European Society for the 
Paediatric Infectious Diseases conference: on day 150 post immunisation, 
MEDI8897 was reported to reduce medically attended ALRI by 70.1% 
[52.3, 81.2] and reduce ALRI hospitalisation by 78.4% [51.9, 90.3]. Phase-
3 trial is planned to be initiated among healthy term newborns in 2019. 
Compared with the maternal vaccine, the timing of mAb only relies on the 
RSV seasonality. However, mAb is not without its limitations. All mAbs, by 
definition, only recognise one epitope each. For example, Palivizumab 
only recognises the site II antigenic site on the F protein and MEDI8897 is 
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a variant of antibody D25 which recognises the site Ø (Domachowske et 
al. 2018). Recently, it was reported that Palivizumab-resistant RSV was 
isolated from an infant treated with palivizumab (Adams et al. 2010). 
Escape mutant viruses with amino acid changes in site II were isolated 
from children treated with palivizumab (Qing Zhu et al. 2011). As 
MEDI8897 is planned to be used in a wider group of children than 
Palivizumab, epitope-specific resistance could be worse and would likely 
impact on the efficacy. A global baseline dataset is needed to monitor 
future variations of RSV sequence for the future in case there is selective 
pressure favouring escape mutants following widespread use of 
MEDI8897 or other mAbs. It is possible that the composition of mAbs 
would be reviewed and decided annually before each RSV season, similar 
to the IFV vaccine (WHO 2019). Although maternal vaccine would likely 
not have this limitation owing to polyclonal response, a recent study 
reported a narrower range of antibody specificities produced by B-
lymphocytes from infants after RSV infection than from adults (Goodwin et 
al. 2018).  
6.6 Proposals for future studies 
6.6.1 Proposals related to global seasonality of respiratory 
viruses studies 
An update of the description and modelling using multi-year viral data 
An update of the description and modelling work in Chapter 2 can be 
conducted using multi-year data. This can address the limitation of not being 
able to identify multi-year seasonal patterns for RSV that were reported in 
some northern European countries. There is increasing need for the forecast 
of IFV and RSV seasons so that their seasonal prophylaxis can be planned. 
In theory, such forecast is possible using the methodology presented in this 
work. However, due to the lack of multi-year viral data for IFV and RSV, the 
current prediction tool could not be applied to such forecast. For this update, 
at least three years of monthly/weekly viral data are necessary. There are 
two potential data sources that can be considered. The first one is based on 
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the ongoing WHO RSV surveillance which was initiated in 14 countries in 
2016 (World Health Organization 2019); seven more countries have been 
added for the second phase in 2019 (personal communication). In a few 
years of time, at least five years of RSV data for some countries would be 
available for multi-year modelling. The second strategy is to apply the model 
to the data from European Centre for Disease Prevention and Control 
(ECDC). However, all ECDC member states are in the temperate regions 
and this limits the extrapolation of the model. Nonetheless, this could serve 
as a plausibility check of the model for prospectively predicting RSV seasons. 
It is also expected that labs from LMICs will have more capacities in future, 
e.g. multi-plex PCR will be available in more sites from LMICs. As a result, 
more PIV, including PIV subtypes 1–4, and MPV monthly activity data for at 
least three years will be available for modelling.  
Understanding the impact of IFV pandemics on the seasonality of other 
respiratory viruses 
In the seasonality study of this thesis, only IFV data during the 2009 swine flu 
pandemic were excluded while data of RSV, PIV, and MPV were included, 
assuming that their seasonality is not impacted by the pandemic IFV. 
However, there is one published study in Israel reporting that when IFV 
A(H1N1)pdm09 appeared, RSV seasons were delayed until IFV 
A(H1N1)pdm09 declined (Hirsh et al. 2014). This is potentially important for 
the preparedness for the next IFV pandemic. Should an IFV pandemic occur, 
RSV prophylaxis can be postponed accordingly. Future studies can compare 
the RSV seasons in pre-pandemic period (before 2009), pandemic period 
(2009–2010), and post-pandemic period (2011 onwards). Viral activity data of 
IFV A(H1N1)pdm can also be collected for each site to reflect the local IFV 
pandemic activity if available. 
Understanding the global transmission dynamics of RSV, PIV, and MPV 
Future studies can consider together the global transmission of RSV, PIV, 
and MPV. This requires multi-year viral activity data and sequence data of 
each virus, using similar methodology to the studies for IFV (Bedford et al. 
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2015; Lemey et al. 2014; Rambaut et al. 2008; Russell et al. 2008). However, 
genomic data of RSV, PIV, and MPV are still limited at the moment. For RSV, 
an international collaboration named “DIVERGE (DIVErsity in Rsv 
GEnomes)” has been established to carry out whole genome sequencing of 
over eight hundred RSV samples taken from children under five years of age 
in six LMICs (Anonymous 2019a). This could help better understand the 
transmission dynamics of RSV. 
6.6.2 Proposals for future viral-pneumococcal association 
studies 
The association between viral infection and pneumococcal infection is still not 
well understood on individual-patient level. Future individual-patient-level 
studies are warranted to confirm the findings from population-level studies. 
Moreover, it is important for future individual-patient-level studies to assess 
the risk of secondary pneumococcal infections given the age, comorbidity 
status, and even PCV immunisation status, which will be of great importance 
for the clinical management of patients with viral infections. 
In terms of methodology, like population-level studies, it is essential for 
individual-patient-level studies to control for potential confounders, including 
seasonal and non-seasonal confounders. Self-controlled case series design 
could be one option as this design eliminates all time-invariant confounders. 
This study design was recently applied to assess the association between 
IFV infection and subsequent myocardial infarction (Kwong et al. 2018).
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Chapter 7 Conclusions 
This thesis provides an overall picture of global seasonality of IFV, RSV, PIV, 
and MPV by incorporating data from various sources, including systematic 
literature searches, online public datasets, and unpublished datasets shared 
by RSV GEN. It is the first study that highlights the difference in the 
seasonality of IFV and RSV, especially in the tropical regions. This is also the 
first study to describe global seasonality of PIV and MPV, two important 
viruses in the aetiology of ALRI. By modelling the association between 
meteorological factors and viral seasonality, this study presents a practical 
tool for the prediction of local IFV and RSV seasonality given the local 
monthly temperature and relative humidity. The global seasonality patterns 
presented in this study are important for health-care services planning and 
immunisation strategies. This thesis also evaluates the role of RSV 
seasonality in LMICs planning the introduction of RSV prophylaxis and 
supports the seasonal approach for LMICs with clear RSV seasonality. 
Future studies should consider describing and modelling the activity of IFV, 
RSV, PIV and MPV on a multi-year scale to enable the forecast of their 
seasonality. 
This thesis critically reviews the methodologies and findings of published 
studies on the association between viral acute respiratory infection and 
subsequent pneumococcal disease. The main methodological challenges of 
existing studies include the failure to use individual patient data, control for 
seasonal factors of viral infection and pneumococcal disease, or include 
other factors related to the association (e.g., virus type, age, comorbidity and 
pneumococcal serotype). These challenges could explain the inconsistent 
results from the existing studies. Based on the findings of the systematic 
review, an ecological study was conducted using laboratory-confirmed viral 
infection and pneumococcal infection, stratified by age group. This study 
provides consistent support of the association between respiratory infection 
associated with IFV or RSV and subsequent invasive pneumococcal disease 
across all age groups. While addressing some of the methodological 
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challenges listed above, the study is unable to conduct an individual-patient-
level analysis so is unable to incorporate factors including comorbidity status 
and pneumococcal serotypes. These limitations can be addressed in future 
studies to optimise the clinical management of patients with viral infection 
and to better evaluate the additional IFV and RSV vaccine effect on the 
prevention of potential secondary pneumococcal infection.
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AH absolute humidity 
AIC Akaike information criterion 
ALRI acute lower respiratory infection 
ANC antenatal care 
AP attributable percentage 
APP annual positive proportion 
ARI acute respiratory infection 
AUROC area under the Receiver Operating Characteristic curve 
BCG Bacillus Calmette–Guérin 
BOV bocavirus 
CFU colony-forming units 




DAT direct antigen test 
ECDC European Centre for Disease Prevention and Control 
ECOSS Electronic Communication of Surveillance in Scotland  
EV enterovirus 
GISRS Global Influenza Surveillance and Response System 
Hep Hepatitis 
IF immunofluorescence 
IFV influenza virus 
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Abbreviation Fullname 
ILI influenza-like illness 
INDV individual 
IPD invasive pneumococcal disease 
IR incidence rate 
LMIC lower and middle income country 
m month(s) 
mAb monoclonal antibody 
MPV metapneumovirus 
mV maternal vaccine 
NIC national influenza center 
npIPD non-pneumonic pneumococcal disease 
PAHO Pan American Health Organization 
PB pneumococcal bacteraemia 
PCR polymerase chain reaction 
PCV pneumococcal conjugate vaccine 
PD pneumococcal disease 
PIV parainfluenza virus 
POP population 
PP pneumococcal pneumonia 
PPV pneumococcal polysaccharide vaccine 
Pse pneumococcal sepsis 
RAT rapid antigen test 
REGR regression 
RH relative humidity 
RNA Ribonucleic acid 
RR relative risk 
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Abbreviation Fullname 
RSV respiratory syncytial virus 
RV rhinovirus 
SPIDER Scottish Pneumococcal Invasive Disease Enhanced 
Reporting  
T temperature 
TPP test-positive proportion 
UV index clear-sky ultraviolet index 
VARI viral acute respiratory infection 
WHO World Health Organization 
y year(s) 
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A2. Search strategy for the global seasonality 
systematic literature review 
Medline 
1. pneumonia.mp. or exp Pneumonia/  
2. bronchiolitis.mp. or exp Bronchiolitis/  
3. *Respiratory Syncytial Viruses/ or *Respiratory Syncytial Virus Infections/ 
or respiratory syncytial.mp. or *Respiratory Syncytial Virus, Human/  
4. influenza.mp. or Influenza, Human/  
5. parainfluenza.mp.  
6. metapneumovirus.mp. or *Metapneumovirus/  
7. lower respiratory infection*.mp.  
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. Seasons/ or season*.mp.  
10. temporal.mp. or exp Spatio-Temporal Analysis/  
11. periodic*.mp. or exp Periodicity/  
12. surveillance.ti,ab. or exp Population Surveillance/  
13. 9 or 10 or 11 or 12  
14. ep.fs.  
15. 8 and 13 and 14  
18. limit 15 to (humans and yr="2000 -2017") 
12907 results returned 
EMbase 
1. pneumonia.mp. or exp pneumonia/  
2. bronchiolitis.mp. or exp Bronchiolitis/  
3. exp lower respiratory tract infection/ or (lower respiratory adj1 
infection*).mp. 
4. influenza.mp. or exp influenza/  
5. exp Human respiratory syncytial virus/ or exp respiratory syncytial virus 
infection/ or exp Respiratory syncytial pneumovirus/ or respiratory 
syncytial.mp.  
6. parainfluenza.mp. or exp Parainfluenza virus infection/  
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7. exp Human metapneumovirus/ or exp Human metapneumovirus infection/ 
or metapneumovirus.mp.  
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. exp season/ or season*.mp. or exp seasonal variation/  
10. exp disease surveillance/ or exp sentinel surveillance/ or 
surveillance.ti,ab.  
11. periodic*.mp. or exp periodicity/  
12. exp spatiotemporal analysis/ or temporal.mp.  
13. 9 or 10 or 11 or 12  
14. ep.fs.  
15. 8 and 13 and 14  
16. limit 15 to (human and yr="2000 -2017") 
10378 results returned 
Global Health 
1. pneumonia.mp. or exp pneumonia/  
2. bronchiolitis.mp. or exp bronchiolitis/  
3. (lower respiratory adj1 infection*).mp.  
4. exp influenza/ or influenza.mp.  
5. respiratory syncytial.mp. or Human respiratory syncytial virus.od.  
6. exp parainfluenza/ or parainfluenza.mp.  
7. exp Human metapneumovirus/ or metapneumovirus.mp.  
8. 1 or 2 or 3 or 4 or 5 or 6 or 7 
9. exp seasonal variation/ or exp seasonality/ or season*.mp. 
10. exp surveillance/ or surveillance.mp. or exp sentinel surveillance/  
11. temporal.mp. or temporal variation/  
12. periodic*.mp. or exp periodicity/  
13. 9 or 10 or 11 or 12 
14. 8 and 13  
15. limit 14 to yr="2000 -2017" 
14039 results returned 
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A3. Details of seasonality data from online public 
sources 
Sources Virus Year Site Other 
Information 
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A4. Details of seasonality data from RSV GEN 







RSV PIV MPV 
Rosalyn 
Singleton 
YK Delta, Alaska USA -164.2, 62.9 ALRI RADT  ✓   
Barbara Rath Berlin Germany 13.4, 52.5 ALRI PCR ✓ ✓ ✓ ✓ 
Darmaa Badarch Ulaanbaatar Mongolia 106.9, 47.9 ALRI PCR ✓ ✓   
Jianwei Wang Beijing China 116.4, 39.9 ALRI PCR  ✓   
Eric A. F. Simões Aurora, Colorado USA -104.8, 39.7 ALRI PCR   ✓ ✓ 
Eric A. F. Simões State of Colorado USA -105.8, 39.6 ALRI PCR  ✓   
Hongjie Yu nationwide China 104.2, 35.9 ALRI PCR  ✓   
Quique Bassat Rabat Morocco -6.8, 34 ALRI PCR ✓ ✓ ✓  
Najwa Khuri-
Bulos 
Amman Jordan 35.9, 31.9 ALRI PCR ✓ ✓ ✓ ✓ 
Shobha Broor Ballabgarh, Faridabad 
and Haryana 
India 77.3, 28.3 ALRI PCR  ✓   
Nusrat Homaira Kishoregonj, Bogra, 
Comilla and Barisal 
Bangladesh 90.5, 23.8 ALRI PCR ✓    
W. Abdullah 
Brooks 
Kamalapur Bangladesh 90.4, 23.7 ALRI serology and PCR  ✓   
Doli Goswami Dhaka and Matlab Bangladesh 90.7, 23.3 severe 
pneumonia 
PCR  ✓   
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RSV PIV MPV 
Daniel E. Noyola San Luis Potosí Mexico -101, 22.2 ALRI IF or PCR  ✓   
Claudia Turner Tak Province Thailand 99.1, 16.9 ALRI PCR  ✓   
Yong Poovorawa
n 
Khon Kaen Thailand 102.8, 16.4 ILI PCR ✓ ✓   
Nigel Bruce San Lorenzo and 
Comitancillo 
Guatemala -91.7, 15.1 ALRI RADT  ✓   
John P. 
McCracken 
Quetzaltenango Guatemala -91.5, 14.9 ALRI PCR ✓ ✓   
John P. 
McCracken 
Santa Rosa Guatemala -90.4, 14.2 ALRI PCR ✓ ✓   
Wilfrido Clara Santa Ana El Salvador -89.6, 14 ALRI IFA  ✓   
Somsak 
Thamtithiwat 
Nakhon Phanom and 
Sa Kaeo 
Thailand 101.1, 13.8 ALRI PCR ✓ ✓   
Yong Poovorawa
n 
Bangkok Thailand 100.5, 13.8 ILI PCR ✓ ✓  ✓ 
Sujatha Sistla Puducherry India 78.9, 13.8 ILI PCR ✓ ✓ ✓  
Yong Poovorawa
n 
Chonburi Thailand 101, 13.4 ILI PCR  ✓   
Martin Antonio Basse Gambia -14.2, 13.3 severe 
pneumonia 
PCR  ✓   
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RSV PIV MPV 
Karen L. Kotloff Bamako Mali -8, 12.6 severe 
pneumonia 
PCR  ✓ ✓ ✓ 
Lay-Myint 
Yoshida 
Nha Trang City Vietnam 109.2, 12.2 ALRI PCR ✓ ✓ ✓  
Philippe Buchy Kampong Cham city 
and Takeo city 
Cambodia 105.1, 11.5 ALRI PCR  ✓   
Socorro P. 
Lupisan 
Tacloban Philippines 125, 11.3 ALRI serology, PCR or 
culture 
 ✓   
Marilla G. Lucero Bohol Philippines 123.9, 9.7 ALRI PCR or culture ✓ ✓ ✓ ✓ 
Jorge Jara David City, Chiriquí 
Province 
Panama -82.4, 8.4 ALRI IF or PCR  ✓   
Joel M. 
Montgomery 
Lwak Kenya 34.4, -0.1 ALRI PCR  ✓   
D. James Nokes Kilifi Kenya 40.1, -3.2 ALRI DFA ✓ ✓ ✓ ✓ 
Bradford D. 
Gessner 
Lombok Island Indonesia 116.3, -8.7 ALRI RADT  ✓   
Candice Romero Tambopata district Peru -69.2, -12.6 ALRI PCR ✓ ✓   
Phil Seidenberg Lusaka Zambia 28.3, -15.4 severe 
pneumonia 
PCR  ✓ ✓ ✓ 
Maria Tereza da 
Costa Oliveira 
Belo Horizonte Brazil -43.9, -19.9 ALRI IFA or PCR ✓ ✓   
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RSV PIV MPV 
Rodrigo Fasce Iquique Chile -70.1, -20.2 ALRI IF ✓ ✓ ✓  
Peter Byass Agincourt South Africa 31.2, -24.8 ALRI PCR ✓    
Cheryl Cohen Agincourt South Africa 31.2, -24.8 ALRI PCR  ✓   
Quique Bassat Manhiça Mozambique 32.8, -25.4 ALRI PCR   ✓ ✓ 
Vicky L. Baillie Soweto South Africa 27.9, -26.2 severe 
pneumonia 
PCR  ✓   
Shabir A. Madhi Soweto South Africa 27.9, -26.2 ALRI PCR ✓   ✓ 
Cheryl Cohen Klerksdorp South Africa 26.6, -26.9 ALRI PCR  ✓   
Cheryl Cohen Pietermaritzburg South Africa 30.4, -29.6 ALRI PCR  ✓   
Nusrat Homaira New South Wales Australia 146.9, -31.3 respiratory 
symptoms 
multiple tests  ✓   
Heather J. Zar Paarl, Western 
Province 
South Africa 19, -33.7 ALRI PCR  ✓ ✓  
Angela Gentile Buenos Aires Argentina -58.4, -34.6 ALRI PCR ✓    
Rodrigo Fasce Concepcion Chile -73, -36.8 ALRI IF  ✓ ✓  
LON=longitude; LAT=latitude; NK=not known; ALRI=acute lower respiratory infection; ARI=acute respiratory infection; 
ILI=influenza-like illness; PCR=polymerase chain reaction; IF=immunofluorescence; DFA=direct fluorescent antibody test; 
IFA=indirect fluorescent antibody test; RADT=rapid antigen-detection test.  
*Any IFV includes IFV, IFV A, IFV B, IFV A(H1N1), IFV A(H1N1)pdm and IFV A(H3N2). 
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A5. Questionnaire of quality assessment in 
seasonality papers 
Q1. Were subjects included representative of the population in the study site? 
 A. Yes. Very good representativeness. Subjects were all ages, without underlying 
medical conditions. 
 B. Yes. Good representativeness. Subjects were not all ages, without 
underlying medical conditions. 
 C. Yes. Likely to be representative with 
regard to seasonality of viruses 
Subjects were from very narrow age bands 
(e.g. neonatal), without underlying medical 
conditions. 
 D. No. Unlikely to be representative. 
(Should be excluded) 
Subjects with underlying medical 
conditions. 
Q2. Did the test method(s) and practice remain stable throughout study period? 
 A. Yes. Very stable. One or two test methods with stable test 
practice throughout study period. 
 B. Yes. Stable. >2 test methods with stable test practice 
throughout study period. 
 C. No, but changes were unlikely to 
affect seasonality results. 
>2 test methods with changes of test 
practice but should not affect seasonality 
results. 
 D. No. Changes were unlikely to affect 
seasonality results. (Should be 
excluded) 
Changes of test methods or practice related 
to known seasonality. 
Q3. What was the quality of the timings of positive test results reported? 
 A. Very good. Timings of positive tests were reported as 
the date when specimens were taken 
(often found in prospective studies). 
 B. Good. Timings of positive tests were taken from 
related diagnosis (often found in hospital 
databases). 
 C. Fair. Timings of positive tests were reported as 
the date when specimens were received in 
labs (can be found in laboratory databases). 
 D. Bad. (Should be excluded) Timings of positive tests could be 
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A6. Technical details of the seasonality model 
Model assumption 
The model assumption is that, for each month of each site, the relative 
strength of viral activity (i.e. annual average percentage, AAP) is associated 
with the relative measurements of meteorological factors. For example, if the 
temperature of a month in a site is 10˚C lower than the site’s annual average 
temperature, in other words, the mean-centred temperature of this month is –
10˚C, then the viral activity of this month is likely to be higher compared to 
other months of the year. Of note, I allow the relationship between relative 
viral activity and relative measurements of meteorological factors to be non-
linear by using local regression (LOESS). 
Data preparation 
For each site included in our study, I extracted meteorological data from the 
nearest weather station provided by the US National Centers for 
Environmental Information using R package “GSODR”. The meteorological 
data I extracted included daily temperature, relative humidity, absolute 
humidity (calculated from temperature and relative humidity) and wind speed. 
In each site, I calculated the monthly average temperature, relative humidity, 
absolute humidity and wind speed during the period matched with the range 
of dates of the virus data. If no meteorological data were available to match 
with date of the virus data, other nearest years were included alternatively. I 
then calculated the mean-centred temperature, relative humidity, absolute 
humidity and wind speed by subtracting the annual average value from the 
monthly average value for inclusion in the model. Additionally, I included the 
duration of daytime in hours of each site, calculated using R package 
“suncalc”. 
Model comparison and selection 
I modelled the monthly AAP by LOESS using candidate variables including 
mean-centred temperature, mean-centred relative humidity, mean-centred 
absolute humidity, mean-centred wind speed and duration of daytime. I 
required a minimum of 120 sites with ≥100 positives per virus for more robust 
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models. As such, I was able to model monthly activity of IFV and RSV only. 
The candidate models include all combinations of up to two candidate 
variables. I focused the model on the prediction of epidemic months (i.e. a 
dichotomous result, epidemic or non-epidemic). In the prediction model, I 
allow the threshold of determining an epidemic month to change (different 
from a fixed threshold of 75% in our observed data). Therefore, I was able to 
compare the models by their area under the Receiver Operating 
Characteristic curve (AUROC) in predicting the epidemic months, via leave-
one-out cross validation.  
The model comparison was done via a two-step process. At the first step, I 
explored a range of the parameter spans in LOESS from 0.05 to 0.95 within 
each candidate model and identified the optimum span that maximised the 
AUROC for that model. Then, as the second step, I compared the AUROCs 
across the candidate models with their optimum span parameters. The 
results showed that the model “Temperature + Relative Humidity” had higher 
AUROCs than the other candidate models (detailed results in the table on 
next page). Therefore, I chose the model “Temperature + Relative Humidity” 
in the main analysis.  
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Table Results of model comparison through leave-one-out cross validation 
AUROC = area under the receiver operating characteristic curve. For each virus, the three highest AUROCs are highlighted in 
bold. 
Candidate model (predictors) 
IFV  IFV A  IFV B  IFV A(H1N1)pdm  IFV A(H3N2)  RSV 
Span AUROC  Span AUROC  Span AUROC  Span AUROC  Span AUROC  Span AUROC 
Temperature 0.25 0.7363  0.30 0.7419  0.45 0.7406  0.50 0.7531  0.30 0.7262  0.30 0.7501 
Relative Humidity 0.90 0.5851  0.75 0.6022  0.25 0.5722  0.45 0.5624  0.60 0.6345  0.55 0.6751 
Absolute Humidity 0.55 0.6640  0.90 0.6584  0.55 0.6867  0.65 0.7151  0.75 0.6065  0.50 0.6449 
Hours of daytime 0.15 0.6880  0.20 0.6805  0.30 0.6944  0.35 0.7008  0.25 0.6980  0.10 0.7704 
Wind Speed 0.10 0.5338  0.25 0.5151  0.60 0.5181  0.20 0.5365  0.10 0.5589  0.50 0.6205 
Temperature + Relative Humidity 0.70 0.7442  0.60 0.7468  0.50 0.7604  0.40 0.7769  0.75 0.7319  0.30 0.8023 
Temperature + Absolute Humidity 0.30 0.7503  0.55 0.7493  0.25 0.7530  0.30 0.7617  0.55 0.7485  0.20 0.8038 
Temperature + Hours of daytime 0.95 0.7332  0.70 0.7439  0.20 0.7780  0.30 0.7719  0.10 0.7371  0.05 0.7677 
Temperature + Wind Speed 0.60 0.7315  0.95 0.7305  0.75 0.7352  0.95 0.7556  0.85 0.7221  0.30 0.7871 
Relative Humidity + Wind Speed 0.95 0.5757  0.95 0.6011  0.05 0.5456  0.90 0.5740  0.25 0.6274  0.25 0.6743 
Relative Humidity + Hours of daytime 0.50 0.6931  0.35 0.7004  0.10 0.6837  0.45 0.7280  0.75 0.7131  0.55 0.7992 
Absolute Humidity + Wind Speed 0.30 0.6661  0.95 0.6614  0.50 0.6814  0.10 0.6905  0.95 0.6259  0.15 0.7019 
Absolute Humidity + Hours of daytime 0.05 0.6990  0.05 0.7017  0.05 0.7057  0.05 0.7392  0.10 0.7081  0.05 0.7846 
Absolute Humidity + Relative Humidity 0.30 0.7136  0.30 0.7203  0.30 0.7343  0.30 0.7632  0.20 0.7039  0.60 0.7715 
Wind Speed + Hours of daytime 0.15 0.6746  0.30 0.6770  0.90 0.6775  0.90 0.7087  0.15 0.6853  0.40 0.7834 
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After I determined the model, I identified the optimal threshold for determining 
the epidemic months for each virus. This was done by finding the threshold 
that maximised the Cohen’s kappa. The Receiver Operating Characteristic 
(ROC) curves for all the viruses are attached in the figure below. The optimal 
threshold was 55% for IFV, IFV A, and RSV, and was 60% for IFV B, IFV 
A(H1N1)pdm, and IFV A(H3N2). 
 
Figure ROC curves of the prediction models 
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Model assessment 
I assessed the model performance by quantifying the degree of agreement in 
determining the epidemic months between observation and prediction of 
each site, by the leave-one-out method. I calculated Cohen’s kappa, 
sensitivity, specificity, positive predictive value and negative predictive value. 
Moreover, according to the observed and predicted epidemic months, I 
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A7. The user manual of the seasonality prediction 
tool 
Based on the prediction model, I developed an interactive tool for the local 
prediction of IFV and RSV epidemics. The tool is freely available in 
http://resceu.ecdf.ed.ac.uk/shiny/ShinyPred/. To use this tool, simply follow the 
step-by-step instructions below: 
Prerequisite: make sure that you have monthly temperature and relative 
humidity data available for the site you would like to estimate for. 
 Step 1: Go to http://resceu.ecdf.ed.ac.uk/shiny/ShinyPred/. 
 Step 2: Input your temperature and relative humidity data in the 
corresponding cells. Make sure no cells are left blank. 
 Step 3: Click “Generate” (may take a few seconds) 
 
Interface of the data input 
 Step 4: View results. Select the virus from the left panel. For each 
virus, the result is available in both figure and table. 
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 Step 5 (optional): Save results. To save a figure, right click the figure 
and select “Save image as”. To save a table, select the preferred 
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A8. Details of the included studies from systematic 
literature review of viral seasonality 
PRISMA flow chart 
 
*Other reasons include military setting, special medical condition and no 
stable sampling practice; these studies were excluded by quality 
assessment. 
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Description of studies included from literature, by site latitude 







RSV PIV MPV 
Brittain-Long, 2012 
1 
Gothenburg Sweden 12, 57.7 respiratory 
symptoms 
PCR ✓ ✓ ✓ ✓ 
Balmaks, 2014 2 Riga Latvia 24.1, 56.9 ALRI PCR  ✓   
Koetz, 2006 3 Halmstad and 
Halland County 
Sweden 12.8, 56.8 ARI PCR  ✓   
McCormick, 2002 4 Belfast UK -5.9, 54.6 NK NK  ✓   
Weigl, 2002 5 Kiel Germany 10.1, 54.3 ARI EIA or PCR  ✓   
Robinson, 2005 6 Edmonton Canada -113.5, 53.5 NK PCR  ✓  ✓ 
Aberle, 2010 7 Vienna Austria -7.8, 53.3 ARI PCR    ✓ 
Aberle, 2008 8 Vienna Austria -7.8, 53.3 ARI PCR  ✓   
Reeves, 2017 9 England UK -1.2, 52.4 respiratory 
symptoms 
multiple tests ✓ ✓ ✓ ✓ 
Ramaekers, 2017 10 Leuven Belgium 4.7, 50.9 ARI PCR ✓ ✓ ✓ ✓ 
Annan, 2016 11 Bonn Germany 7.1, 50.7 ARI PCR   ✓  
Armengaud, 2007 
12 
Paris France 2.4, 48.9 ARI IFA  ✓   
Visseaux, 2017 13 Paris France 2.4, 48.9 ILI + 
pneumonia 
PCR ✓  ✓ ✓ 
Terletskaia-
Ladwig, 2005 14 
Stuttgart Germany 9.2, 48.8 suspected RSV ELISA or PCR  ✓   
Berner, 2001 15 Freiburg Germany 7.8, 48 ARI antigen test  ✓   
Heininger, 2009 16 Basel Switzerland 7.6, 47.6 ARI PCR  ✓  ✓ 
Resch, 2000 17 Graz Austria 15.4, 47.1 ARI IF  ✓   
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Sadeghi, 2011 18 Bern Switzerland 7.4, 46.9 respiratory 
diseases 
DFA   ✓ ✓ 
Muhlemann, 2006 
19 
Bern Switzerland 7.4, 46.9 ARI DFA  ✓   
Ljubin-Sternak, 
2014 20 
Zagreb Croatia 16, 45.8 ARI DFA    ✓ 
Mlinaric-Galinovic, 
2008 21 
Zagreb Croatia 16, 45.8 ARI culture  ✓   
Guo, 2014 22 Karamay China 84.9, 45.6 ILI PCR ✓    
Al-Assam, 2009 23 Nova Scotia Canada -63.7, 44.7 NK NK  ✓   
Foulongne, 2006 24 Montpellier France 3.9, 43.6 respiratory 
diseases 
DFA and viral 
culture 
 ✓  ✓ 
Shi, 2014 25 Fuxin China 121.7, 42 ILI HAI ✓    
Sun, 2013 26 Liaoning China 122.5, 41.9 ILI HAI ✓    
Alonso, 2007 27 Sacyl Spain -4.7, 41.7 bronchiolitis IF  ✓   
Godoy, 2016 28 Catalonia Spain 1.5, 41.6 NK DFA   ✓  
Esper, 2004 29 New Haven, 
Connecticut 
USA -72.9, 41.3 NK DFA    ✓ 
Goktas, 2016 30 Istanbul Turkey 29, 41 ARI PCR ✓ ✓ ✓ ✓ 
Calvo, 2010 31 Leganés Spain -3.8, 40.3 bronchiolitis PCR  ✓   
Wu, 2016 32 Beijing China 116.4, 39.9 ARI PCR   ✓  
Liu, 2013 33 Beijing China 116.4, 39.9 ALRI PCR ✓    
Williams, 2010 34 Davidson and 
Monroe County 
USA -82.3, 39.7 ARI or fever PCR    ✓ 
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Iwane, 2004 35 Davidson and 
Monroe County 
USA -82.3, 39.7 ARI PCR or culture  ✓ ✓  
Hervas, 2012 36 Mallorca Spain 2.7, 39.6 bronchiolitis ELISA  ✓   
Bayrakdar, 2016 37 nationwide Turkey 35.2, 39 respiratory 
diseases 
PCR    ✓ 
Jain, 2015 38 Chicago and 
Nashville 
USA -87.2, 39 pneumonia PCR ✓ ✓  ✓ 
Jain, 2015 39 Chicago and 
Nashville 
USA -87.2, 39 pneumonia PCR   ✓  
Kanra, 2005 40 nationwide Turkey 35.2, 39 respiratory 
symptoms 
EIA  ✓   
Saha, 2016 41 Northern China China 111.1, 38.6 ILI or SARI PCR or culture ✓    
Mizuta, 2013 42 Yamagata Japan 140.4, 38.2 ARI HAI  ✓ ✓ ✓ 
Sirimi, 2016 43 Athens Greece 23.7, 38 NK IF  ✓   
Sato, 2005 44 Niigata City Japan 139, 37.9 respiratory 
symptoms 
PCR  ✓   
Kang, 2013 45 Seoul Republic of Korea 127, 37.6 NK PCR  ✓  ✓ 
Kim, 2006 46 Seoul Republic of Korea 127, 37.6 NK IFA ✓  ✓  
Huang, 2013 47 Lanzhou China 103.8, 36.1 ARI PCR   ✓  
Jin, 2012 48 Lanzhou China 103.8, 36.1 ALRI PCR ✓ ✓  ✓ 
Nakamura, 2013 49 Fukui Japan 136.2, 36.1 ARI PCR    ✓ 
Feng, 2014 50 nationwide China 104.2, 35.9 ALRI NA   ✓ ✓ 
Liu, 2016 51 Shandong China 117.9, 35.9 ILI PCR ✓    
Wilfret, 2008 52 North Carolina USA -79, 35.8 NK DFA, EIA or 
culture 
 ✓   
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Fodha, 2004 53 Sousse Tunisia 10.6, 35.8 ALRI DFA and PCR  ✓   
Hamada, 2014 54 Tokyo Japan 139.7, 35.7 ALRI PCR  ✓ ✓ ✓ 
Aziz, 2015 55 Sulaimani Iraq 45.4, 35.6 ARI DFA or PCR    ✓ 
Saikusa, 2005 56 Yokohama Japan 139.6, 35.4 ARI PCR or culture ✓ ✓   
Jeong, 2010 57 Busan Republic of Korea 129.1, 35.2 ARI PCR  ✓   
Richter, 2016 58 Nicosia Cyprus 33.4, 35.2 ARI PCR ✓ ✓   
Yoshioka, 2012 59 Kyoto Japan 135.8, 35 ARI PCR    ✓ 
Kaneko, 2002 60 Shizuoka Japan 138.4, 35 ALRI ELFA or EIA  ✓   
Kaida, 2006 61 Osaka Japan 135.5, 34.7 ARI PCR  ✓  ✓ 
Zhang, 2016 62 Xi’an China 108.9, 34.3 ARI PCR  ✓   
Yang, 2012 63 Xuzhou China 117.3, 34.2 ILI NK ✓    
Chadha, 2015 64 Srinagar India 74.8, 34.1 ILI or SARI PCR ✓    
Finianos, 2016 65 Beirut Lebanon 35.5, 33.9 ARI PCR  ✓   
Onozuka, 2015 66 Fukuoka Japan 130.4, 33.6 respiratory 
illness 
antigen test or 
PCR 
 ✓   





Mexico -115.3, 32.4 ILI + SARI PCR ✓    
Bdour, 2001 69 Zarqa Jordan 36.1, 32.1 ALRI DFA  ✓   
Bimouhen, 2016 70 nationwide Morocco -7.1, 31.8 ILI or SARI PCR  ✓   
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China 110.9, 31.7 pneumonia PCR  ✓ ✓  
Zhao, 2012 72 Ma’anshan China 118.5, 31.7 ILI PCR ✓    
Ji, 2009 73 Suzhou China 120.6, 31.3 ARI PCR ✓    
Lu, 2015 74 Suzhou China 120.6, 31.3 ALRI PCR  ✓   
Wan, 2009 75 Suzhou China 120.6, 31.3 ARI DFA   ✓ ✓ 
Fu, 2015 76 Shanghai China 121.5, 31.2 ILI PCR   ✓  
Wang, 2016 77 Dazhou China 107.5, 31.2 ILI PCR ✓    
Zhao, 2013 78 Shanghai China 121.5, 31.2 respiratory 
symptoms 
PCR  ✓   
Zhou, 2014 79 Shanghai China 121.5, 31.2 ILI PCR ✓    
Chen, 2016 80 Shanghai China 121.5, 31 ILI PCR ✓    
Refaey, 2016 81 Damanhour district Egypt 30.5, 31 SARI PCR ✓    
Kong, 2016 82 Wuhan China 114.3, 30.6 ILI PCR    ✓ 
Horton, 2017 83 nationwide Jordan 36.2, 30.6 SARI PCR  ✓ ✓ ✓ 
Huo, 2013 84 Jingzhou China 112.2, 30.3 SARI PCR  ✓   
Tang, 2008 85 Hangzhou China 120.2, 30.3 ALRI DFA ✓ ✓ ✓  
Yang, 2011 86 Sichuan China 102.8, 30.3 ILI HAI ✓    
Zheng, 2016 87 Jingzhou China 112.2, 30.3 SARI PCR ✓    
Chen, 2010 88 Chongqing China 106.9, 29.4 ALRI PCR    ✓ 
Qi, 2016 89 Chongqing China 106.9, 29.4 ILI PCR ✓    
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
Appendices 204 







RSV PIV MPV 
Zhang, 2010 90 Chongqing China 106.9, 29.4 ARI PCR  ✓   
Khadadah, 2010 91 nationwide Kwait 47.5, 29.3 ALRI PCR  ✓   
Yu, 2012 92 Zhejiang China 119.8, 29.1 ILI PCR ✓    
Ayora-Talavera, 
2017 68 
Sonora Mexico -110.6, 29.1 ILI + SARI PCR ✓    
Binod, 2012 93 Delhi India 77.1, 28.7 ILI PCR ✓    
Chadha, 2012 94 Delhi India 77.1, 28.7 ILI or SARI HAI ✓    
Chadha, 2015 64 Delhi India 77.1, 28.7 ILI or SARI PCR ✓    
Cui, 2016 95 Eastern China China 116.4, 28.7 ALRI PCR  ✓   
Liu, 2015 96 Nanchang China 115.9, 28.7 ILI PCR ✓    
Bharaj, 2009 97 Delhi India 77.1, 28.7 ALRI PCR  ✓   
Ayora-Talavera, 
2017 68 
Chihuahua Mexico -106, 28.4 ILI + SARI PCR ✓    
Chen, 2014 98 Changsha China 112.9, 28.2 ILI HAI ✓    
Xiao, 2013 99 Changsha China 112.9, 28.2 ALRI PCR    ✓ 
Artiles-Campelo, 
2006 100 
Gran Canaria Spain -15.4, 28.1 ARI RADT ✓ ✓ ✓  
Fergie, 2007 101 Corpus Christi, 
Texas 
USA -97.4, 27.8 NK RADT  ✓   
Light, 2008 102 Florida USA -81.5, 27.7 NK RADT, PCR or 
culture 
 ✓   
Mathisen, 2011 103 Kathmandu Nepal 85.3, 27.7 severe 
pneumonia 
PCR ✓ ✓ ✓  
Saha, 2016 41 Southern China China 112.5, 27.6 ILI or SARI PCR or culture ✓    
Chadha, 2015 64 Dibrugarh India 94.9, 27.5 ILI or SARI PCR ✓    
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Chu, 2016 104 Sarlahi Nepal 85.6, 27 ARI PCR  ✓   
Swamy, 2017 105 Jaipur India 75.8, 26.9 ARI PCR  ✓   
Chadha, 2015 64 Lucknow India 80.9, 26.8 ILI or SARI PCR ✓    
Dangi, 2014 106 Lucknow India 80.9, 26.8 ILI or SARI PCR ✓    
Jain, 2014 107 Lucknow India 80.9, 26.8 SARI PCR  ✓   
Horton, 2017 83 nationwide Egypt 30.8, 26.8 SARI PCR  ✓ ✓ ✓ 
Wu, 2010 108 Nanping China 118.2, 26.6 ILI HAI ✓    
Iha, 2016 109 Okinawa Japan 127.7, 26.2 ILI RADT ✓    
Light, 2007 110 Miami USA -80.2, 25.8 bronchiolitis RADT  ✓   
Ayora-Talavera, 
2017 68 
Nuevo Leon Mexico -100.2, 25.4 ILI + SARI PCR ✓    





Mexico -100.6, 25.3 ILI + SARI PCR ✓    
Hsieh, 2010 112 Taipei China 121.6, 25 respiratory 
diseases 
RADT or culture   ✓  
Li, 2011 113 Quanzhou China 118.7, 24.9 ILI PCR ✓    
Wu, 2012 114 Kunming China 102.8, 24.9 ALRI DFA  ✓ ✓  
Asad, 2017 115 Karachi Pakistan 67, 24.9 ARI PCR  ✓   
Qiu, 2014 116 Shaoguan China 113.6, 24.8 ILI PCR ✓    
Akhter, 2009 117 Riyadh Saudi Arabia 46.7, 24.7 ILI or SARI IF ✓ ✓ ✓  
Lee, 2007 118 Northern Taiwan China 121.8, 24.7 NK RADT  ✓   
Luo, 2012 119 Yunnan China 101.3, 24.5 ILI NK ✓    
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Ayora-Talavera, 
2017 68 
Sinaloa Mexico -107.2, 24.5 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Baja California Sur Mexico -110.2, 24.1 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Durango Mexico -104.4, 24 ILI + SARI PCR ✓    
Chen, 2014 120 Qingyuan China 113.1, 23.7 ILI PCR ✓    
Hsieh, 2016 121 Taiwan China 121, 23.7 ILI NK ✓    
Cui, 2015 122 Shantou China 116.7, 23.4 respiratory 
symptoms 
PCR ✓ ✓ ✓  
Huang, 2001 123 Guangdong China 113.8, 23.4 ILI culture ✓    
Ni, 2009 124 Honghe China 103.4, 23.4 ILI HAI ✓    
Ayora-Talavera, 
2017 68 
Tamaulipas Mexico -99.1, 23.4 ILI + SARI PCR ✓    
Fang, 2013 125 Huizhou China 114.4, 23.1 ARI PCR ✓    
Guan, 2015 126 Guangzhou China 113.3, 23.1 ALRI PCR ✓    
Li, 2008 127 Guangzhou China 113.3, 23.1 ILI HAI ✓    
Liu, 2011 128 Dongguang China 113.8, 23 ILI culture ✓    
Agrawal, 2009 129 Kolkata India 88.4, 22.6 ARI PCR ✓ ✓   
Chadha, 2012 94 Kolkata India 88.4, 22.6 ILI or SARI HAI ✓    
Chadha, 2015 64 Kolkata India 88.4, 22.6 ILI or SARI PCR ✓    
Chen, 2006 130 Shenzhen China 114.1, 22.5 ILI HAI ✓    
He, 2014 131 Shenzhen China 114.1, 22.5 ARI PCR  ✓ ✓ ✓ 
Qin, 2015 132 Shenzhen China 114.1, 22.5 ILI HAI ✓    
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Wu, 2011 133 Shenzhen China 114.1, 22.5 ILI HAI ✓    
Ye, 2013 134 Shenzhen China 114.1, 22.5 ILI HAI ✓    
Ayora-Talavera, 
2017 68 
Zacatecas Mexico -102.3, 22.5 ILI + SARI PCR ✓    
Noyola, 2005 135 San Luis Potosí Mexico -101, 22.2 ARI DFA or PCR    ✓ 
Ayora-Talavera, 
2017 68 
San Luis Potosí Mexico -101, 22.2 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Aguascalientes Mexico -102.2, 21.5 ILI + SARI PCR ✓    
Horton, 2017 83 nationwide Oman 56, 21.5 SARI PCR  ✓ ✓ ✓ 
Ayora-Talavera, 
2017 68 
Nayarit Mexico -104.5, 21.3 ILI + SARI PCR ✓    
Chadha, 2015 64 Nagpur India 79.1, 21.1 ILI or SARI PCR ✓    
Nguyen, 2007 136 Hanoi Vietnam 105.8, 21 ILI HAI ✓    
Ayora-Talavera, 
2017 68 
Guanajuato Mexico -101.2, 21 ILI + SARI PCR ✓    
Gamino-Arroyo, 
2017 137 
Mexico City and 
San Luis Potosí 
Mexico -100.1, 20.8 ILI PCR  ✓   
Ayora-Talavera, 
2017 68 
Yucatan Mexico -89.4, 20.6 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 





Mexico -100.2, 20.4 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Hidalgo Mexico -98.4, 20.1 ILI + SARI PCR ✓    
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Saha, 2016 41 nationwide Lao PDR 102.5, 19.9 ILI or SARI PCR or culture ✓    
Li, 2005 138 Hainan China 109.9, 19.6 ILI HAI ✓    
Hu, 2014 139 Danzhou China 109.6, 19.5 ILI PCR ✓    
Ayora-Talavera, 
2017 68 
Campeche Mexico -90.3, 19.5 ILI + SARI PCR ✓    





Mexico -101.1, 19.4 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Distrito Federal Mexico -99.1, 19.3 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Mexico Mexico -99.4, 19.2 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Tlaxcala Mexico -98.1, 19.2 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Colima Mexico -103.4, 19.1 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Veracruz-Llave Mexico -96.1, 19.1 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Puebla Mexico -98.1, 19 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Morelos Mexico -99.1, 18.6 ILI + SARI PCR ✓    
Chadha, 2012 94 Pune India 73.9, 18.5 ILI or SARI HAI ✓    
Chadha, 2015 64 Pune India 73.9, 18.5 ILI or SARI PCR ✓    
Choudhary, 2013 
141 
Pune India 73.9, 18.5 ILI or SARI PCR  ✓   
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Matias, 2015 142 San Juan Puerto Rico -66.1, 18.5 bronchiolitis RADT  ✓   
Ayora-Talavera, 
2017 68 
Quintana Roo Mexico -88.2, 18.3 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Tabasco Mexico -92.6, 17.6 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Guerrero Mexico -99.3, 17.3 ILI + SARI PCR ✓    
Ayora-Talavera, 
2017 68 
Oaxaca Mexico -96.4, 17 ILI + SARI PCR ✓    
Hasegawa, 2006 143 Yangon Myanmar 96.2, 16.9 ILI RADT or culture ✓    
Ayora-Talavera, 
2017 68 
Chiapas Mexico -93.1, 16.4 ILI + SARI PCR ✓    
Diene Sarr, 2015 
144,145 
Ndiop Senegal -16.3, 15.9 Fever PCR ✓    
Horton, 2017 83 nationwide Yemen 48.5, 15.6 SARI PCR ✓ ✓ ✓  
Dosseh, 2000 146 Dakar Senegal -17.5, 14.7 ILI HAI or culture ✓    
Schlaudecker, 
2012 147 
Santa Lucía Honduras -87.1, 14.1 ILI PCR ✓ ✓ ✓ ✓ 
Diene Sarr, 2015 
144,145 
Dielmo Senegal -16.4, 13.7 Fever PCR ✓    
van der Sande, 
2004 148 





Pailin and Banteay 
Meanchey 
Cambodia 103, 13.4 ILI PCR ✓    
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Chadha, 2012 94 Chennai India 80.3, 13.1 ILI or SARI HAI ✓    
Chadha, 2015 64 Chennai India 80.3, 13.1 ILI or SARI PCR ✓    
Chadha, 2015 64 Vellore India 79.1, 12.9 ILI or SARI PCR ✓    
Ouedraogo, 2014 
150 
Ouagadougou Burkina Faso -1.5, 12.4 ARI DFA  ✓   
Do, 2016 151 Ho Chi Minh City Vietnam 106.6, 10.8 ALRI PCR  ✓ ✓  
Chadha, 2015 64 Alapphuzha India 76.3, 9.5 ILI or SARI PCR ✓    
Njouom, 2012 152 nationwide Cameroon 12.4, 7.4 ILI PCR  ✓ ✓ ✓ 
Perera, 2010 153 Ragama Sri Lanka 79.9, 7 AURI PCR ✓    
Annan, 2016 11 Kumasi Ghana -1.6, 6.7 ARI PCR   ✓  
Robertson, 2004 
154 
Eleta and Ijaye Nigeria 3.4, 6.6 ALRI ELISA  ✓   
Shapiro, 2017 155 Galle Sri Lanka 80.2, 6.1 ILI PCR ✓    
Akoua-Koffi, 2007 
156 
Abidjan Côte d’Ivoire -4, 5.4 respiratory 
symptoms 
ELISA ✓    
Rodriguez-
Martinez, 2015 157 
Bogota Colombia -74.1, 4.7 ALRI RADT  ✓   
Kenmoe, 2016 158 Yaoundé Cameroon 11.5, 3.8 respiratory 
symptoms 
PCR  ✓   
Monamele, 2017 159 Yaoundé Cameroon 11.5, 3.8 ILI + SARI PCR ✓    
Khor, 2012 160 Kuala Lumpur Malaysia 101.7, 3.1 ARI IF or culture ✓ ✓ ✓  
Nyoka, 2017 161 Dadaab Kenya 40.3, 0.1 ILI + SARI NK  ✓   
Jonnalagadda, 
2017 162 
Quito Ecuador -78.5, -0.2 severe 
pneumonia 
PCR  ✓ ✓ ✓ 
Alonso, 2012 163 Fortaleza Brazil -38.5, -3.7 ARI IFA  ✓   
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Alonso, 2007 164 North Brazil Brazil -65.9, -4.4 ILI NK ✓    
Fe, 2008 165 Ceará Brazil -39.3, -5.5 ARI IF   ✓  
Robertson, 2004 
154 
Cikutra and Ujung 
Berung, Bandung 
Indonesia 107.7, -6.9 ALRI ELISA  ✓   
Yamaoka, 2011 166 Surabaya Indonesia 112.8, -7.3 ILI PCR ✓    
Budge, 2014 167 San Marcos 
province 
Peru -78.2, -7.3 ARI PCR ✓ ✓ ✓ ✓ 
Fagan, 2017 168 the Top End Australia 130.8, -12.5 NK PCR  ✓   
Bouzas, 2016 169 Salvador Brazil -38.5, -13 ARI PCR  ✓   
Hogan, 2016 170 Kimberley, 
Western Australia 
Australia 125.9, -17.3 ALRI multiple tests  ✓   
Costa, 2006 171 Uberlândia Brazil -48.3, -18.9 ARI IF or PCR ✓ ✓   
Checon, 2002 172 Vitória Brazil -40.3, -20.3 ARI IFA  ✓   
Salomao Junior, 
2011 173 
São José do Rio 
Preto 
Brazil -49.4, -20.8 ALRI PCR  ✓   
Brottet, 2016 174 Réunion Island France 55.5, -21.1 ILI PCR ✓    
Sapin, 2001 175 Réunion Island France 55.5, -21.1 ARI DFA  ✓   
Hogan, 2016 170 Pilbara, Western 
Australia 
Australia 121.5, -21.6 ALRI multiple tests  ✓   
Alonso, 2007 164 Southeast Brazil Brazil -43.2, -21.7 ILI NK ✓    
Bellei, 2008 176 São Paulo Brazil -46.6, -23.6 ILI or ARI DFA, culture or 
PCR 
✓    
Pecchini, 2015 177 São Paulo Brazil -46.6, -23.6 ARI IF  ✓ ✓  
Thomazelli, 2007 
178 
São Paulo Brazil -46.6, -23.6 ALRI PCR    ✓ 
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Dede, 2010 179 Alice Springs Australia 133.9, -23.7 bronchiolitis DFA  ✓   
Loscertales, 2002 
180 
Manhiça Mozambique 32.8, -25.3 ALRI ELISA or PCR  ✓   
O’Callaghan-
Gordo, 2011 181 
Manhiça Mozambique 32.8, -25.3 ARI PCR ✓    
Vidal, 2008 182 Curitiba Brazil -49.3, -25.4 ILI or ARI IFA ✓    
Venter, 2011 183 Pretoria South Africa 28.2, -25.7 ARI DFA or PCR ✓ ✓ ✓ ✓ 
Pale, 2017 184 Maputo Mozambique 32.6, -25.9 SARI PCR  ✓   
Hogan, 2016 170 Midwest-
Murchison, 
Western Australia 
Australia 116, -26.5 ALRI multiple tests  ✓   
Alonso, 2007 164 South Brazil Brazil -50.2, -27.7 ILI NK ✓    
Hogan, 2016 170 Goldfields, 
Western Australia 
Australia 121.5, -30.8 ALRI multiple tests  ✓   
Hogan, 2016 170 Wheatbelt, 
Western Australia 
Australia 118, -32 ALRI multiple tests  ✓   
Hogan, 2016 170 Perth, Western 
Australia 
Australia 115.9, -32 ALRI multiple tests  ✓   
Vega-Briceno, 
2007 185 
Santiago Chile -70.7, -33.4 respiratory 
diseases 
PCR   ✓  
Hogan, 2016 170 South West, 
Western Australia 
Australia 116.2, -34.2 ALRI multiple tests  ✓   
Viegas, 2004 186 Buenos Aires Argentina -58.4, -34.6 ALRI IFA ✓ ✓ ✓  
Hogan, 2016 170 Great Southern, 
Western Australia 
Australia 117, -35 ALRI multiple tests  ✓   
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Bryce, 2012 207 D A A No 
Deng, 2009 208 A D A No 
Li, 2008 209 A D C No 
Mahamat, 2013 210 A D A No 
Matthew, 2009 211 D A A No 
Tantawy, 2015 212 D A A No 
Aberle, 2010 27 B A B Yes 
Aberle, 2008 28 B A B Yes 
Agrawal, 2009 149 B A A Yes 
Akhter, 2009 137 B B B Yes 
Akoua-Koffi, 2007 176 A A B Yes 
Al-Assam, 2009 43 B C C Yes 
Alonso, 2007 47 A A B Yes 
Alonso, 2012 183 B A A Yes 
Alonso, 2007 184 A C C Yes 
Annan, 2016 31 B A A Yes 
Armengaud, 2007 32 A A A Yes 
Artiles-Campelo, 2006 120 B A B Yes 
Asad, 2017 135 B A A Yes 
Ayora-Talavera, 2017 88  A A A Yes 
Aziz, 2015 75 B A B Yes 
Balmaks, 2014 22 B A A Yes 
Bayrakdar, 2016 57 A A B Yes 
Bdour, 2001 89 B A B Yes 
Bellei, 2008 196 B A A Yes 
Berner, 2001 35 B C C Yes 
Bharaj, 2009 117 B A A Yes 
Bimouhen, 2016 90 A A A Yes 
Binod, 2012 113 A A C Yes 
Bouzas, 2016 189 B A A Yes 
Brittain-Long, 2012 21 A A A Yes 
Brottet, 2016 194 A A B Yes 
Calvo, 2010 51 B A A Yes 
Chadha, 2012 114 A A A Yes 
Chadha, 2015 84 A A A Yes 
Checon, 2002 192 B A B Yes 
Chen, 2006 150 A A A Yes 
Chen, 2014 118 A A B Yes 
Chen, 2014 140 A A A Yes 
Chen, 2010 108 A A B Yes 
Chen, 2016 100 A A A Yes 
Choudhary, 2013 161 B A B Yes 
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Chu, 2016 124 B A A Yes 
Costa, 2006 191 B A A Yes 
Cui, 2015 142 B A A Yes 
Cui, 2016 115 B A A Yes 
Dangi, 2014 126 A A A Yes 
Dede, 2010 199 B A C Yes 
Do, 2016 171 B A A Yes 
Dosseh, 2000 166 A A B Yes 
Esper, 2004 49 B A A Yes 
Fagan, 2017 188 A C C Yes 
Fang, 2013 145 A A A Yes 
Fe, 2008 185 B A A Yes 
Feng, 2014 91 B A A Yes 
Feng, 2014 70 A A A Yes 
Fergie, 2007 121 A A C Yes 
Finianos, 2016 85 B A A Yes 
Fodha, 2004 73 C A B Yes 
Foulongne, 2006 44 B A A Yes 
Fu, 2015 96 A A A Yes 
Gamino-Arroyo, 2017 157 A A A Yes 
Godoy, 2016 48 A A A Yes 
Goktas, 2016 50 A A C Yes 
Guan, 2015 146 B A B Yes 
Guo, 2014 42 A A A Yes 
Hamada, 2014 74 B A B Yes 
Hasegawa, 2006 163 A A A Yes 
He, 2014 151 B A A Yes 
Heininger, 2009 36 B A B Yes 
Hervas, 2012 56 B A B Yes 
Hogan, 2016 190 B A B Yes 
Horton, 2017 103 A A A Yes 
Hsieh, 2016 141 A C C Yes 
Hsieh, 2010 132 B A B Yes 
Hu, 2014 159 A A A Yes 
Huang, 2013 67 A A A Yes 
Huang, 2001 143 A A B Yes 
Huo, 2013 104 B A A Yes 
Iha, 2016 129 C A C Yes 
Iwane, 2004 55 B A B Yes 
Jain, 2014 127 A A A Yes 
Jain, 2015 58 A A A Yes 
Jain, 2015 59 B A A Yes 
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Jeong, 2010 77 A A B Yes 
Ji, 2009 93 B A A Yes 
Jin, 2012 68 B A B Yes 
Jonnalagadda, 2017 182 B A A Yes 
Kaida, 2006 81 B A C Yes 
Kaneko, 2002 80 B A B Yes 
Kang, 2013 65 A A C Yes 
Kanra, 2005 60 B A A Yes 
Kenmoe, 2016 178 B A A Yes 
Khadadah, 2010 111 A A B Yes 
Khor, 2012 180 B A B Yes 
Kim, 2006 66 A A B Yes 
Koetz, 2006 23 B A B Yes 
Kong, 2016 102 B A B Yes 
Lee, 2007 138 B A B Yes 
Li, 2011 133 A A B Yes 
Li, 2008 147 A A A Yes 
Li, 2005 158 A A A Yes 
Light, 2007 130 B A B Yes 
Light, 2008 122 B A B Yes 
Liu, 2016 71 A C B Yes 
Liu, 2015 116 A A A Yes 
Liu, 2011 148 A A A Yes 
Liu, 2013 53 B A A Yes 
Ljubin-Sternak, 2014 40 B A A Yes 
Loscertales, 2002 200 B A A Yes 
Lu, 2015 94 B A A Yes 
Luo, 2012 139 A A C Yes 
Mathisen, 2011 123 B A A Yes 
Matias, 2015 162 B A B Yes 
McCormick, 2002 24 C A B Yes 
Mizuta, 2013 62 A A B Yes 
Mlinaric-Galinovic, 2008 41 B A B Yes 
Monamele, 2017 179 A A A Yes 
Muhlemann, 2006 39 B C C Yes 
Nakamura, 2013 69 A A A Yes 
Nguyen, 2007 156 A A A Yes 
Ni, 2009 144 A A C Yes 
Njouom, 2012 172 A A A Yes 
Noyola, 2005 155 B A B Yes 
Nyoka, 2017 181 C C C Yes 
O'Callaghan-Gordo, 2011 201 B A B Yes 
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Onozuka, 2015 86 A A B Yes 
Ouedraogo, 2014 170 B A A Yes 
Pale, 2017 204 B A A Yes 
Pecchini, 2015 197 B A A Yes 
Perera, 2010 173 A A A Yes 
Qi, 2016 109 A A A Yes 
Qin, 2015 152 A A A Yes 
Qiu, 2014 136 A A A Yes 
Ramaekers, 2017 30 A A A Yes 
Reeves, 2017 213 B B A Yes 
Refaey, 2016 101 A A A Yes 
Resch, 2000 37 B A B Yes 
Richter, 2016 78 B A A Yes 
Robertson, 2004 174 B A A Yes 
Robinson, 2005 26 B A B Yes 
Rodriguez-Martinez, 2015 177 B A A Yes 
Sadeghi, 2011 38 B A B Yes 
Saha, 2016 61 A C C Yes 
Saikusa, 2005 76 B A B Yes 
Salomao Junior, 2011 193 B A B Yes 
Sapin, 2001 195 B A B Yes 
Sato, 2005 64 B A A Yes 
Schlaudecker, 2012 167 B A A Yes 
Shapiro, 2017 175 A A A Yes 
Shi, 2014 45 A A A Yes 
Sirimi, 201663 B A B Yes 
Sun, 2013 46 A A A Yes 
Swamy, 2017 125 A A A Yes 
Tang, 2008 105 B A A Yes 
Terletskaia-Ladwig, 2005 34 B B A Yes 
Thomazelli, 2007 198 B A A Yes 
Timmermans, 2016 169 A A A Yes 
van der Sande, 2004 168 B A A Yes 
Vega-Briceno, 2007 205 B A B Yes 
Venter, 2011 203 B A A Yes 
Vidal, 2008 202 A A A Yes 
Viegas, 2004 206 B A B Yes 
Visseaux, 2017 33 B A B Yes 
Wahab, 2001 131 B A B Yes 
Wan, 2009 95 B A A Yes 
Wang, 2016 97 A A A Yes 
Weigl, 2002 25 B A A Yes 
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Wilfret, 2008 72 A A A Yes 
Williams, 2010 54 B A A Yes 
Wu, 2010 128 A A A Yes 
Wu, 2011 153 A A C Yes 
Wu, 2012 134 B A A Yes 
Wu, 2016 52 A A A Yes 
Xiao, 2013 119 A A B Yes 
Yamaoka, 2011 186 A A A Yes 
Yang, 2011 106 A A A Yes 
Yang, 2012 83 A A A Yes 
Ye, 2013 154 A A A Yes 
Yin, 2017 87 B A A Yes 
Yoshioka, 2012 79 B A A Yes 
Yu, 2012 112 A A C Yes 
Yusuf, 2007 160 A A B Yes 
Zhang, 2016 82 A A A Yes 
Zhang, 2010 110 B A A Yes 
Zhao, 2013 98 B A A Yes 
Zhao, 201292 A A C Yes 
Zheng, 2016 107 B A A Yes 
Zhou, 2014 99 A A C Yes 
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A11. Epidemic months of IFV, RSV, PIV and MPV grouped by country 
IFV 
WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Africa Region Algeria nationwide ✓ ✓          ✓ 
Africa Region Burkina Faso nationwide  ✓      ✓ ✓ ✓ ✓ ✓ 
Africa Region Cameroon nationwide   ✓ ✓ ✓    ✓ ✓ ✓ ✓ 
Africa Region Cameroon Yaoundé   ✓  ✓    ✓ ✓ ✓ ✓ 
Africa Region Central African Republic nationwide       ✓ ✓ ✓    
Africa Region Côte d’Ivoire Abidjan   ✓   ✓    ✓   
Africa Region Democratic Republic of 
the Congo 
nationwide ✓ ✓  ✓ ✓ ✓      ✓ 
Africa Region Ethiopia nationwide ✓ ✓ ✓ ✓      ✓ ✓  
Africa Region Ghana nationwide    ✓ ✓ ✓ ✓   ✓ ✓ ✓ 
Africa Region Kenya Kilifi   ✓    ✓ ✓  ✓ ✓ ✓ 
Africa Region Kenya nationwide  ✓ ✓ ✓   ✓ ✓ ✓ ✓ ✓  
Africa Region Madagascar nationwide ✓ ✓ ✓  ✓ ✓ ✓   ✓ ✓ ✓ 
Africa Region Mali nationwide  ✓ ✓     ✓ ✓ ✓   
Africa Region Mauritania nationwide  ✓ ✓ ✓     ✓    
Africa Region Mauritius nationwide ✓ ✓ ✓ ✓ ✓  ✓  ✓    
Africa Region Mozambique nationwide  ✓    ✓  ✓  ✓ ✓ ✓ 
Africa Region Mozambique Manhiça  ✓ ✓ ✓ ✓        
Africa Region Niger nationwide ✓ ✓ ✓        ✓ ✓ 
Africa Region Nigeria nationwide ✓ ✓ ✓ ✓    ✓ ✓ ✓ ✓  
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Africa Region Senegal nationwide        ✓ ✓ ✓ ✓  
Africa Region Senegal Dielmo        ✓  ✓ ✓  
Africa Region Senegal Ndiop  ✓      ✓  ✓ ✓  
Africa Region Senegal Dakar   ✓   ✓ ✓ ✓ ✓ ✓   
Africa Region Sierra Leone nationwide    ✓   ✓ ✓  ✓ ✓  
Africa Region South Africa Soweto     ✓ ✓ ✓ ✓ ✓    
Africa Region South Africa Agincourt      ✓ ✓ ✓ ✓    
Africa Region South Africa nationwide      ✓ ✓ ✓ ✓    
Africa Region South Africa Pretoria    ✓ ✓ ✓  ✓     
Africa Region Tanzania nationwide ✓ ✓ ✓  ✓ ✓     ✓ ✓ 
Africa Region Togo nationwide     ✓ ✓ ✓   ✓ ✓ ✓ 
Africa Region Uganda nationwide        ✓ ✓ ✓ ✓  
Africa Region Zambia nationwide  ✓ ✓ ✓   ✓ ✓ ✓ ✓   
Eastern Mediterranean 
Region 
Afghanistan nationwide  ✓        ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Bahrain nationwide ✓ ✓        ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Egypt nationwide ✓ ✓ ✓        ✓ ✓ 
Eastern Mediterranean 
Region 
Egypt Damanhour district ✓ ✓      ✓ ✓ ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Iran (Islamic Republic of) nationwide ✓ ✓          ✓ 
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Eastern Mediterranean 
Region 
Iraq nationwide ✓ ✓           
Eastern Mediterranean 
Region 
Jordan Amman ✓ ✓   ✓       ✓ 
Eastern Mediterranean 
Region 
Jordan nationwide ✓  ✓ ✓        ✓ 
Eastern Mediterranean 
Region 
Lebanon nationwide ✓ ✓ ✓         ✓ 
Eastern Mediterranean 
Region 
Morocco Rabat ✓ ✓          ✓ 
Eastern Mediterranean 
Region 
Morocco nationwide ✓ ✓         ✓ ✓ 
Eastern Mediterranean 
Region 
Oman nationwide ✓  ✓ ✓ ✓     ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Pakistan nationwide ✓ ✓ ✓        ✓ ✓ 
Eastern Mediterranean 
Region 
Qatar nationwide ✓ ✓ ✓       ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Saudi Arabia Riyadh           ✓ ✓ 
Eastern Mediterranean 
Region 
Yemen nationwide ✓    ✓ ✓ ✓    ✓ ✓ 
European Region Armenia nationwide  ✓ ✓ ✓         
European Region Aruba nationwide ✓  ✓ ✓ ✓  ✓     ✓ 
European Region Austria nationwide  ✓ ✓          
European Region Azerbaijan nationwide ✓ ✓           
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
European Region Belarus nationwide   ✓ ✓         
European Region Belgium nationwide ✓ ✓ ✓          
European Region Belgium Leuven ✓ ✓ ✓          
European Region Bermuda nationwide  ✓   ✓ ✓       
European Region Bosnia and Herzegovina nationwide ✓ ✓           
European Region Bulgaria nationwide ✓ ✓ ✓          
European Region Cyprus Nicosia ✓ ✓  ✓         
European Region Denmark nationwide ✓ ✓ ✓          
European Region Finland nationwide ✓ ✓ ✓         ✓ 
European Region France nationwide ✓ ✓ ✓          
European Region France Réunion Island     ✓ ✓ ✓  ✓ ✓   
European Region France Paris ✓ ✓ ✓          
European Region French Guiana nationwide ✓ ✓ ✓ ✓ ✓ ✓       
European Region Georgia nationwide ✓ ✓ ✓          
European Region Germany Berlin ✓ ✓ ✓          
European Region Germany nationwide ✓ ✓ ✓          
European Region Greece nationwide  ✓ ✓          
European Region Guadeloupe nationwide ✓ ✓ ✓        ✓  
European Region Iceland nationwide ✓ ✓ ✓          
European Region Ireland nationwide ✓ ✓ ✓          
European Region Kazakhstan nationwide ✓ ✓           
European Region Kyrgyzstan nationwide ✓ ✓           
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
European Region Lithuania nationwide ✓ ✓ ✓          
European Region Malta nationwide ✓ ✓           
European Region Martinique nationwide ✓ ✓ ✓         ✓ 
European Region Netherlands nationwide ✓ ✓ ✓          
European Region New Caledonia nationwide   ✓ ✓   ✓ ✓ ✓ ✓  ✓ 
European Region Norway nationwide ✓ ✓ ✓         ✓ 
European Region Poland nationwide ✓ ✓ ✓          
European Region Portugal nationwide ✓ ✓          ✓ 
European Region Republic of Moldova nationwide  ✓ ✓          
European Region Romania nationwide  ✓ ✓          
European Region Russian Federation nationwide ✓ ✓ ✓          
European Region Slovakia nationwide ✓ ✓ ✓          
European Region Slovenia nationwide ✓ ✓ ✓          
European Region Spain nationwide ✓ ✓          ✓ 
European Region Spain Gran Canaria ✓ ✓ ✓ ✓       ✓ ✓ 
European Region Sweden nationwide ✓ ✓ ✓         ✓ 
European Region Switzerland nationwide ✓ ✓ ✓          
European Region Turkey nationwide ✓ ✓          ✓ 
European Region Turkey Istanbul ✓ ✓ ✓ ✓         
European Region UK nationwide ✓ ✓ ✓         ✓ 
European Region UK England ✓ ✓          ✓ 
European Region Ukraine nationwide  ✓ ✓ ✓         
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Region of the Americas Argentina Buenos Aires     ✓ ✓ ✓ ✓     
Region of the Americas Argentina nationwide     ✓ ✓ ✓ ✓     
Region of the Americas Barbados nationwide  ✓ ✓   ✓ ✓   ✓ ✓  
Region of the Americas Belize nationwide  ✓ ✓ ✓         
Region of the Americas Bolivia nationwide    ✓ ✓ ✓ ✓  ✓ ✓   
Region of the Americas Brazil Belo Horizonte    ✓ ✓ ✓ ✓ ✓ ✓   ✓ 
Region of the Americas Brazil nationwide   ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Brazil North Brazil  ✓ ✓        ✓  
Region of the Americas Brazil Southeast Brazil     ✓ ✓ ✓ ✓  ✓   
Region of the Americas Brazil South Brazil      ✓ ✓   ✓   
Region of the Americas Brazil São Paulo      ✓ ✓ ✓ ✓    
Region of the Americas Brazil Curitiba     ✓ ✓ ✓ ✓     
Region of the Americas Brazil Uberlândia   ✓  ✓  ✓ ✓     
Region of the Americas Canada nationwide ✓ ✓ ✓         ✓ 
Region of the Americas Chile Iquique   ✓   ✓ ✓      
Region of the Americas Chile nationwide     ✓ ✓ ✓ ✓ ✓    
Region of the Americas Colombia nationwide ✓  ✓ ✓ ✓ ✓ ✓ ✓  ✓ ✓  
Region of the Americas Costa Rica nationwide ✓      ✓  ✓ ✓ ✓ ✓ 
Region of the Americas Cuba nationwide     ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Dominican Republic nationwide   ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Ecuador nationwide ✓ ✓ ✓ ✓ ✓  ✓ ✓     
Region of the Americas El Salvador nationwide     ✓ ✓ ✓  ✓ ✓ ✓  
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Region of the Americas Guatemala Santa Rosa   ✓ ✓  ✓ ✓ ✓ ✓    
Region of the Americas Guatemala Quetzaltenango ✓ ✓ ✓ ✓      ✓ ✓  
Region of the Americas Guatemala nationwide ✓ ✓ ✓ ✓  ✓ ✓   ✓   
Region of the Americas Haiti nationwide         ✓ ✓ ✓ ✓ 
Region of the Americas Honduras nationwide ✓      ✓ ✓ ✓ ✓ ✓  
Region of the Americas Honduras Santa Lucía        ✓ ✓ ✓   
Region of the Americas Jamaica nationwide ✓ ✓   ✓ ✓    ✓ ✓ ✓ 
Region of the Americas Mexico nationwide ✓ ✓ ✓         ✓ 
Region of the Americas Mexico Aguascalientes ✓ ✓          ✓ 
Region of the Americas Mexico Baja California Norte ✓ ✓           
Region of the Americas Mexico Baja California Sur ✓ ✓ ✓          
Region of the Americas Mexico Campeche ✓ ✓ ✓    ✓  ✓ ✓   
Region of the Americas Mexico Coahuila De Zaragoza ✓ ✓       ✓ ✓   
Region of the Americas Mexico Colima ✓ ✓ ✓         ✓ 
Region of the Americas Mexico Chiapas ✓           ✓ 
Region of the Americas Mexico Chihuahua ✓ ✓         ✓ ✓ 
Region of the Americas Mexico Distrito Federal ✓ ✓          ✓ 
Region of the Americas Mexico Durango ✓ ✓           
Region of the Americas Mexico Guanajuato ✓ ✓          ✓ 
Region of the Americas Mexico Guerrero ✓ ✓ ✓   ✓   ✓ ✓   
Region of the Americas Mexico Hidalgo ✓ ✓           
Region of the Americas Mexico Jalisco ✓ ✓           
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
Appendices 237 
WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Region of the Americas Mexico Mexico ✓ ✓          ✓ 
Region of the Americas Mexico Michoacan de Ocampo ✓ ✓           
Region of the Americas Mexico Morelos ✓ ✓           
Region of the Americas Mexico Nayarit ✓ ✓ ✓        ✓  
Region of the Americas Mexico Nuevo Leon ✓ ✓          ✓ 
Region of the Americas Mexico Oaxaca ✓ ✓           
Region of the Americas Mexico Puebla ✓ ✓          ✓ 
Region of the Americas Mexico Queretaro de Arteaga ✓ ✓          ✓ 
Region of the Americas Mexico Quintana Roo ✓ ✓     ✓ ✓ ✓ ✓   
Region of the Americas Mexico San Luis Potosí ✓ ✓          ✓ 
Region of the Americas Mexico Sinaloa ✓ ✓ ✓        ✓  
Region of the Americas Mexico Sonora ✓ ✓           
Region of the Americas Mexico Tabasco ✓ ✓       ✓    
Region of the Americas Mexico Tamaulipas ✓ ✓         ✓ ✓ 
Region of the Americas Mexico Tlaxcala ✓ ✓ ✓          
Region of the Americas Mexico Veracruz-Llave ✓ ✓ ✓       ✓ ✓ ✓ 
Region of the Americas Mexico Yucatan ✓      ✓ ✓ ✓ ✓ ✓  
Region of the Americas Mexico Zacatecas ✓ ✓          ✓ 
Region of the Americas Nicaragua nationwide       ✓ ✓ ✓ ✓ ✓  
Region of the Americas Panama nationwide     ✓ ✓ ✓ ✓     
Region of the Americas Paraguay nationwide     ✓ ✓ ✓ ✓     
Region of the Americas Peru Tambopata district ✓     ✓ ✓      
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Region of the Americas Peru nationwide ✓    ✓ ✓ ✓ ✓ ✓    
Region of the Americas Peru San Marcos province          ✓ ✓ ✓ 
Region of the Americas Suriname nationwide  ✓ ✓ ✓   ✓ ✓ ✓    
Region of the Americas Trinidad and Tobago nationwide ✓ ✓       ✓ ✓ ✓  
Region of the Americas Uruguay nationwide     ✓ ✓ ✓ ✓     
Region of the Americas USA nationwide ✓ ✓ ✓         ✓ 
Region of the Americas USA Chicago and Nashville ✓ ✓ ✓         ✓ 
Region of the Americas Venezuela (Bolivarian 
Republic of) 
nationwide   ✓ ✓ ✓      ✓  
Southeast Asia Region Bangladesh Kishoregonj, Bogra, 
Comilla and Barisal 
     ✓ ✓ ✓     
Southeast Asia Region Bangladesh nationwide    ✓ ✓ ✓ ✓ ✓ ✓    
Southeast Asia Region Bhutan nationwide ✓ ✓ ✓ ✓ ✓  ✓ ✓     
Southeast Asia Region India Puducherry ✓ ✓  ✓ ✓        
Southeast Asia Region India nationwide  ✓ ✓ ✓   ✓ ✓ ✓    
Southeast Asia Region India Chennai ✓ ✓ ✓ ✓      ✓ ✓ ✓ 
Southeast Asia Region India Srinagar ✓ ✓ ✓ ✓        ✓ 
Southeast Asia Region India Dibrugarh     ✓ ✓ ✓ ✓    ✓ 
Southeast Asia Region India Lucknow       ✓ ✓ ✓ ✓   
Southeast Asia Region India Nagpur ✓  ✓    ✓ ✓ ✓ ✓ ✓  
Southeast Asia Region India Vellore ✓  ✓     ✓ ✓ ✓ ✓ ✓ 
Southeast Asia Region India Alapphuzha     ✓ ✓ ✓ ✓     
Southeast Asia Region India Delhi  ✓ ✓    ✓ ✓ ✓    
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Southeast Asia Region India Kolkata  ✓   ✓ ✓ ✓ ✓ ✓   ✓ 
Southeast Asia Region India Pune   ✓ ✓   ✓ ✓ ✓ ✓   
Southeast Asia Region Indonesia nationwide ✓ ✓ ✓ ✓ ✓      ✓ ✓ 
Southeast Asia Region Maldives nationwide  ✓ ✓ ✓      ✓  ✓ 
Southeast Asia Region Myanmar nationwide       ✓ ✓     
Southeast Asia Region Nepal nationwide  ✓ ✓    ✓ ✓ ✓    
Southeast Asia Region Nepal Kathmandu ✓ ✓ ✓     ✓     
Southeast Asia Region Sri Lanka nationwide ✓ ✓ ✓ ✓ ✓ ✓      ✓ 
Southeast Asia Region Sri Lanka Ragama     ✓  ✓  ✓  ✓ ✓ 
Southeast Asia Region Sri Lanka Galle    ✓ ✓ ✓       
Southeast Asia Region Thailand Nakhon Phanom and Sa 
Kaeo 
 ✓ ✓    ✓ ✓ ✓ ✓   
Southeast Asia Region Thailand Bangkok  ✓     ✓ ✓ ✓ ✓ ✓  
Southeast Asia Region Thailand Khon Kaen  ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓  
Southeast Asia Region Thailand nationwide ✓ ✓ ✓    ✓ ✓ ✓ ✓ ✓  
Western Pacific Region Australia nationwide       ✓ ✓ ✓    
Western Pacific Region Cambodia nationwide       ✓ ✓ ✓ ✓ ✓  
Western Pacific Region Cambodia Battambang, Oddar 
Meanchey, Pailin and 
Banteay Meanchey 
       ✓ ✓ ✓ ✓  
Western Pacific Region China nationwide ✓ ✓ ✓ ✓   ✓ ✓    ✓ 
Western Pacific Region China Hong Kong ✓ ✓ ✓ ✓  ✓ ✓      
Western Pacific Region China Shantou ✓  ✓ ✓ ✓        
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Western Pacific Region China Huizhou ✓ ✓ ✓ ✓       ✓ ✓ 
Western Pacific Region China Guangzhou ✓ ✓ ✓ ✓ ✓       ✓ 
Western Pacific Region China Karamay ✓ ✓          ✓ 
Western Pacific Region China Taiwan ✓ ✓ ✓    ✓ ✓ ✓   ✓ 
Western Pacific Region China Danzhou   ✓ ✓      ✓ ✓ ✓ 
Western Pacific Region China Guangdong    ✓ ✓ ✓ ✓      
Western Pacific Region China Suzhou ✓  ✓    ✓ ✓     
Western Pacific Region China Lanzhou ✓  ✓ ✓       ✓ ✓ 
Western Pacific Region China Hainan     ✓  ✓ ✓ ✓    
Western Pacific Region China Shandong ✓ ✓ ✓         ✓ 
Western Pacific Region China Nanchang ✓ ✓ ✓  ✓ ✓ ✓      
Western Pacific Region China Honghe ✓ ✓ ✓ ✓    ✓     
Western Pacific Region China Chongqing ✓ ✓ ✓   ✓ ✓     ✓ 
Western Pacific Region China Shenzhen   ✓  ✓ ✓ ✓ ✓  ✓  ✓ 
Western Pacific Region China Shaoguan  ✓ ✓ ✓ ✓ ✓   ✓   ✓ 
Western Pacific Region China Northern China ✓ ✓ ✓         ✓ 
Western Pacific Region China Southern China ✓ ✓ ✓    ✓ ✓ ✓   ✓ 
Western Pacific Region China Fuxin ✓  ✓         ✓ 
Western Pacific Region China Liaoning ✓ ✓ ✓          
Western Pacific Region China Hangzhou ✓ ✓ ✓ ✓    ✓ ✓   ✓ 
Western Pacific Region China Dazhou ✓ ✓ ✓    ✓    ✓ ✓ 
Western Pacific Region China Zhejiang ✓ ✓ ✓         ✓ 
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Western Pacific Region China Jingzhou ✓ ✓      ✓    ✓ 
Western Pacific Region China Shanghai ✓ ✓ ✓    ✓ ✓    ✓ 
Western Pacific Region China Beijing ✓ ✓ ✓        ✓  
Western Pacific Region Fiji nationwide   ✓ ✓ ✓    ✓ ✓   
Western Pacific Region Japan nationwide ✓ ✓ ✓          
Western Pacific Region Japan Okinawa ✓ ✓ ✓ ✓ ✓   ✓    ✓ 
Western Pacific Region Japan Yokohama ✓ ✓ ✓          
Western Pacific Region Lao PDR nationwide        ✓ ✓ ✓ ✓ ✓ 
Western Pacific Region Malaysia nationwide ✓ ✓ ✓ ✓ ✓ ✓ ✓  ✓    
Western Pacific Region Malaysia Kuala Lumpur ✓  ✓  ✓  ✓  ✓ ✓ ✓ ✓ 
Western Pacific Region Mongolia Ulaanbaatar ✓  ✓        ✓ ✓ 
Western Pacific Region Mongolia nationwide ✓ ✓ ✓          
Western Pacific Region New Zealand nationwide       ✓ ✓ ✓    
Western Pacific Region Philippines Bohol ✓  ✓  ✓ ✓ ✓ ✓     
Western Pacific Region Philippines nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Western Pacific Region Republic of Korea nationwide ✓ ✓ ✓ ✓         
Western Pacific Region Republic of Korea Seoul ✓   ✓ ✓       ✓ 
Western Pacific Region Singapore nationwide ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓     
Western Pacific Region Vietnam Nha Trang City ✓ ✓ ✓ ✓ ✓ ✓ ✓      
Western Pacific Region Vietnam nationwide   ✓ ✓ ✓ ✓ ✓ ✓  ✓ ✓  
Western Pacific Region Vietnam Hanoi   ✓  ✓ ✓ ✓   ✓  ✓ 
 




WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Africa Region Burkina Faso Ouagadougou         ✓ ✓   
Africa Region Cameroon Yaoundé         ✓ ✓ ✓  
Africa Region Cameroon nationwide          ✓ ✓  
Africa Region Gambia Basse          ✓ ✓ ✓ 
Africa Region Gambia Banjul   ✓     ✓ ✓ ✓ ✓  
Africa Region Kenya Kilifi ✓ ✓ ✓         ✓ 
Africa Region Kenya Lwak   ✓  ✓ ✓ ✓ ✓ ✓  ✓  
Africa Region Kenya Dadaab ✓ ✓ ✓   ✓     ✓ ✓ 
Africa Region Mali Bamako   ✓     ✓ ✓ ✓ ✓ ✓ 
Africa Region Mozambique Manhiça  ✓ ✓ ✓         
Africa Region Mozambique Maputo  ✓ ✓ ✓ ✓        
Africa Region Nigeria Eleta and Ijaye ✓     ✓ ✓   ✓ ✓ ✓ 
Africa Region South Africa Soweto   ✓ ✓ ✓ ✓ ✓ ✓     
Africa Region South Africa Agincourt ✓ ✓ ✓ ✓ ✓        
Africa Region South Africa Pietermaritzburg ✓ ✓ ✓ ✓     ✓ ✓ ✓  
Africa Region South Africa Klerksdorp   ✓ ✓ ✓ ✓       
Africa Region South Africa Paarl, Western Province    ✓ ✓ ✓ ✓      
Africa Region South Africa Pretoria    ✓ ✓ ✓ ✓      
Africa Region Zambia Lusaka ✓ ✓ ✓ ✓    ✓     
Eastern Mediterranean 
Region 
Egypt nationwide ✓ ✓ ✓        ✓ ✓ 
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Eastern Mediterranean 
Region 
Jordan Amman ✓ ✓ ✓          
Eastern Mediterranean 
Region 
Jordan Zarqa  ✓ ✓ ✓         
Eastern Mediterranean 
Region 
Jordan nationwide ✓ ✓ ✓          
Eastern Mediterranean 
Region 
Kwait nationwide ✓ ✓          ✓ 
Eastern Mediterranean 
Region 
Lebanon Beirut ✓ ✓          ✓ 
Eastern Mediterranean 
Region 
Morocco Rabat ✓ ✓           
Eastern Mediterranean 
Region 
Morocco nationwide ✓ ✓           
Eastern Mediterranean 
Region 
Oman nationwide ✓ ✓ ✓      ✓ ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Pakistan Karachi ✓ ✓      ✓ ✓ ✓ ✓  
Eastern Mediterranean 
Region 
Qatar Doha ✓ ✓         ✓ ✓ 
Eastern Mediterranean 
Region 
Saudi Arabia Riyadh ✓           ✓ 
Eastern Mediterranean 
Region 
Tunisia Sousse ✓ ✓ ✓          
Eastern Mediterranean 
Region 
Yemen nationwide ✓ ✓ ✓   ✓   ✓  ✓ ✓ 
European Region Aruba nationwide       ✓ ✓ ✓ ✓ ✓  
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European Region Austria Vienna ✓ ✓ ✓ ✓        ✓ 
European Region Austria Graz ✓ ✓ ✓ ✓        ✓ 
European Region Belgium Leuven ✓          ✓ ✓ 
European Region Croatia Zagreb ✓ ✓ ✓ ✓        ✓ 
European Region Cyprus Nicosia ✓ ✓           
European Region France Paris ✓          ✓ ✓ 
European Region France Montpellier ✓ ✓          ✓ 
European Region France Réunion Island ✓ ✓ ✓ ✓        ✓ 
European Region Germany Berlin ✓ ✓          ✓ 
European Region Germany Stuttgart ✓ ✓ ✓         ✓ 
European Region Germany Kiel ✓ ✓ ✓         ✓ 
European Region Germany Freiburg ✓ ✓ ✓ ✓ ✓       ✓ 
European Region Greece Athens ✓ ✓ ✓          
European Region Latvia Riga  ✓ ✓ ✓         
European Region Spain Sacyl ✓ ✓ ✓       ✓ ✓ ✓ 
European Region Spain Gran Canaria ✓          ✓ ✓ 
European Region Spain Leganés ✓          ✓ ✓ 
European Region Spain Mallorca ✓ ✓          ✓ 
European Region Sweden Gothenburg ✓ ✓ ✓         ✓ 
European Region Sweden Halmstad and Halland 
County 
 ✓ ✓          
European Region Switzerland Basel ✓ ✓          ✓ 
European Region Switzerland Bern ✓ ✓ ✓         ✓ 
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European Region Turkey Istanbul ✓   ✓ ✓  ✓   ✓ ✓ ✓ 
European Region Turkey nationwide ✓ ✓ ✓          
European Region UK Belfast ✓ ✓          ✓ 
European Region UK England ✓          ✓ ✓ 
Region of the Americas Argentina nationwide     ✓ ✓ ✓      
Region of the Americas Argentina Buenos Aires     ✓ ✓ ✓      
Region of the Americas Barbados nationwide  ✓ ✓    ✓ ✓ ✓ ✓   
Region of the Americas Belize nationwide          ✓ ✓ ✓ 
Region of the Americas Bolivia nationwide   ✓ ✓ ✓ ✓ ✓      
Region of the Americas Brazil Belo Horizonte ✓ ✓ ✓ ✓ ✓    ✓    
Region of the Americas Brazil nationwide   ✓ ✓ ✓ ✓ ✓      
Region of the Americas Brazil Fortaleza    ✓ ✓ ✓ ✓      
Region of the Americas Brazil Salvador   ✓ ✓ ✓     ✓ ✓ ✓ 
Region of the Americas Brazil Vitória  ✓ ✓ ✓         
Region of the Americas Brazil São Paulo   ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Brazil São José do Rio Preto   ✓ ✓   ✓  ✓ ✓   
Region of the Americas Brazil Uberlândia   ✓ ✓ ✓        
Region of the Americas Canada nationwide ✓ ✓ ✓         ✓ 
Region of the Americas Canada Nova Scotia ✓ ✓ ✓ ✓         
Region of the Americas Canada Edmonton ✓ ✓ ✓          
Region of the Americas Chile Concepcion      ✓ ✓ ✓     
Region of the Americas Chile Iquique    ✓ ✓ ✓       
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Region of the Americas Chile nationwide     ✓ ✓ ✓ ✓     
Region of the Americas Colombia nationwide   ✓ ✓ ✓ ✓ ✓  ✓ ✓ ✓  
Region of the Americas Colombia Bogota   ✓ ✓ ✓ ✓       
Region of the Americas Costa Rica nationwide ✓      ✓ ✓ ✓ ✓ ✓  
Region of the Americas Cuba nationwide        ✓ ✓ ✓ ✓  
Region of the Americas Dominica nationwide   ✓  ✓ ✓  ✓     
Region of the Americas Dominican Republic nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Ecuador nationwide ✓ ✓ ✓ ✓ ✓        
Region of the Americas Ecuador Quito  ✓ ✓ ✓ ✓ ✓ ✓      
Region of the Americas El Salvador Santa Ana     ✓ ✓ ✓ ✓     
Region of the Americas El Salvador nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Guatemala Santa Rosa      ✓ ✓ ✓ ✓ ✓   
Region of the Americas Guatemala Quetzaltenango ✓ ✓     ✓ ✓ ✓ ✓ ✓  
Region of the Americas Guatemala San Lorenzo and 
Comitancillo 
 ✓   ✓  ✓ ✓ ✓ ✓ ✓  
Region of the Americas Guatemala nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Honduras nationwide       ✓ ✓ ✓ ✓ ✓  
Region of the Americas Honduras Santa Lucía       ✓  ✓ ✓ ✓  
Region of the Americas Mexico San Luis Potosí ✓ ✓         ✓ ✓ 
Region of the Americas Mexico nationwide ✓ ✓ ✓       ✓ ✓  
Region of the Americas Mexico Mexico City  ✓ ✓ ✓   ✓ ✓   ✓ ✓ 
Region of the Americas Mexico Mexico City and San Luis 
Potosí 
✓        ✓ ✓ ✓ ✓ 
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Region of the Americas Nicaragua nationwide        ✓ ✓ ✓ ✓ ✓ 
Region of the Americas Panama David City, Chiriquí 
Province 
      ✓ ✓ ✓ ✓ ✓  
Region of the Americas Panama nationwide        ✓ ✓ ✓ ✓ ✓ 
Region of the Americas Paraguay nationwide    ✓ ✓ ✓ ✓ ✓     
Region of the Americas Peru Tambopata district    ✓ ✓ ✓       
Region of the Americas Peru nationwide   ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Peru San Marcos province    ✓ ✓ ✓       
Region of the Americas Puerto Rico San Juan ✓   ✓     ✓ ✓ ✓ ✓ 
Region of the Americas Suriname nationwide ✓ ✓ ✓ ✓ ✓ ✓ ✓      
Region of the Americas Trinidad and Tobago nationwide ✓ ✓ ✓ ✓ ✓    ✓ ✓   
Region of the Americas Uruguay nationwide      ✓ ✓ ✓     
Region of the Americas USA YK Delta, Alaska ✓ ✓ ✓ ✓ ✓     ✓ ✓ ✓ 
Region of the Americas USA State of Colorado ✓ ✓ ✓          
Region of the Americas USA Corpus Christi, Texas ✓ ✓          ✓ 
Region of the Americas USA Miami ✓ ✓      ✓ ✓ ✓ ✓ ✓ 
Region of the Americas USA Florida ✓ ✓ ✓       ✓ ✓ ✓ 
Region of the Americas USA North Carolina ✓ ✓         ✓ ✓ 
Region of the Americas USA Chicago and Nashville ✓ ✓ ✓        ✓ ✓ 
Region of the Americas USA Davidson and Monroe 
County 
✓ ✓ ✓          
Region of the Americas Venezuela nationwide ✓ ✓     ✓ ✓ ✓    
Southeast Asia Region Bangladesh Dhaka ✓ ✓    ✓ ✓   ✓ ✓ ✓ 
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Southeast Asia Region Bangladesh Matlab          ✓ ✓ ✓ 
Southeast Asia Region India Ballabgarh, Faridabad and 
Haryana 
✓ ✓  ✓     ✓ ✓   
Southeast Asia Region India Puducherry ✓       ✓ ✓  ✓ ✓ 
Southeast Asia Region India Kolkata ✓ ✓        ✓ ✓  
Southeast Asia Region India Pune ✓      ✓ ✓ ✓   ✓ 
Southeast Asia Region India Lucknow ✓          ✓ ✓ 
Southeast Asia Region India Delhi ✓        ✓ ✓ ✓  
Southeast Asia Region India Jaipur ✓ ✓         ✓ ✓ 
Southeast Asia Region Indonesia Lombok Island  ✓ ✓ ✓         
Southeast Asia Region Indonesia Cikutra and Ujung Berung, 
Bandung 
  ✓ ✓ ✓        
Southeast Asia Region Nepal Sarlahi         ✓ ✓ ✓  
Southeast Asia Region Nepal Kathmandu ✓       ✓ ✓ ✓   
Southeast Asia Region Thailand Tak Province          ✓ ✓  
Southeast Asia Region Thailand Nakhon Phanom and Sa 
Kaeo 
       ✓ ✓ ✓   
Southeast Asia Region Thailand Bangkok       ✓ ✓ ✓ ✓   
Southeast Asia Region Thailand Khon Kaen   ✓    ✓ ✓ ✓ ✓   
Southeast Asia Region Thailand Chonburi       ✓  ✓  ✓  
Western Pacific Region Australia New South Wales    ✓ ✓ ✓ ✓ ✓     
Western Pacific Region Australia Alice Springs   ✓ ✓ ✓ ✓ ✓ ✓ ✓    
Western Pacific Region Australia the Top End ✓ ✓ ✓ ✓ ✓        
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Western Pacific Region Australia Kimberley, Western 
Australia 
 ✓ ✓ ✓ ✓ ✓  ✓   ✓ ✓ 
Western Pacific Region Australia Pilbara, Western Australia   ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Australia Midwest-Murchison, 
Western Australia 
     ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Australia Goldfields, Western 
Australia 
     ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Australia Wheatbelt, Western 
Australia 
     ✓ ✓ ✓ ✓    
Western Pacific Region Australia Perth, Western Australia      ✓ ✓ ✓ ✓    
Western Pacific Region Australia Great Southern, Western 
Australia 
     ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Australia South West, Western 
Australia 
     ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Cambodia Kampong Cham city and 
Takeo city 
       ✓ ✓ ✓ ✓  
Western Pacific Region China nationwide ✓ ✓ ✓ ✓      ✓ ✓ ✓ 
Western Pacific Region China Beijing ✓ ✓          ✓ 
Western Pacific Region China Hong Kong   ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓   
Western Pacific Region China Shantou ✓  ✓  ✓        
Western Pacific Region China Eastern China ✓ ✓ ✓       ✓ ✓ ✓ 
Western Pacific Region China Beijing, Shanghai, 
Chongqing, Guangdong, 
Gansu and Sichuan 
✓ ✓ ✓ ✓       ✓ ✓ 
Western Pacific Region China Shenzhen ✓ ✓ ✓ ✓ ✓  ✓ ✓    ✓ 
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
Appendices 250 
WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Western Pacific Region China Jingzhou ✓        ✓ ✓ ✓ ✓ 
Western Pacific Region China Lanzhou ✓  ✓ ✓       ✓ ✓ 
Western Pacific Region China Northern Taiwan  ✓ ✓ ✓ ✓  ✓ ✓ ✓ ✓   
Western Pacific Region China Suzhou ✓ ✓ ✓         ✓ 
Western Pacific Region China Hangzhou ✓ ✓ ✓         ✓ 
Western Pacific Region China Xi’an ✓       ✓  ✓ ✓ ✓ 
Western Pacific Region China Chongqing ✓ ✓         ✓ ✓ 
Western Pacific Region China Shanghai ✓ ✓ ✓   ✓  ✓  ✓  ✓ 
Western Pacific Region China Kunming ✓ ✓     ✓ ✓ ✓ ✓  ✓ 
Western Pacific Region China Bengbu ✓           ✓ 
Western Pacific Region Japan nationwide ✓ ✓       ✓ ✓ ✓ ✓ 
Western Pacific Region Japan Tokyo ✓ ✓      ✓  ✓ ✓ ✓ 
Western Pacific Region Japan Osaka ✓      ✓    ✓ ✓ 
Western Pacific Region Japan Yamagata ✓         ✓ ✓ ✓ 
Western Pacific Region Japan Fukuoka ✓       ✓ ✓ ✓ ✓ ✓ 
Western Pacific Region Japan Yokohama ✓         ✓ ✓ ✓ 
Western Pacific Region Japan Shizuoka ✓ ✓ ✓ ✓      ✓  ✓ 
Western Pacific Region Japan Niigata City         ✓  ✓ ✓ 
Western Pacific Region Malaysia Kuala Lumpur ✓ ✓     ✓ ✓ ✓ ✓ ✓ ✓ 
Western Pacific Region Mongolia Ulaanbaatar  ✓ ✓ ✓         
Western Pacific Region New Zealand nationwide      ✓ ✓ ✓ ✓    
Western Pacific Region Philippines Bohol ✓       ✓ ✓ ✓ ✓ ✓ 
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Western Pacific Region Philippines Tacloban        ✓ ✓ ✓ ✓ ✓ 
Western Pacific Region Republic of Korea Busan          ✓ ✓ ✓ 
Western Pacific Region Republic of Korea Seoul ✓ ✓        ✓ ✓ ✓ 
Western Pacific Region Vietnam Nha Trang City       ✓ ✓ ✓ ✓   
Western Pacific Region Vietnam Ho Chi Minh City        ✓ ✓ ✓ ✓  
 
PIV 
WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Africa Region Cameroon nationwide  ✓ ✓ ✓  ✓  ✓     
Africa Region Ghana Kumasi   ✓ ✓ ✓ ✓       
Africa Region Kenya Kilifi  ✓ ✓ ✓   ✓ ✓ ✓  ✓ ✓ 
Africa Region Mali Bamako    ✓ ✓ ✓ ✓      
Africa Region Mozambique Manhiça     ✓   ✓ ✓ ✓ ✓ ✓ 
Africa Region South Africa Paarl, Western Province   ✓ ✓ ✓  ✓ ✓ ✓    
Africa Region South Africa Pretoria    ✓    ✓ ✓ ✓ ✓ ✓ 
Africa Region Zambia Lusaka ✓ ✓ ✓ ✓ ✓    ✓   ✓ 
Eastern Mediterranean 
Region 
Egypt nationwide     ✓ ✓ ✓ ✓ ✓ ✓   
Eastern Mediterranean 
Region 
Jordan Amman ✓   ✓ ✓  ✓  ✓ ✓ ✓  
Eastern Mediterranean 
Region 
Jordan nationwide ✓   ✓ ✓     ✓ ✓ ✓ 
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Eastern Mediterranean 
Region 
Morocco Rabat   ✓  ✓  ✓ ✓ ✓ ✓ ✓  
Eastern Mediterranean 
Region 
Oman nationwide ✓ ✓ ✓  ✓   ✓  ✓  ✓ 
Eastern Mediterranean 
Region 
Saudi Arabia Riyadh    ✓   ✓  ✓ ✓ ✓ ✓ 
Eastern Mediterranean 
Region 
Yemen nationwide ✓   ✓ ✓    ✓  ✓ ✓ 
European Region Belgium Leuven ✓   ✓ ✓ ✓ ✓   ✓ ✓ ✓ 
European Region France Paris ✓   ✓ ✓ ✓ ✓   ✓  ✓ 
European Region Germany Berlin ✓  ✓ ✓ ✓ ✓    ✓ ✓ ✓ 
European Region Germany Bonn ✓  ✓   ✓  ✓ ✓ ✓ ✓  
European Region Spain Gran Canaria  ✓ ✓ ✓ ✓ ✓    ✓ ✓ ✓ 
European Region Spain Catalonia    ✓ ✓ ✓ ✓ ✓   ✓  
European Region Sweden Gothenburg   ✓ ✓ ✓ ✓    ✓ ✓ ✓ 
European Region Switzerland Bern ✓  ✓ ✓ ✓ ✓    ✓ ✓ ✓ 
European Region Turkey Istanbul ✓   ✓  ✓ ✓ ✓     
European Region UK England   ✓ ✓ ✓ ✓    ✓ ✓ ✓ 
Region of the Americas Argentina nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Argentina Buenos Aires       ✓ ✓ ✓ ✓   
Region of the Americas Barbados nationwide  ✓ ✓ ✓    ✓  ✓ ✓  
Region of the Americas Bolivia nationwide     ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Brazil nationwide ✓   ✓ ✓  ✓ ✓ ✓ ✓ ✓  
Region of the Americas Brazil Ceará ✓  ✓   ✓   ✓ ✓ ✓  
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Region of the Americas Brazil São Paulo   ✓ ✓  ✓   ✓    
Region of the Americas Canada nationwide ✓  ✓ ✓ ✓ ✓ ✓    ✓ ✓ 
Region of the Americas Chile Concepcion ✓   ✓  ✓  ✓  ✓   
Region of the Americas Chile Iquique    ✓  ✓ ✓   ✓   
Region of the Americas Chile nationwide     ✓ ✓ ✓ ✓ ✓ ✓   
Region of the Americas Chile Santiago    ✓ ✓ ✓ ✓   ✓   
Region of the Americas Colombia nationwide  ✓ ✓ ✓ ✓ ✓ ✓  ✓ ✓ ✓  
Region of the Americas Costa Rica nationwide ✓  ✓  ✓ ✓ ✓ ✓  ✓   
Region of the Americas Cuba nationwide  ✓ ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Dominican Republic nationwide   ✓ ✓ ✓ ✓ ✓ ✓ ✓  ✓  
Region of the Americas Ecuador nationwide ✓ ✓   ✓ ✓   ✓ ✓ ✓ ✓ 
Region of the Americas Ecuador Quito  ✓   ✓ ✓ ✓    ✓  
Region of the Americas El Salvador nationwide  ✓  ✓ ✓ ✓ ✓ ✓ ✓ ✓   
Region of the Americas Guatemala nationwide   ✓ ✓ ✓ ✓ ✓      
Region of the Americas Honduras nationwide  ✓ ✓ ✓ ✓ ✓  ✓ ✓    
Region of the Americas Honduras Santa Lucía   ✓  ✓ ✓ ✓      
Region of the Americas Mexico nationwide ✓ ✓ ✓ ✓ ✓ ✓  ✓  ✓   
Region of the Americas Nicaragua nationwide ✓    ✓ ✓ ✓ ✓     
Region of the Americas Panama nationwide ✓  ✓ ✓ ✓ ✓ ✓ ✓     
Region of the Americas Paraguay nationwide     ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Peru nationwide ✓    ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Peru San Marcos province ✓    ✓   ✓ ✓ ✓ ✓ ✓ 
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Region of the Americas Suriname nationwide ✓ ✓ ✓       ✓  ✓ 
Region of the Americas Uruguay nationwide     ✓ ✓ ✓ ✓ ✓  ✓  
Region of the Americas USA Aurora, Colorado ✓ ✓ ✓ ✓ ✓ ✓     ✓ ✓ 
Region of the Americas USA Chicago and Nashville  ✓ ✓ ✓ ✓ ✓ ✓      
Region of the Americas USA Davidson and Monroe 
County 
 ✓ ✓ ✓ ✓   ✓ ✓    
Region of the Americas Venezuela nationwide ✓ ✓ ✓ ✓  ✓  ✓     
Southeast Asia Region India Puducherry  ✓  ✓ ✓  ✓   ✓   
Southeast Asia Region Nepal Kathmandu    ✓ ✓ ✓ ✓ ✓     
Western Pacific Region China Hong Kong ✓ ✓ ✓ ✓ ✓ ✓     ✓ ✓ 
Western Pacific Region China Shantou ✓ ✓  ✓ ✓        
Western Pacific Region China Beijing, Shanghai, 
Chongqing, Guangdong, 
Gansu and Sichuan 
 ✓ ✓ ✓ ✓ ✓ ✓ ✓     
Western Pacific Region China nationwide   ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Western Pacific Region China Shanghai    ✓ ✓  ✓ ✓ ✓    
Western Pacific Region China Shenzhen   ✓ ✓ ✓    ✓ ✓ ✓  
Western Pacific Region China Taipei   ✓ ✓ ✓ ✓ ✓ ✓ ✓   ✓ 
Western Pacific Region China Lanzhou  ✓ ✓ ✓ ✓      ✓  
Western Pacific Region China Hangzhou ✓  ✓ ✓  ✓ ✓ ✓  ✓ ✓  
Western Pacific Region China Beijing     ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Western Pacific Region China Suzhou ✓  ✓ ✓ ✓ ✓ ✓ ✓  ✓   
Western Pacific Region China Kunming  ✓ ✓ ✓     ✓  ✓ ✓ 
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Western Pacific Region China Bengbu    ✓ ✓ ✓ ✓     ✓ 
Western Pacific Region Japan nationwide     ✓ ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Japan Tokyo     ✓ ✓ ✓ ✓     
Western Pacific Region Japan Yamagata     ✓ ✓ ✓      
Western Pacific Region Malaysia Kuala Lumpur  ✓ ✓ ✓ ✓ ✓ ✓ ✓  ✓   
Western Pacific Region New Zealand nationwide      ✓ ✓ ✓ ✓ ✓   
Western Pacific Region Philippines Bohol ✓ ✓ ✓ ✓ ✓    ✓ ✓ ✓ ✓ 
Western Pacific Region Republic of Korea Seoul    ✓ ✓ ✓ ✓   ✓ ✓  
Western Pacific Region Vietnam Nha Trang City ✓ ✓ ✓ ✓ ✓ ✓ ✓     ✓ 
Western Pacific Region Vietnam Ho Chi Minh City ✓  ✓ ✓        ✓ 
 
MPV 
WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Africa Region Cameroon nationwide      ✓ ✓      
Africa Region Kenya Kilifi ✓ ✓        ✓ ✓ ✓ 
Africa Region Mali Bamako  ✓ ✓     ✓     
Africa Region Mozambique Manhiça  ✓ ✓ ✓  ✓ ✓      
Africa Region South Africa Soweto   ✓   ✓ ✓ ✓ ✓    
Africa Region South Africa Pretoria  ✓  ✓ ✓  ✓ ✓ ✓    
Africa Region Zambia Lusaka  ✓ ✓     ✓    ✓ 
Eastern Mediterranean Region Egypt nationwide ✓ ✓ ✓          
Eastern Mediterranean Region Iraq Sulaimani ✓ ✓ ✓       ✓ ✓ ✓ 
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Eastern Mediterranean Region Jordan Amman  ✓ ✓ ✓         
Eastern Mediterranean Region Jordan nationwide  ✓ ✓ ✓         
Eastern Mediterranean Region Oman nationwide  ✓ ✓ ✓ ✓     ✓   
European Region Austria Vienna ✓ ✓ ✓ ✓ ✓       ✓ 
European Region Belgium Leuven ✓ ✓ ✓ ✓        ✓ 
European Region Croatia Zagreb ✓ ✓ ✓         ✓ 
European Region France Montpellier ✓ ✓ ✓          
European Region France Paris ✓ ✓  ✓ ✓       ✓ 
European Region Germany Berlin ✓ ✓ ✓ ✓        ✓ 
European Region Sweden Gothenburg ✓ ✓ ✓         ✓ 
European Region Switzerland Basel ✓         ✓ ✓ ✓ 
European Region Switzerland Bern ✓ ✓    ✓     ✓ ✓ 
European Region Turkey nationwide ✓ ✓ ✓  ✓        
European Region Turkey Istanbul ✓  ✓ ✓  ✓     ✓ ✓ 
European Region UK England ✓ ✓ ✓ ✓        ✓ 
Region of the Americas Argentina nationwide       ✓ ✓ ✓ ✓   
Region of the Americas Brazil São Paulo     ✓ ✓  ✓ ✓ ✓ ✓  
Region of the Americas Canada nationwide ✓ ✓ ✓ ✓        ✓ 
Region of the Americas Canada Edmonton ✓ ✓ ✓ ✓ ✓        
Region of the Americas Chile nationwide       ✓ ✓ ✓ ✓   
Region of the Americas Colombia nationwide   ✓ ✓ ✓ ✓  ✓ ✓ ✓ ✓ ✓ 
Region of the Americas Cuba nationwide ✓ ✓ ✓   ✓  ✓  ✓ ✓  
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Region of the Americas Dominican Republic nationwide      ✓ ✓ ✓ ✓ ✓   
Region of the Americas Ecuador nationwide  ✓ ✓ ✓ ✓        
Region of the Americas Ecuador Quito  ✓ ✓ ✓ ✓      ✓  
Region of the Americas Guatemala nationwide      ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Honduras Santa Lucía        ✓ ✓ ✓ ✓  
Region of the Americas Mexico San Luis Potosí  ✓ ✓        ✓ ✓ 
Region of the Americas Nicaragua nationwide ✓         ✓   
Region of the Americas Panama nationwide ✓     ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Paraguay nationwide     ✓ ✓ ✓ ✓ ✓ ✓ ✓  
Region of the Americas Peru nationwide ✓ ✓       ✓ ✓ ✓ ✓ 
Region of the Americas Peru San Marcos province    ✓ ✓ ✓       
Region of the Americas Suriname nationwide   ✓  ✓  ✓ ✓   ✓ ✓ 
Region of the Americas Uruguay nationwide ✓       ✓ ✓ ✓   
Region of the Americas USA Aurora, Colorado ✓ ✓ ✓ ✓         
Region of the Americas USA New Haven, 
Connecticut 
✓  ✓ ✓         
Region of the Americas USA Davidson and 
Monroe County 
 ✓ ✓ ✓ ✓        
Region of the Americas USA Chicago and 
Nashville 
✓ ✓ ✓ ✓ ✓        
Southeast Asia Region Thailand Bangkok       ✓ ✓ ✓ ✓ ✓  
Western Pacific Region China Chongqing ✓ ✓ ✓        ✓ ✓ 
Western Pacific Region China nationwide ✓ ✓ ✓ ✓ ✓ ✓      ✓ 
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WHO Region Country Region Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Western Pacific Region China Shenzhen  ✓ ✓ ✓ ✓ ✓    ✓   
Western Pacific Region China Lanzhou ✓ ✓ ✓       ✓  ✓ 
Western Pacific Region China Wuhan ✓ ✓ ✓ ✓ ✓       ✓ 
Western Pacific Region China Changsha ✓  ✓ ✓ ✓        
Western Pacific Region China Suzhou   ✓ ✓ ✓ ✓      ✓ 
Western Pacific Region Japan nationwide  ✓ ✓ ✓ ✓ ✓       
Western Pacific Region Japan Tokyo   ✓ ✓ ✓ ✓   ✓    
Western Pacific Region Japan Osaka  ✓ ✓ ✓         
Western Pacific Region Japan Yamagata  ✓ ✓ ✓ ✓ ✓      ✓ 
Western Pacific Region Japan Fukui ✓  ✓ ✓ ✓ ✓       
Western Pacific Region Japan Kyoto   ✓ ✓ ✓  ✓  ✓    
Western Pacific Region New Zealand nationwide       ✓ ✓ ✓ ✓   
Western Pacific Region Philippines Bohol ✓ ✓      ✓ ✓ ✓ ✓  
Western Pacific Region Republic of Korea Seoul    ✓ ✓ ✓       
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A12. Subgroup analysis of duration of epidemics and site latitudes 
IFV vs RSV and within IFV subtypes 
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IFV vs PIV and RSV vs MPV 
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A13. Proportion of the annual overlap between IFV A 
and B, between IFV and RSV, and between MPV 
and RSV 
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A14. Monthly activity of influenza virus and 
respiratory syncytial virus against mean-centred 
temperature and relative humidity: observed data 
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A15. Incidence rate ratios applied to the estimate of 
RSV incidence within under 1 year old 
 
IRR=incidence rate ratio; results were compared with <5y group. 
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A16. Data availability of RSV seasonality in LMICs 
Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
AFRICA REGION (available in 9/46 countries)  
Algeria (0) — — — — — — — 
Angola (0) — — — — — — — 
Benin (0) — — — — — — — 
Botswana (0) — — — — — — — 
Burkina Faso (1) Ouedraogo, 2014 Ouagadougou children monthly 2010.7 2011.6 No 
Burundi (0) — — — — — — — 
Cabo Verde (0) — — — — — — — 
Cameroon (2) Kenmoe, 2016 Yaoundé <16y monthly 2011.9 2013.9 No 
Njouom, 2012 nationwide all monthly 2009.1 2009.12 No 
Central African 
Republic (0) 
— — — — — — — 
Chad (0) — — — — — — — 
Comoros (0) — — — — — — — 
Congo, Dem. Rep. (0) — — — — — — — 
Congo, Rep. (0) — — — — — — — 
Côte d'Ivoire (0) — — — — — — — 
Equatorial Guinea (0) — — — — — — — 
Eritrea (0) — — — — — — — 
Ethiopia (0) — — — — — — — 
Gabon (0) — — — — — — — 
Gambia (2) van der Sande, 2004 Banjul <3y monthly 1993.10 2002.9 Yes 
RSV GEN Basse 28d-<5y monthly 2011.11 2013.10 No 
Ghana (0) — — — — — — — 
Guinea (0) — — — — — — — 
Guinea-Bissau (0) — — — — — — — 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Kenya (3) RSV GEN Kilifi <5y monthly 2002.1 2010.12 Yes 
RSV GEN Lwak <5y monthly 2007.1 2010.12 No 
Nyoka, 2017 Dadaab all monthly 2007.9 2011.8 Yes 
Lesotho (0) — — — — — — — 
Liberia (0) — — — — — — — 
Madagascar (0) — — — — — — — 
Malawi (0) — — — — — — — 
Mali (1) RSV GEN Bamako 28d-<5y monthly 2012.1 2013.12 No 
Mauritania (0) — — — — — — — 
Mauritius (0) — — — — — — — 
Mozambique (2) Loscertales, 2002 Manhiça children monthly 1999.2 2000.1 No 
Pale, 2017 Maputo <3y monthly 2015.1 2015.12 No 
Namibia (0) — — — — — — — 
Niger (0) — — — — — — — 
Nigeria (1) Robertson, 2004 Eleta & Ijaye <5y monthly 1999.6 2001.5 No 
Rwanda (0) — — — — — — — 
São Tomé and 
Principe (0) 
— — — — — — — 
Senegal (0) — — — — — — — 
Sierra Leone (0) — — — — — — — 
South Africa (6) Venter, 2011 Pretoria <5y monthly 2006.1 2007.12 No 
RSV GEN Soweto 28d-<5y monthly 2011.9 2013.8 No 
RSV GEN Agincourt <5y monthly 2010.1 2014.12 Yes 
RSV GEN Pietermaritzburg <5y monthly 2010.1 2014.12 Yes 
RSV GEN Klerksdorp <5y monthly 2011.1 2014.12 Yes 
RSV GEN Paarl 2y-<5y monthly 2012.1 2014.7 No 
South Sudan (0) — — — — — — — 
Swaziland (0) — — — — — — — 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Tanzania (0) — — — — — — — 
Togo (0) — — — — — — — 
Uganda (0) — — — — — — — 
Zambia (1) RSV GEN Lusaka 28d-<5y monthly 2011.11 2013.10 No 
Zimbabwe (0) — — — — — — — 
REGION OF THE AMERICAS (available in 18/24 countries)  
Belize (1) PAHO nationwide all weekly 2016.1 2017.12 No 
Bolivia (1) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Brazil (8) Alonso, 2012 Fortaleza 1m-16y weekly 2001.1 2008.12 No 
Bouzas, 2016 Salvador 6-23m monthly 2009.9 2013.8 No 
Checon, 2002 Vitória <5y monthly 1997.7 1998.6 No 
Pecchini, 2015 São Paulo <5y monthly 2005.3 2007.2 No 
Salomao Junior, 
2011 
São José do Rio 
Preto 
<7y monthly 2004.5 2005.4 No 
Costa [22], 2006 Uberlândia <5y monthly 2001.1 2004.12 No 
PAHO nationwide all  weekly 2016.1 2016.12 No 
RSV GEN Belo Horizonte <5y monthly 2011.1 2013.12 No 
Colombia (2) Rodriguez-Martinez, 
2015 
Bogota <3y monthly 2009.6 2011.5 No 
PAHO nationwide all weekly 2010.1 2017.12 Yes 
Costa Rica (1) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Cuba (1) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Dominica (1) PAHO nationwide all weekly 2015.1 2017.12 No 
Dominican Republic 
(1) 
PAHO nationwide all weekly 2010.1 2017.12 Yes 
Ecuador (2) Jonnalagadda, 2017 Quito 2-59m monthly 2008.2 2010.1 No 
PAHO nationwide all weekly 2012.1 2017.12 Yes 
El Salvador (2) PAHO nationwide all weekly 2010.1 2017.12 Yes 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
RSV GEN Santa Ana <5y monthly 2008.1 2012.12 No 
Grenada (0) — — — — — — — 
Guatemala (4) PAHO nationwide all weekly 2010.1 2017.12 Yes 
RSV GEN Santa Rosa <5y monthly 2008.1 2013.12 Yes 
RSV GEN Quetzaltenango <5y monthly 2010.1 2013.12 Yes 
RSV GEN San Lorenzo and 
Comitancillo 
<2y monthly 2013.1 2014.12 No 
Guyana (0) — — — — — — — 
Haiti (0) — — — — — — — 
Honduras (2) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Schlaudecker, 2012 Santa Lucía <5y monthly 2010.2 2011.1 No 
Jamaica (0) — — — — — — — 
Mexico (4) Yusuf, 2007 Mexico City all monthly 2001.1 2002.12 No 
Gamino-Arroyo, 
2017 
Mexico City and 
San Luis Potosí 
all monthly 2010.5 2014.4 Yes 
PAHO nationwide all weekly 2010.1 2017.12 Yes 
RSV GEN San Luis Potosí <5y monthly 2004.1 2014.12 Yes 
Nicaragua (1) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Paraguay (1) PAHO nationwide all weekly 2010.1 2017.12 Yes 
Peru (3) Budge, 2014 San Marcos <3y weekly 2009.10 2011.9 No 
PAHO nationwide all weekly 2010.1 2017.12 Yes 
RSV GEN Tambopata >5y monthly 2013.1 2013.12 No 
St. Lucia (0) — — — — — — — 
St. Vincent and the 
Grenadines (0) 
— — — — — — — 
Suriname (1) PAHO nationwide all weekly 2013.1 2017.12 No 
Venezuela, RB (1) PAHO nationwide all weekly 2010.1 2017.12 No 
EASTERN MEDITERRANEAN REGION (available in 7/16 countries)  
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Afghanistan (0) — — — — — — — 
Djibouti (0) — — — — — — — 
Egypt, Arab Rep. (1) Horton, 2017 nationwide all daily 2008.1 2013.12 Yes 
Iran, Islamic Rep. (0) — — — — — — — 
Iraq (0) — — — — — — — 
Jordan (3) Bdour Zarqa <2y monthly 1997.6 1999.5 No 
Horton, 2017 nationwide all daily 2008.1 2013.12 Yes 
RSV GEN Amman <2y monthly 2010.4 2013.3 Yes 
Lebanon (1) Finianos, 2016 Beirut <17y monthly 2013.10 2014.9 No 
Libya (0) — — — — — — — 
Morocco (2) RSV GEN Rabat <5y monthly 2011.1 2011.12 No 
Bimouhen, 2016 nationwide all monthly 2015.5 2016.4 No 
Pakistan (1) Asad, 2017 Karachi <5y monthly 2009.8 2012.7 No 
Sudan (0) — — — — — — — 
Syrian Arab Republic 
(0) 
— — — — — — — 
Tunisia (1) Fodha, 2004 Sousse <35d monthly 2000.6 2002.5 No 
West Bank and Gaza 
(0) 
— — — — — — — 
Yemen, Rep. (1) Horton, 2017 nationwide all daily 2008.1 2013.12 No 
EUROPEAN REGION (available in 1/20 countries)  
Albania (0) — — — — — — — 
Armenia (0) — — — — — — — 
Azerbaijan (0) — — — — — — — 
Belarus (0) — — — — — — — 
Bosnia and 
Herzegovina (0) 
— — — — — — — 
Bulgaria (0) — — — — — — — 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Georgia (0) — — — — — — — 
Kazakhstan (0) — — — — — — — 
Kyrgyz Republic (0) — — — — — — — 
Macedonia, FYR (0) — — — — — — — 
Moldova (0) — — — — — — — 
Montenegro (0) — — — — — — — 
Romania (0) — — — — — — — 
Russian Federation 
(0) 
— — — — — — — 
Serbia (0) — — — — — — — 
Tajikistan (0) — — — — — — — 
Turkey (2) Goktas, 2016 Istanbul all monthly 2014.9 2015.8 No 
Kanra, 2005 nationwide <2y monthly 2000 2002 No 
Turkmenistan (0) — — — — — — — 
Ukraine (0) — — — — — — — 
Uzbekistan (0) — — — — — — — 
SOUTHEAST ASIA REGION (available in 5/11 countries)  
Bangladesh (2) RSV GEN Dhaka <5y monthly 2005.1 2007.12 Yes 
RSV GEN Matlab 28d-<5y monthly 2012.1 2013.12 No 
Bhutan (0) — — — — — — — 
India (7) RSV GEN Ballabgarh, 
Faridabad & 
Haryana 
<5y monthly 2010.1 2012.12 No 
RSV GEN Puducherry all monthly 2011.11 2014.10 No 
Agrawal, 2009 Kolkata <6y monthly 2007.1 2008.12 No 
Choudhary, 2013 Pune all monthly 2009.9 2011.8 No 
Jain, 2014 Lucknow all monthly 2011.5 2013.4 No 
Bharaj, 2009 Delhi <6y monthly 2005.4 2007.3 No 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Swamy, 2017 Jaipur <5y monthly 2013.1 2014.12 No 
Indonesia (2) RSV GEN Lombok <2y monthly 2000.1 2002.12 Yes 
Robertson, 2014 Bandung <5y monthly 1999.2 2001.1 No 
Korea, Dem. People's 
Rep. (0) 
— — — — — — — 
Maldives (0) — — — — — — — 
Myanmar (0) — — — — — — — 
Nepal (2) Chu, 2016 Sarlahi <6y monthly 2011.9 2013.8 No 
Mathisen, 2011 Kathmandu <3y monthly 2006.1 2007.12 No 
Sri Lanka (0) — — — — — — — 
Thailand (5) RSV GEN Tak Province <2y monthly 2007.11 2010.10 No 
RSV GEN Nakhon Phanom 
and Sa Kaeo 
<5y monthly 2008.1 2011.12 Yes 
RSV GEN Bangkok all monthly 2011.1 2017.12 Yes 
RSV GEN Khon Kaen all monthly 2011.1 2015.12 No 
RSV GEN Chonburi all monthly 2013.2 2014.1 No 
Timor-Leste (0) — — — — — — — 
WESTERN PACIFIC REGION (available in 6/19 countries)  
American Samoa (0) — — — — — — — 
Cambodia (1) RSV GEN Kampong Cham 
& Takeo 
<5y monthly 2007.4 2009.3 No 
China (17) Cui, 2015 Shantou <17y monthly 2010.12 2011.11 No 
Cui, 2016 Eastern China all monthly 2009.1 2013.12 Yes 




<5y monthly 2009.1 2012.12 No 
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Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Gansu and 
Sichuan 
He, 2014 Shenzhen >18y monthly 2007.7 2010.6 No 
Huo, 2013 Jingzhou <5y monthly 2011.1 2011.12 No 
Jin, 2012 Lanzhou <15y monthly 2006.12 2009.11 No 
Lee, 2007 Northern Taiwan <196m weekly 2001.1 2005.12 No 
Lu, 2015 Suzhou <=28d monthly 2010.1 2014.12 Yes 
Tang, 2008 Hangzhou <14y monthly 2001.1 2006.12 No 
Zhang, 2016 Xi'an all monthly 2009.1 2014.12 No 
Zhang, 2010 Chongqing <18y monthly 2006.4 2009.3 Yes 
Zhao, 2013 Shanghai <5y monthly 2009.10 2012.9 No 
Wu, 2012 Kunming <15y monthly 2015.11 2017.10 No 
Yin, 2017 Bengbu <15y monthly 2015.7 2016.6 No 
Dept. Health, Hong 
Kong 
Hong Kong all weekly 2014.1 2017.12  
RSV GEN nationwide <5y monthly 2009.9 2013.8 Yes 
RSV GEN Beijing 2m-<5y monthly 2011.1 2012.12 No 
Fiji (0) — — — — — — — 
Kiribati (0) — — — — — — — 
Lao PDR (0) — — — — — — — 
Malaysia (1) Khor, 2012 Kuala Lumpur <6y monthly 1982.1 2008.12 No 
Marshall Islands (0) — — — — — — — 
Micronesia, Fed. Sts. 
(0) 
— — — — — — — 
Mongolia (1) RSV GEN Ulaanbaatar 1m-<2y monthly 2015.6 2016.5 No 
Nauru (0) — — — — — — — 
Papua New Guinea 
(0) 
— — — — — —  
Global seasonality of respiratory viruses and the association between viral acute respiratory infection and subsequent pneumococcal 
disease 
Appendices 272 
Country (n of  sites) Data source Site name Age of subjects Unit of data Available from Available to Multi-year 
Philippines (2) RSV GEN Bohol 28d-<2y monthly 2000.7 2004.6 Yes 
RSV GEN Tacloban <5y monthly 2008.5 2012.7 No 
Samoa (0) — — — — — — — 
Solomon Islands (0) — — — — — — — 
Tonga (0) — — — — — — — 
Tuvalu (0) — — — — — — — 
Vanuatu (0) — — — — — — — 
Vietnam (2) RSV GEN Nha Trang City <5y monthly 2008.1 2012.12 No 
Do, 2016 Ho Chi Minh City 1m-<2y monthly 2009.5 2010.4 No 
 
A17. Comparisons of duration of RSV epidemics between temperate and tropical 
regions in LMICs 
Region Clear seasonality Year-round activity 
<4m 4m 5m 6m >6m 
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A18. Estimated of the coverage of mAb and mV 
 
mAb=(long-acting) monoclonal antibody; mV=maternal vaccine 
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A19. Country-specific comparisons among different mAb immunisation approaches in 
preventing RSV-ALRI, considering year-to-year variations 
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A20. Country-specific comparisons among different mAb immunisation approaches in 
preventing RSV-severe-ALRI, considering year-to-year variations 
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A21. Country-specific comparisons among different mV immunisation approaches in 
preventing RSV-ALRI, considering year-to-year variations 
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A22. Country-specific comparisons among different mV immunisation approaches in 
preventing RSV-severe-ALRI, considering year-to-year variations 
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A23. List of ICD-10 codes used 
 ICD-10 codes Content 
Influenza virus 
infection 
J09 Influenza due to certain 
identified influenza virus 
J10 Influenza due to other identified 
influenza virus 




J12.1 Respiratory syncytial virus 
pneumonia 
J20.5 Acute bronchitis due to 
respiratory syncytial virus 
J21.0 Acute bronchiolitis due to 
respiratory syncytial virus 
Pneumococcal 
pneumonia 
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A24. Number of IPD and viral infection cases included 
by year 
Year IPD IFV RSV PIV MPV 
2009 538 6022 2327 1006 310 
2010 525 1430 1987 446 456 
2011 499 1941 2785 839 493 
2012 482 1422 3077 985 646 
2013 576 2442 2270 1375 928 
2014 439 1837 3102 1111 924 
2015 653 4127 2892 1750 1101 
2016 712 5028 3798 1566 899 
2017 706 7539 2900 1861 975 
IPD=invasive pneumococcal disease; IFV=influenza virus; RSV=respiratory 
syncytial virus; PIV=parainfluenza virus; MPV=metapneumovirus 
A25. Percentage of IPD attributable to ICD-coded IFV 
and RSV hospitalisations by age group 
Age Group Lag* (wk) 






















An arrow (↑ up or ↓ down) indicates a significant difference in the attributable 
percentage, compared with corresponding estimate in the main analysis. 
*Time lag between viral infection and subsequent IPD; IPD=invasive 
pneumococcal disease; wk=week; IFV=influenza virus; RSV=respiratory 
syncytial virus; y=year(s) 
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A26. Percentage of PP attributable to each virus by 
age group 
Age Group Lag* (wk) 
Attributable Percentage of PP 
IFV RSV PIV MPV 


























An arrow (↑ up or ↓ down) indicates a significant difference in the attributable 
percentage, compared with corresponding estimate in the main analysis. 
*Time lag between viral infection and subsequent PP; PP=pneumococcal 
pneumonia; wk=week; IFV=influenza virus; RSV=respiratory syncytial virus; 
PIV=parainfluenza virus; MPV=metapneumovirus; y=year(s) 
A27. Percentage of PP attributable to ICD-coded IFV 
and RSV hospitalisations by age group 
Age Group Lag* (wk) 
Attributable Percentage of IPD 
IFV RSV 










All ages 1 0↓ 0↓ 
An arrow (↑ up or ↓ down) indicates a significant difference in the attributable 
percentage, compared with corresponding estimate in the main analysis. 
*Time lag between viral infection and subsequent PP; PP=pneumococcal 
pneumonia; wk=week; IFV=influenza virus; RSV=respiratory syncytial virus; 
y=year(s) 
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